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NMR INSIGHTS INTO DC-SIGN RECOGNITION OF FUCOSYLATED ANTIGENS 
This dissertation is focused on the study of the human protein DC-SIGN, a key 
lectin involved in the development of diverse pathologies, paying attention to 
the conformational, dynamics and energy aspects that modulate its 
interaction with carbohydrate ligands. In particular, the present work has 
exhaustively analyzed recognition events involving ligands that contain the 
natural monosaccharide L-fucose.  
The interest in studying this protein has extensively grown since the beginning 
of this century. DC-SIGN is a membrane receptor within the C-type lectin 
family that is directly involved in diverse infectious processes, being HIV one 
of the most relevant examples described at first. Moreover, it has been also 
demonstrated its implication in several other pathologic processes involving 
many different organisms, namely viruses (Ebola), bacteria (M. tuberculosis), 
fungi (C. albicans) and parasites (S. mansoni). DC-SIGN recognizes those 
oligosaccharides that coat the external membrane or envelope of the cited 
pathogens. The range of oligosaccharides that can be recognized by this lectin 
is fairly wide, although most of them always contain the monosaccharides D-
mannose (Man) and L-fucose (Fuc), which directly interact at the primary 
binding site. The recognition of D-mannose had been widely investigated at a 
molecular level, especially by using X-Ray crystallography. Thus, this work has 
concerned the interaction with Fuc-containing antigens, essentially at 
describing the recognition of the histo blood group antigens A and B from a 
molecular point of view. These ligands display similar scaffolds with two 
terminal sugars, one common (L-fucose), and other that is different in each 
case: D-galactose (Gal, B antigen) or N-acetyl-D-galactosamine (GalNAc, A 
antigen). Considering the complexity of the system, the project has been 
undertaken by using Nuclear Magnetic Resonance (NMR) experiments, which 
have provided essential data both from the receptor´s perspective and from 
the ligand´s one. 
From the gathered information, a suitable and detailed model of interaction 
between DC-SIGN and both antigens has been proposed, which enables 
explaining their slightly enhanced affinities in comparison with that of a single 
Fuc moiety. Moreover, the results reasonably fit with those previously 
reported data from solid phase arrays and have highlighted relevant aspects 
on the recognition these antigens when compared to the Lewis-type related 
ones. In particular, it has been reported that the stability of the LewisX/DC-




SIGN complex is contributed by the interaction of the terminal D-galactose at 
a secondary site, as well as a stable hydrophobic contact formed between the 
N-acetyl group of the central sugar (N-acetyl-D-glucosamine) and a close 
protein residue (Val351). It has been found herein that the terminal D-
galactose in the B antigen actually plays the opposite role. Namely, it 
establishes favorable aliphatic contacts with the nearby Val351, whereas no 
significant interactions are observed at the secondary site. These features also 
explain why Lewis-type antigens are usually slightly better binders of DC-SIGN 
that the blood group determinants.  
Finally, the crucial role played by the protein scaffold and the extended 
structure of the studied glycan have been scrutinized as well. Langerin, a 
homologue receptor of DC-SIGN, shows a drastically different interaction 
mode with the blood group antigen B than that demonstrated herein for DC-
SIGN. Indeed, the terminal Gal residue points towards the secondary site 
rather than establishing aliphatic contacts as in DC-SIGN. Additional 
differences have also been found out between the A and B antigens in terms 
of dynamics. Specifically, our NMR studies have revealed that the B antigen, 
but not the A, can be targeted by DC-SIGN through its terminal Gal moiety. On 
one hand, this finding evidences the low specificity already known for this 
type of receptors and proves the underlying complexity in developing 
selective inhibitors for this particular lectin. On the other hand, it points out 
how subtle structural differences are at the heart of the found different 
affinities and dynamic behavior of the ligands, hence encouraging the search 
for a global perspective to jointly understand all these factors and efficiently 
apply them for drug design.  
As already mentioned, DC-SIGN selectivity is rather broad, a common feature 
shared by the lectins within the same family. However, this wide selectivity 
usually overlaps with that of other lectins, but does not exactly match. For DC-
SIGN, understanding such a selectivity have aided at determining the mode in 
which this lectin is able to recognize the B antigen through the terminal Gal. 
Specifically, 19F-NMR data have allowed to evaluating the required geometric 
features for the efficient recognition of a given monosaccharide. Concerning L-
Fuc, three fluorinated analogues (at C2, C3 and C4, respectively), have been 
evaluated, assessing that this monosaccharide is exclusively recognized 
through its hydroxyls groups at C3 and C4, but not through OH2 and OH3 as 
reported for other related lectins (e.g. langerin and MBP). Moreover, one of 
the used fluorofucoses (3F-Fuc) is not commercial and has been de novo 
synthesized as a part of the thesis project.  
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Finally, additional recognition studies have been performed for other two 
representative Lewis-type oligosaccharides found in the glycoproteins from 
the parasite S. Mansoni. In particular, the LDNF antigen presents an structure 
very similar to that of the “Lewis X” antigen, except for the presence of 
GalNAc at its end rather than Gal. Instead, the other antigen, the LDN-DF, 
essentially contains the LDNF trisaccharide along with an additional L-Fuc 
residue.  
Our NMR-based methodology, in combination with computational tools, has 
provided key data to propose the 3D recognition models for both molecules. 
Interestingly, the recognition of LDNF takes place through a binding pose that 
is remarkably similar to that described for the “Lewis X” antigen. In contrast, 
in spite of including two L-Fuc residues in its structure, LDN-DF displays a very 
poor affinity for DC-SIGN, which is related to the particular 3D arrangement of 
the sugars forming its structure: the interaction with L-Fuc places the 
surrounding sugar residues away from the binding site so that their positive 
contribution to the binding disappear. Once more, these results highlight how 
the available 3D-models provide essential information for explaining and 
predicting the recognition features of a given oligosaccharide by a biological 












































RESONANCIA MAGNÉTICA NUCLEAR APLICADA AL ESTUDIO 
SOBRE EL RECONOCIMIENTO MOLECULAR DE LIGANDOS CON 
FUCOSA MEDIADO POR EL RECEPTOR DC-SIGN                                      
La presente tesis doctoral se dirige al estudio de la proteína humana DC-SIGN 
desde una perspectiva estructural, atendiendo a aquellos aspectos que, a nivel 
molecular, determinan su interacción con sus ligandos de tipo carbohidrato 
(conformación, interacciones intermoleculares (vdW)…). En concreto, el 
trabajo aquí expuesto se ha enfocado en el análisis de los procesos de 
reconocimiento en los que participan ligandos que contienen el monosacárido 
natural L-fucosa en su estructura.  
El interés por estudiar dicha proteína se ha acrecentado desde comienzos de 
este siglo, cuando DC-SIGN fue definitivamente identificada como un receptor 
de membrana de la familia de las C-type lectins y, más importante, se 
demostró su implicación directa en los procesos de infección por VIH. A partir 
de aquí, sucesivos trabajos permitieron subrayar la importancia de este 
receptor en otros procesos infecciosos que incluían patógenos de todo tipo, 
ya fueran virus (Ébola), bacterias (M. tuberculosis), hongos (C. albicans) o 
parásitos (S. mansoni). Desde un punto de vista estructural, es bien sabido que 
DC-SIGN reconoce e interacciona con oligosacáridos presentes en la superficie 
externa de estos agentes patógenos. El abanico de oligosacáridos que esta 
proteína es capaz de reconocer es bastante amplio, aunque es bien sabido que 
todos ellos contienen fundamentalmente los monosacáridos D-manosa y L-
fucosa, con los que interacciona directamente. La interacción con D-manosa 
ha sido ampliamente estudiada a nivel molecular, especialmente mediante 
cristalografía de rayos X, lo cual ha permitido disponer de varios modelos que 
describen con un alto grado de detalle cómo ocurre el reconocimiento de este 
azúcar y cómo influyen tanto la estructura de la proteína como la del propio 
oligosacárido en dicho reconocimiento. En cambio, aunque la interacción de 
DC-SIGN con L-fucosa ha sido estudiada en paralelo, mucha de la información 
existente referente al reconocimiento de oligosacáridos fucosilados no está 
completamente justificada desde un punto de vista estructural, lo que ha 
dificultado en muchos casos la búsqueda de patrones estructurales que 
permitan entender bien cómo tiene lugar el reconocimiento.  
Por este motivo, la tesis se ha centrado fundamentalmente en describir desde 
un punto de vista molecular el reconocimiento de los determinantes 
antigénicos de la sangre A y B, cuyas estructuras son similares y contienen 




dos azúcares terminales, uno común, que es la L-fucosa, y uno que los 
diferencia, que es la D-galactosa para el antígeno B y la N-acetil-D-
galactosamina para el A. Existe una limitada cantidad de información acerca 
de cómo tiene lugar el reconocimiento de los antígenos de tipo Lewis, 
diferentes en cuanto a composición y organización de los enlaces entre 
residuos. Sin embargo, no hay ningún trabajo precedente que haya descrito el 
reconocimiento molecular de los antígenos que en esta tesis se han estudiado. 
A través de la información recopilada por medio de experimentos de 
Resonancia Magnética Nuclear (RMN), se han conseguido modelos 3D de la 
interacción entre DC-SIGN y ambos antígenos, que han permitido explicar por 
qué estas estructuras poseen una afinidad ligeramente superior a la exhibida 
por la L-Fuc, y concuerdan con los datos previamente publicados mediante 
ensayos en fase sólida. Además, los modelos propuestos han permitido 
subrayar aspectos relevantes acerca del reconocimiento de antígenos de este 
tipo y compararlos con los antígenos de tipo Lewis. Así, para el antígeno 
“Lewis X” hay una doble contribución a la estabilidad, que viene tanto de la D-
Gal terminal que interacciona en el sitio secundario como de la GlcNAc 
central, que forma una interacción hidrofóbica estable con un residuo cercano 
de la proteína (Val351) a través de su grupo acetilo. En cambio, se ha podido 
demostrar que el rol de estabilizar dicha interacción alifática es asumido por la 
D-Gal terminal en el caso de los ligandos aquí estudiados, mientras que la 
importancia de las interacciones en el sitio secundario es menor. Además, se 
han encontrado diferencias entre los propios antígenos A y B en cuanto al 
reconocimiento desde un punto de vista dinámico. Los estudios de RMN han 
revelado que el determinante B, pero no el A, puede unirse a DC-SIGN a través 
de la D-Gal terminal, lo cual pone de manifiesto por un lado la baja 
especificidad de este receptor y, por ende, aumenta la dificultad de 
desarrollar inhibidores exclusivos para esta lectina. Por otro lado, este trabajo 
señala lo sutiles que pueden ser las variaciones estructurales que hacen que 
las afinidades y el comportamiento de ligandos similares sean diferentes y lo 
esencial que resulta entender el conjunto de factores que gobiernan estos 
cambios para explotarlos en beneficio del desarrollo de fármacos. 
Adicionalmente, la selectividad de DC-SIGN se ha estudiado usando técnicas 
de 19F-RMN con las que se han descifrado los requerimientos estructurales 
necesarios para que un azúcar simple sea reconocido por DC-SIGN. En el caso 
de la L-Fuc, se emplearon tres análogos fluorados (En C2, C3, y C4, 
respectivamente). Sorprendentemente, se encontró que este monosacárido 
solo puede ser reconocido a través de sus grupos hidroxilo en C3 y C4, pero no 
xv 
 
a través de C2 y C3 como se ha observado en otras lectinas (ej. langerina y 
MBP). Además, como parte de la tesis y en colaboración con la Universidad de 
Southampton, se ha desarrollado un proceso de síntesis completamente 
nuevo para obtener la L-Fuc fluorada en C3, la única de las tres Fuc fluoradas 
cuya síntesis no se había descrito. 
Finalmente, el trabajo principal de la tesis se ha expandido al estudio de dos 
antígenos de tipo Lewis representativos que se encuentran formando parte 
de las glicoproteínas del parásito S. mansoni a lo largo de sus diferentes 
estadios de desarrollo (LDNF y LDN-DF). De forma análoga, las técnicas de 
RMN se han aplicado a la descripción de esta interacción con ayuda de 
técnicas computacionales. Curiosamente, el reconocimiento del LDNF tiene 
lugar de forma similar al del antígeno “Lewis X”. En cambio, el LDN-DF, a pesar 
de poseer dos residuos de Fuc en su estructura, posee una afinidad 
notablemente baja debido a cómo estos residuos están ordenados en la 
estructura 3D, lo que hace que la contribución de los azúcares vecinos sea 
despreciable y la estabilización positiva desaparezca. Estos resultados 
destacan, una vez más, la importancia de disponer de modelos 
tridimensionales fidedignos para evaluar y predecir los factores geométricos 
que determinan si la estructura de un oligosacárido es adecuada para su 

































































1.1. The immune response 
Our body is a complex system of specialized cells organized in different tissues 
and organs. All of them, together with nervous and circulatory systems, work 
in coordination to ensure the individual surveillance, establishing a correct 
balance that is termed homeostasis. However, there is an endless battle 
between our cells and a plethora of foreign organisms that continuously 
threaten such a crucial balance. Those organisms, which include viruses, 
bacteria, parasites and fungi, are commonly named as pathogens, and the 
group of specific cells, tissues and organs in charge of attacking and 
eliminating these threads form what we jointly know as the immune system. 
Apart, disruption of normal homeostasis does not have to be necessarily 
triggered by external entities; sometimes the alterations come also from 
injured or damaged tissues (trauma), or from malfunctioning cells (tumoral 
cells), and the immune system takes actions to control these as well [1]. 
The immune cells are collectively called leucocytes, and are divided into 
several subsets of cells primarily distinguished by their roles. Actions to 
eradicate pathogens or restore normal tissue operation can be carried out 
directly by leucocytes, and this clearance process is referred to as cell-
mediated immunity. In addition, certain specialized leucocytes (B cells) 
produce soluble molecules (antibodies), which directly act as effectors 
without cell intervention, and this process is called humoral immunity [2].  
Commonly, the immune responses are classified in two main types that 
essentially differ from each other in two basic aspects: the mechanism to 
detect the thread and the speed of the response [2-3]: 
 The innate immune response is immediately triggered within minutes or 
hours after loss of the correct homeostatic state. The cell types included 
in this group are dendritic cells (DCs), macrophages, mast cells, 
granulocytes (neutrophils, basophils and eosinophils) and natural killer 
cells (NK cells). These cells are often present in large amounts and are 
spread out over most of peripheral tissues, thus activating quick 
mechanisms to attack, repair, and/or recruit other cells for managing 
infections. Besides, the innate immune system includes pre-existing 
physiological barriers (skin, gastric acids, secreted enzymes) that hamper 
pathogen entry, and other enzymes present in the blood which are part 
of the complement system (proteases, antimicrobial peptides). Once 
activated, these enzymes are aimed at breaking down bacterial 
membranes.  





At the molecular level, the innate response is initiated by recognition 
processes involving the patrolling cells and certain molecular components 
that become accessible in the extracellular milieu, either released or 
exhibited by damaged/dead host cells (damage-associated molecular 
patterns, DAMPs), or presented in the surface of the invading organisms 
(pathogen-associated molecular patterns, PAMPs). In both cases, the 
recognition is mediated by pattern recognition receptors (PRRs), fixed to 
the plasma membrane or free as soluble receptors in the extracellular 
environment. To note, DAMPs and PAMPs are usually common molecular 
signatures shared by many types of host cells and pathogens, and PRRs 
are therefore adapted to recognize these multiple patterns, conferring to 
innate immune cells the property of broad recognition. This feature also 
enables a faster detection of potential dangers. 
 
 The adaptive immune response is driven by cells named lymphocytes, 
which are subdivided in B lymphocytes and T lymphocytes. This response 
takes much longer to become effective, often few days, in part because 
lymphocytes are present in low numbers and located at lymphoid tissues, 
where they need to be firstly stimulated by other leukocytes. Once 
activated, these cells must proliferate to eventually promote protective 
effects, and consequently, the overall response is delayed. However, 
adaptive responses are crucial because they give rise to immunological 
memory, a key aspect of the immune response that strengthen our 
defenses in case of a repeated exposure to the same thread and allow us 
to face the evolving mechanisms of harmful pathogens to evade or block 
the immune responses. In this regard, lymphocytes make use of 
processes like somatic recombination to produce almost unlimited 
amounts of different antigen receptors that are highly specific. Thus, 
each antigen receptor is designed to exclusively recognize one molecular 
component present in a specific pathogen (antigen), in contrast to PRRs. 
Those lymphocytes bearing the suitable receptors to target an invading 
pathogen are selected and develop into short-lived effector cells and 
long-lived memory cells. The first wave of effector cells initiate a primary 
immune response, whereas the memory cells will help the organism to 
trigger a secondary immune response: a faster and stronger wave of 





Figure 1.1. Schematic evolution of an infection process over time. When the density of 
foreign microorganisms overpasses a certain threshold level, the innate response is 
initiated (within the first 24 hours after the pathogen entry). The adaptive response 
starts much later (about 72-96 hours later), and the effector cells are in charge of 
completely neutralizing the thread (black profile). Once finished, a percentage of 
memory cells are maintained, triggering a faster global immune response after a 
subsequent re-infection. 
Although this classification method is robust and allows to distinguishing 
leucocytes according to their roles, it is important to highlight that the 
immune cascade is not strictly sequential: every immune response always 
encompasses the two mechanisms working at once, the innate and the 
adaptive, and this interplay has a beneficial synergic effect in the host defense 
(Figure 1.2). When a pathogen surpasses the physical barriers and the 
homeostasis is endangered, complement activation can take place to contain 
the infection. Simultaneously, macrophages, DCs and granulocytes are 
continuously sampling the local microenvironments in search of PAMPs by 
means of their PRRs. In case of infection, some cells of the innate immune 
system, like granulocytes, directly fight the menace through phagocytosis. In 
parallel, other cells like DCs are engaged in recognizing and taking up the 
entire pathogen or pathogen debris to the lymph nodes, where they stimulate 
the response mediated by lymphocytes [4]. While some lymphocytes are 
developing into memory cells, others are recruited to the sites of 
inflammation and act as effector cells, helping to kill microbes, or alternatively 
activating signaling pathways to stimulate new lymphocytes and cells from the 
innate immune system.  
In this “dialogue” between cells from innate and adaptive systems, cytokines 
play a crucial role in establishing intercellular cross-talk. They constitute a 
wide family of peptides that leukocytes use to send information about the 




state of the tissues and the presence of external pathogens. Particularly, 
chemokines are a subset of relevant cytokines that immune cells employ to 
promote migration of other cells to the sites of actuation. Dendritic cells and 
macrophages, as well as CD4 T cells, are actually considered as the key 
mediators between the innate and the adaptive response (Figure 1.2), since 
these subtypes are specialized in cell-cell communication and regulatory 
functions in immunity [5]. 
 
Figure 1.2. Common leukocytes of the immune system and their responses against an 
ongoing infection. The arrows with the blue labels represent some different cytokines 
secreted as a result of the interaction with a pathogen or activation via another 




1.1.1. Cells of the immune system 
All cells from the immune system share a common origin. Stem cells are the 
earliest blood cells, which will subsequently differentiate into different 
precursors (myeloid and lymphoid) to ultimately originate various subtypes of 
leucocytes, as well as other blood cells (erythrocytes, platelets). Myeloid 
precursors will develop into most of the blood cells and innate leucocytes 
(Figure 1.3). The later ones will distribute throughout the entire organism 
through the blood circulation and the lymphatic system. In contrast, lymphoid 
precursors will give rise to B and T lymphocytes at the primary lymphoid 
tissues (bone marrow and thymus, respectively (Figure 1.3)). Dendritic cells 
(DCs) are a particular case since some subsets derive from myeloid precursors 
and other from lymphoid ones [1][6-7]. Specific details about DCs will be 
addressed to a larger extent in the next section.  
 
Figure 1.3. Origin of the leukocytes. To note, most of the DCs come from myeloid 
precursors, although a certain DC lineage has been evidenced to have a lymphoid 
precursor (not represented).  
The main innate leucocytes, apart from dendritic cells, are macrophages, mast 
cells, neuthrophils, basophils, eosinophils, and natural killer cells (NK cells) 
[5,8] (Figure 1.2): 
 Macrophages reside in all tissues and are relatively long-lived. They are 
capable of removing harmful microorganisms by phagocytosis. 




Additionally, they release cytokines and chemokines to promote local 
inflammation and cell recruitment. 
 Neutrophils are the most abundant leucocytes in the bloodstream, with a 
quite short life (up to 5 days). As macrophages, neutrophils exhibit a 
great capacity to eat and destroy entire pathogens by phagocytosis, using 
preexisting toxic components stored in specialized granules. Also, they 
can undertake the formation of neutrophil extracellular traps (NETs).  
 Mast cells are fixed to mucosal and connective tissues, where they act as 
sentinels, detecting tissue injuries or pathogens. They are aimed at 
triggering inflammation through the release of cytokines and histamine, 
especially in response to pathological and allergic processes. 
 Eosinophils are involved in analogous inflammatory responses to 
allergies, but in contrast to mast cells, they can be recruited to the 
affected areas. They may also perform particular immune processes to 
fight parasitic infections. 
 Basophils often support eosinophil-mediated activities and contribute to 
increase the inflammatory stress. 
 NK cells display a remarkable cytotoxic character, turned on when they 
detect via their PRRs unusual amounts of specialized molecules in the 
surface of infected host cells or tumoral cells, thus coercing them to 
suicide and neutralizing the thread. This mechanism is singularly fast and 
subsequent inflammation is not always needed.  
As mentioned above, lymphocytes are subdivided in two subtypes: B cells and 
T cells. 
 B lymphocytes circulate in the blood and lymph in an immature or resting 
state. Through their B cell receptors (BCRs), they detect in a very specific 
fashion intact antigens either as soluble molecules or attached to 
pathogens, T cells or other antigen-presenting cells such as DCs. Once 
activated, they generate a progeny of plasma cells that produce and 
release soluble antibodies, intended for targeting and marking pathogens 
for clearance (humoral response). 
 T lymphocytes lack the ability to recognize native antigens. Instead, their 
specialized T cell receptors (TCRs) are adapted to target a specific 
complex existing at the surface of dendritic cells and macrophages, called 
peptide-MHC complex. The peptide fragment belongs to a pathogen 
previously internalized and processed by the innate leucocyte. The MHC 
counterpart can be of two types: the MHC class I is recognized by 




involved in such recognition process. As a result of the interaction, these 
lymphocytes induce cell apoptosis, similar to B cells. The MHC class II is 
recognized by helper T cells, analogously named CD4 T cells, in which the 
CD4 molecule works as the co-receptor. These immune cells differentiate 
under the influence of different cytokines to accomplish regulatory 
functions for innate and adaptive responses. As examples, Th1 cells 
stimulate the cytotoxic activity mediated by CD8 T cells and B cells, 
whereas Th2 and Th17 lymphocytes recruit and maintain eosinophils and 
neutrophils, respectively. Treg cells are essential lymphocytes specialized 
in suppressing the responses of other immune cells, contributing to 
maintain tolerance to self-antigens. 
1.2. Dendritic cells and DC-SIGN: the biological 
context 
DC-SIGN (Dendritic Cell-Specific ICAM-3-Grabbing Non-integrin) is one of the 
multiple pathogen recognition receptors (PRRs) that dendritic cells possess to 
recognize both foreign and self-antigens and to take the suitable actions to 
mediate intercellular communication and/or directly confront the danger. 
Amongst PRRs, DC-SIGN has awaken a particular interest for many scientists in 
diverse research areas due to its direct or indirect implication in a broad range 
of pathologies related to the immune system, including all kind of infections 
(virus, bacteria, fungi, parasites), autoimmune diseases and cancer. To 
uncover its role in so many different events, it is essential to firstly understand 
the biological and immunological context in which this receptor works, to 
finally address the quest for therapeutics from a structural point of view.  
1.2.1. Dendritic cells 
Dendritic cells, as well as macrophages, are usually referred to as antigen 
presenting cells (APCs) [9], given their efficient ability to process antigens 
taken from pathogens and present them to B and T lymphocytes. This route is 
crucial for the resultant adaptive response, since the specificity of individual T 
and B receptors is so high that an encounter with their specific antigens is 
rather unlikely. Dendritic cells can migrate to the lymph nodes and display 
notable amounts of MHC-peptide complexes, thus making possible the 
activation of hundreds to thousands of lymphocytes per single DC, all at once 
[10-11]. 
After their initial differentiation from stem cells, all dendritic cells remain in an 
immature stage (imDCs) and two “classical” types are clearly differentiated 




[6,12]: the interstitial or dermal DCs, which stay inside the skin dermis, and 
Langerhans cells (LCs), which finish their migration at the epidermis [13]. Both 
subtypes are involved in T cell activation, whereas B cell stimulation is 
exclusively supported by interstitial DCs [14]. Other subsets of DCs have been 
also described and studied:  
 Follicular dendritic cells (FDCs) do not develop at the bone marrow 
and are involved in B cell proliferation along with interstitial DCs [15].  
 Plasmacytoid dendritic cells (pDCs). Their roles remain still unclear, 
but they are thought to be involved in anti-viral defense through 
cytokine secretion [7].  
 
Figure 1.4. DC response to an interaction with an external pathogen initiated by 
surface PRRs. 
Under their “guard” role, immature dendritic cells exhibit a great potential to 
detect and sample all kind of antigens by means of their PRRs, which chiefly 
include C-type lectin-like receptors (CLR) and TOLL-like receptors (TLR). After 
targeting a specific molecular pattern, the immature DC internalizes the 
antigen/pathogen and its maturation is then started [16-18] (Figure 1.4): the 
cell upregulates the production of co-stimulatory molecules and cytokines and 
drastically loss its ability to capture antigens by reducing the expression of 
PRRs [19-20]. Simultaneously, the DC activates the corresponding cellular 
machinery to process the pathogen components and assemble the resulting 




migrate to the nearby lymph nodes [23] to present the peptide-loaded MHC 
complex at their surfaces for T cell inspection, and eventually die.  
Finally, it is worth noting the role of certain DCs within the context of 
immunological tolerance. To avoid lymphocytes recognizing self-antigens and 
attacking the host cells, the immune system rely on two strategies to ensure 
tolerance against self-antigens [24]. Some DCs in the medulla contribute to 
delete maturing self-reactive T cells (central tolerance) [25]. Lymphoid DCs are 
long-lived cells that may make use of the previously mentioned routes to 
present self-antigens attached to MHC molecules and silence those T cell 
populations that react to self-motifs (peripheral tolerance) [26]. 
1.2.2. C-type lectins and DC-SIGN in immunity 
The functional differentiation between DC subsets is underlined by the 
presence of many different pathogen recognition receptors. Some of these 
PRRs are fairly specific for certain infectious agents, namely TOLL-like, NOD-
like and RIG-like receptors [27-29]. However, other molecular sensors like C-
type lectins are typical examples of receptors with a broad pattern of 
recognition [30]. Indeed, specificities between lectins usually overlap with 
each other [31-32] (Figure 1.5). Then, DC specialization depends on their PRR 
palette, the type of response that each lectin triggers according to the antigen 
that is recognizing, and the interplay between different PRRs operating at 
once [33]: 
o Different lectin distribution: for instance, the macrophage mannose 
receptor (MMR) is highly expressed on macrophages [34-35]. DC-SIGN 
and the macrophage galactose-type lectin (MGL) are extensively 
expressed on interstitial DCs, although DC-SIGN is present in DCs from 
lymph nodes and mucosae as well [36], while MGL is preferentially found 
in those DCs maintaining immunological tolerance [37]. Finally, Langerin 
production is limited to Langerhans cells [38]. 
o Type of response: some receptors can lead DCs to stimulate inflammatory 
responses. For example, Dectin-1 initiates inflammatory processes after 
binding to β-glucans [39], DC-SIGN after targeting Lewis antigens on H. 
pylori lipopolysaccharides [40], and TOLL-like receptors are key 
promoters of many inflammatory pathways against different foreign 
organisms [41]. Conversely, other C-type lectins participate in regulatory 
processes aimed at maintaining immunological tolerance and establishing 
cellular cross-talk. As examples, MGL is involved in T cell apoptosis 
through recognition of terminal α–GalNAc residues [42], the dendritic cell 




immunoreceptor (DCIR) acts as mediator for neutrophil repression [43], 
and again, DC-SIGN is a crucial anchor for rolling of immature DCs as well 
as for DC-T cell synapse formation, interactions respectively established 
with fucose-containing ICAM-2 and ICAM-3 glycoproteins [44-45].  
o Simultaneous triggering of several PRRs: it is common that certain 
responses are orchestrated by the joint action of C-type lectins and TOLL-
like receptors. Namely, Dectin-1 can conduct the production of cytokines 
in synergy with TLR-2 [46]. Also, some responses initiated by DC-SIGN 
combine with downstream TLR signaling to upregulate cytokine 
production [47]. 
 
Figure 1.5. Ligand-binding assays performed for six typical monosaccharides 
conjugated to BSA, using 10 common lectins (all human except for SIGNR1) as 
receptors. As noted, all of them can simultaneously recognize D-mannose (Man) and L-
fucose (Fuc), and some of them, like BDCA-2 or MCL, have a broader selectivity, 
remarkably recognizing at least four hexoses. Adapted from [32]. 
Taken together, the combination of all these factors will decide the ultimate 
outcome of an immune response. To note, PRRs are not mere receptors, but 
the antigen recognition also leads to signal transfer to the cytoplasm via 
different signaling pathways [48-49]. These cascades strongly depend on the 
specific recognized antigen and, also important, its three-dimensional 
presentation. For most of C-type lectins, these antigenic structures are 
complex oligosaccharides. DC-SIGN is not an exception [50], and its binding 
preferences will be extensively addressed in the next section from a structural 
point of view. Briefly, DC-SIGN essentially interacts with glycans containing D-
mannose (Man) and L-fucose (Fuc) [51]. Notably, the DC-SIGN-mediated 
cytoplasmic signaling will be different depending on which sugar is recognized, 




 Recognition of Man, for example in surface glycans from C. albicans 
[54] and HIV [55], helps DC-SIGN to modulate a pro-inflammatory 
cytokine programme through RAF1 activation. DC-SIGN cannot 
directly trigger the release of cytokines, but it modulates the 
participation of other receptors like TLR2 and TLR4 [56]. 
 Recognition of Fuc may have a dual role in immunity: on the one 
hand, DC-SIGN interaction with Fuc-containing PAMPs, like those 
from S. mansoni [57], leads to the activation of the Fuc signalosome, 
dissimilar to RAF1, which eventually promotes a long-term humoral 
immunity against the pathogen [58]. On the other hand, DC-SIGN is 
thought to be involved in sustaining immune tolerance through 
recognition of self-glycoproteins with antigens bearing Fuc, such as 
Lewis and blood group antigens. Alike, DC-SIGN take part in cell-cell 
communication, for instance through interaction with LeY antigens of 
ICAM-2 (DC adhesion and rolling) [59] and the macrophage receptor 
1, Mac-1 (DC-neutrophil clustering) [60]. 
 
Figure 1.6. DC functions mediated by glycan recognition through the DC-SIGN 
receptor. A) DC maturation and secretion of pro-inflammatory cytokines after 
recognizing pathogenic Man-containing antigens. B) DC adhesion and rolling based on 
recognition of LeY motifs. C) DC-T cell crosstalk established by interaction with the LeX 
antigen. 
1.2.3. When the immune system fails: DC-SIGN as Trojan 
horse for disease development 
As DC-SIGN, some C-type lectin receptors lack the ability to autonomously 
trigger inflammation, whereas other CLRs are “self-sufficient” for that task. 
The abilities of the different PRRs to recognize invading organisms through 
carbohydrate-mediated interactions have been thoroughly studied over the 
A) B) C) 




last decades [61]. In most of cases, these receptors predominantly take up 
beneficial pro-inflammatory responses that aid the surrounding tissues to 
repair damages or oppose to an infection. Thus, Dectin-1 and Dectin-2 are 
essential to repel fungal infections by C. albicans [62] and Aspergillus spp. 
[63], respectively, while MGL increases macrophage activation to kill parasites 
like T. cruzi. [64]. The macrophage C-type lectin (MCL) triggers protective 
mechanisms against M. tuberculosis [65], and Mincle does it against S. 
pneumoniae [66] and K. pneumoniae [67]. Langerin interacts with HIV and has 
been found to efficiently promote viral clearance at Birbeck granules, avoiding 
T cell infection [68]. Also, MCL and Dectin-2 have been described to help in 
clearance of tumor cells [69]. 
But unfortunately, the immune system is not infallible at all: the same 
mechanisms may otherwise contribute to worsen the pathological state [70-
71]. The quick evolutionary skills of many pathogens bring about 
overwhelming situations which the immune system cannot cope with. Thus, 
some pathogens may be able to subvert the effector pathways to ensure its 
entry and dissemination, chiefly by taking advantage of lectin recognition and 
attachment [72-73]. In this context, DC-SIGN is actually a paradigmatic case, 
as this receptor is greatly used by numerous pathogens for their own benefit 
[74]. Broadly speaking, many microorganisms gain access to adaptive T helper 
cells by using DC-SIGN as a vehicle to modulate DC activity [75-76], thereby 
easing disease persistence: 
 DC-SIGN-mediated human immunodeficiency virus (HIV) transmission 
was the first reported case of an infection in which a C-type lectin played 
a crucial role [77]. Once internalized, the viral particles may survive for 
prolonged periods by biasing the endocytic routes of the dendritic cell 
[78] and/or increasing DC-SIGN expression to boost the attachment of 
more viral particles to the membrane, until final T cell targeting [79-80]. 
Simultaneous TLR8 and DC-SIGN targeting facilitates the infection of DCs 
themselves as well [81]. In all cases, the virus-host union is established 
through recognition of the viral glycoprotein gp120 (Figure 1.7A).  
 The ability of dengue virus (DENV) to hold on to the cell membrane is 
entirely ascribed to DC-SIGN interacting with the viral E-envelope 
glycoprotein [82-83]. Indeed, the carbohydrate-lectin interface has been 
already described by using cryoEM [84]. However, a marked controversy 
currently surrounds the exact role of DC-SIGN in this viral infection. DC-
SIGN has been newly suggested to mediate viral entry as well as 




receptors [85]. In contrast, previous works postulated that DC-SIGN is 
dispensable for viral entry [86-87]. 
 
Figure 1.7. Typical carbohydrate antigens from pathogens that are recognized by DC-
SIGN. A) Viral high-mannose N-glycan (VIH). B) Fungal complex N-mannan (C. 
Albicans). C) Bacterial Man-capped LAM (M. Tuberculosis). D) Representative Fuc-
containing glycoprotein from S. mansoni´s SEAs. 
 Infections in DCs driven by Ebola virus (EBOV) have been reported to 
involve both DC-SIGN and its close homologue, L-SIGN [88]. Both lectins 
interact with mannosylated glycoproteins on the viral envelope (GP), 
triggering similar evasion pathways to reach T cells as those exerted by 
HIV [89]. Otherwise, DC-SIGN merely acts as a crucial anchor for the 
pathogen, but do not guide viral internalization. In this regard, other 
research lines have been focused on identifying such entry routes [90-
92]. 
 Regarding other viral-related pathologies, binding of human 
cytomegalovirus (hCMV) [93-94] and hepatitis C virus [95-96] to DC-SIGN 
was already documented the past decade, and more recently, this C-type 
A) B) 
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receptor has been postulated to play analogous roles in several other 
diseases, like those originated by Japanese encephalitis virus [97], Rift 
valley fever virus [98], Kaposi´s sarcoma associated herpesvirus (KSHV) 
[99], measles virus [100] and phlebovirus [101]. Interestingly, DC-SIGN 
and L-SIGN may take part in flu episodes caused by influenza A virus 
(IAV), but as co-receptors for viral entry [102] rather than attachment 
proteins (this first step is mediated by binding of the influenza 
hemagglutinin to sialic acid moieties).  
 Moving to bacterial infections, DC-SIGN has been certainly linked to the 
deadly propagation routes of Mycobacterium tuberculosis in host cells 
[103-104]. This disease is one of the most significant worldwide health 
risks and has encouraged many researchers to focus on DC-SIGN as a 
therapeutic target. As opposed to HIV, M. tuberculosis, via Man-capped 
lipoarabinomannan (ManLAM, Figure 1.7C), binds to DC-SIGN to only 
suppress DC maturation signaling [105], precluding effector mechanisms 
in the surrounding environment such as autophagy or apoptosis [106], 
and consequently escaping from the adaptive response and ensuring its 
own surveillance [107-108]. In the study of Porphyromonas gingivalis, a 
similar subversive route involving DC-SIGN-TLR2 cross-talk has been 
identified as well [109].  
 Fungal infections, especially those involving Candida species, have also 
attracted attention on DC-SIGN [54]. Notably, many C-type lectins 
actually contribute to recognize the PAMPs on the cell wall [110-111], 
although DC-SIGN and MMR seem to be the main mediators in DCs. 
Specifically, DC-SIGN bind to complex highly-mannosylated N-glycans on 
yeast´s cell surface [112] (Figure 1.7B). The same glycans are exploited by 
Saccharomyces [113] and Paraccidioides species [114] to target DCs via 
this protein receptor. 
 Finally, DC-SIGN has proven to be relevant in the persistence of parasitic 
infestations, being those caused by S. mansoni [115] and L. pifanoi [116] 
the most explored ones. In fact, the former case is an illustrative example 
of DC-SIGN targeting driven by Fuc-containing antigens, essentially Lewis-
type structures on the soluble egg antigen (SEA) of S. mansoni (Figure 
1.7D). By contrast, the carbohydrate antigens in Leishmania amastigotes 
remain unclear yet [117]. 
In the same line, tumor cells also spread out and suppress immune responses 
by means of sugar-mediated interactions, originating cancer. MGL contributes 
to this cause through interaction with tumor-related glycoforms of MUC1 




group antigens from tumor-derived CEACAM-1 glycoprotein [120]. In other 
cases, the regulatory mechanisms fail and the inflammatory response is not 
well controlled, thereby exerting harmful effects on the nearby regions [121]. 
In absence of any infection, this malfunctioning gives rise to autoimmune 
diseases. The direct implication of C-type lectins in these disorders has been 
guessed: MBL expression has been considered as a risk factor in diabetic 
complications [122], while DCIR2 expression may be relevant in multiple 
sclerosis [123]. DC-SIGN, as well as MMR, have been linked to exacerbated 
allergic responses triggered by allergens in peanut and pollen [124-125]. 
1.3. C-type lectins and DC-SIGN: structural insights 
Historically, the term “C-type lectin” was coined to refer to all these proteins 
which interact with carbohydrates in a calcium-dependent manner, through a 
compact globular structure called “carbohydrate recognition domain” (CRD) 
[126]. Since the late eighties, this family has steadily grown and currently 
includes more than 1000 protein receptors classified into seventeen 
subgroups (Figure 1.8). However, the term “lectin” would not be strictly 
correct to designate this family, since that “CRD” have been found to be a 
well-conserved structural scaffold shared by many other receptors that, in 
some cases, do not bind to carbohydrates or even to calcium [127-128]. 
Instead, the term “C-type lectin-like domain” (CTLD) is less ambiguous and is 
often used to include all subgroups *129+. Even so, the term “C-type lectin” is 
still used in a wide scope, including members that recognize other substrates 
like proteins or lipids, whereas the term “CRD” is obviously reserved for only 
referencing lectin domains with carbohydrate-binding ability.  
From a structural perspective, all C-type lectin-like domains share a series of 
common structural elements that are highly conserved among different 
species [130-131]. 
The CTLD fold consists of a central core essentially constituted by five β-
strands flanked by two α-helices that lie in perpendicular to each other (Figure 
1.9). The first and last β-strands (β1 and β5) form an antiparallel β-sheet on the 
bottom part of the structure, where both the N- and the C-terminus are 
located. The three remaining β-strands (β2, β3 and β4) are assembled into a β-
sheet that constitutes a quite shallow plateau rather exposed to the external 
environment. Finally, canonical CTLDs also exhibit a characteristic and long 
loop region comprising about 30 amino acids, that extends from the end of β2, 
going around the area limited by the three-stranded β-sheet and the α2-helix. 




In carbohydrate-binding C-type lectins, this loop takes part in glycan 
recognition. 
Apart, the β2-strand typically possesses a highly conserved “WIGL” motif that 
is often used as a landmark for sequence analysis [132-134]. There are also 
four conserved cysteine residues that establish two disulfide bridges between 
α1-β5 and β3-β4, respectively (Figure 1.9).  
 
Figure 1.8. Cartoon representation of the seventeen subgroups that constitute the C-
type lectin superfamily (Adapted from [130] and [61]). Calx-B: calcium binding domain. 
CSPG: chondroitin sulphate proteoglycan. CUB: complement C1r/C1s, UEGF, BMP1. 
EGF: epidermal growth factor. FcRγ: Fc receptor γ-chain. GAG: glycosaminoglycan. 
GPS: G protein-coupled receptor proteolytic site. LDL: low-density lipoprotein. PKD: 
polycystic kidney disease. PSI: plexin–semaphorin–integrin. REJ: receptor for egg jelly. 
SCP: sperm coating glycoprotein. SP-D: surfactant protein D. vWF: von Willebrand 







Figure 1.9. A) On the left, the DC-SIGN CRD (PDB: 1SL5) displaying the characteristic 
structural signatures like the WIGL motif (black ribbon) and the four cysteines (C1-C4) 
that form disulfide bridges. On the right, the typical secondary elements that 
constitute the CTLD fold. B) Comparison between the CRDs of three representative 
lectins from subgroup II which show different occupied calcium sites (ions represented 
as green spheres). PDBs (from left): 1DV8, 2MSB and 3WH2. 
Regarding the calcium ions, at least four Ca2+-binding sites have been 
observed so far, although not all of them are necessarily occupied [135-136]. 
Certainly, crystallographic structures have shown lectins with one, two, three 
or even no calcium ions. All calcium atoms, if present, play roles in folding 
stability and structural integrity, but only Ca2+ ion at site 2 is directly involved 
in carbohydrate binding [31,137]. Sites 1 and 3 contribute to improve the 
stability of the long loop region [138-140], as observed for DC-SIGN [141]. 
Calcium at site 4, as reported for the asialoglycoprotein receptor I (ASGR-I) 
[142], establishes salt bridges between the interface of the β3-β4 sheet and the 
neighboring α2-helix.  
B) 
A) 




Calcium at site 2 is particularly important due to its biological relevance in 
lectin-like activity. In fact, conformational changes derived from the presence 
or absence of Ca2+ sometimes have biological significance [143]. Thus, C-type 
lectins like tetranectin, which does not even bind to carbohydrates, undergo 
structural rearrangements in the long loop region after losing Ca2+ at site 2, 
enabling the binding to plasminogen [144]. Similarly, pH-induced 
destabilization of the loop regions, followed by calcium loss, leads those 
carbohydrate-binding C-type lectins acting as endocytic receptors to release 
the cargo once internalized [145-146].   
Structurally, binding of Ca2+ at site 2 is sustained by three consecutive residues 
of the long loop, including a central proline in a cis conformation, other three 
residues on the nearby β4-strand, which form the so-called “WND” motif, and 
an additional residue located close to the beginning of the loop [143]. The cis-
proline and the tryptophan from the WND motif do not participate in calcium 
binding, but are highly conserved among all CTLDs and therefore considered 
[132]. The other cited residues establish coordination bonds with the Ca2+ 
through their carbonyl groups. The 7- or 8-coordinated sphere is completed 
with water molecules in the unbound form [147], and with two hydroxyl 
groups from a single monosaccharide in the sugar-protein complex. 
Interestingly, earliest observations already pointed out that the sugar 
specificity depends on the specific residues flanking the cis-proline [148]: 
 The C-type lectins displaying the EPN motif are known as mannose-
binding proteins, as they often manifest a marked binding preference for 
sugars with equatorial hydroxyl groups at positions C3 and C4, mainly D-
Man and D-glucose (Glc). This group includes C-type lectins like DC-SIGN, 
Langerin [149] and LSECtin [150]. 
 The C-type lectins containing the QPD motif are commonly named 
galactose-binding proteins. These receptors better bind to sugars with an 
axial hydroxyl group at C4, like D-galactose (Gal). The macrophage Gal-
specific lectin (MGL) [151-152] is the most representative member of this 
group, which also includes the asialoglycoprotein receptor (ASGR) [153] 
and the scavenger receptor C-type lectin (SRCL) [154-155]. 
Overall, the binding site region is constituted by the portion of the long loop 
surrounding the Ca2+ at site 2 and the adjacent area occupied by the three-
stranded β-sheet.  As mentioned above, the interaction with the sugar is 
essentially established by coordination of two adjacent hydroxyls groups to 




exposed in most of cases, this means that such an interaction could be easily 
disrupted in an aqueous environment and perfectly explains the low intrinsic 
affinities often found in sugar-binding C-type lectins (Figure 1.10).  
 DC-SIGNa DC-SIGNRa Langerinb MBP-Ac MBP-Cc 
Man 13.1 2.6 2.3 - - 
Gal 72 20 16.1 212 114 
Glc 23 7.3 7.0 - - 
Fuc 6.7 4.1 2.6 2.9* 8.8* 
α-OMe-Man 12.5 3.4 1.7 8.0 5.7 
α-OMe-Gal 270 112 >200 - - 
α-OMe-Glc 32 9.1 - - - 
ManNAc 8.7 1.3 5.6 - - 
GlcNAc 32 4.7 2.8 12.7* 14.4* 
 
Figure 1.10. Dissociation constants (in mM) determined for several monosaccharides 
by means of competitive assays, using five lectins including DC-SIGN. a) Ref. [156]. b) 
Ref. [149]. c) Ref. [157]. *) Data only available for the Methyl-α-glycosides. 
Secondly, the sugar-lectin complex is stabilized by an additional network of 
hydrogen bonds primarily involving the same coordinated OH groups and the 
surrounding polar sidechains [158-160]. However, this mode of interaction, 
especially in receptors such as DC-SIGN, is geometrically rather “malleable” as 
long as the positioning of hydrogen donors and acceptors does not originate 
steric clashes or electrostatic repulsions. In fact, for Man-binding proteins 
(MBPs), the interaction has been proved to take place in two orientations: the 
conventional mode and an alternative mode where the pyranose ring of the 
sugar is rotated 180º [157,161]. Even the EPN/QPD division neither satisfies 
the classification criteria, as for instance, several Man-binding receptors (like 
selectins or Langerin) are known to recognize Fuc as well [162-163], in which 
OH4 display an axial configuration. Hence, it may occur that several different 
sugars fulfill the geometrical requirements to target the binding site, giving 
rise to another characteristic feature of C-type lectins: broad ligand specificity 
(Figure 1.10). 
Moreover, it becomes clear that binding specificity cannot be limited to 
monosaccharide recognition, as C-type lectins are normally exposed to 
complex oligosaccharides in the biological milieu. Aside from direct polar 
contacts, van der Waals interactions arising from the surrounding 
monosaccharides also contribute to favor or preclude sugar attachment [164-
165], depending on the particular three-dimensional geometry and the 
existing differences in the exposed amino acids for each lectin.  




Finally, the poor affinities agree with the observation that CTLDs usually 
oligomerize into multimeric ensembles (dimers [166-167], trimers [168-169] 
or tetramers [170-171]), thereby increasing their ability to target glycans by 
means of more complex multivalent interactions. The important features 
underlying these interactions will be subsequently detailed for DC-SIGN.  
1.3.1. The structure of DC-SIGN  
DC-SIGN belongs to the group II of C-type lectins, one of the largest and most 
heterogeneous groups (Figure 1.11). All proteins inside this classification are 
transmembrane receptors with a common structural organization: a short 
cytoplasmic tail, a transmembrane domain and an extracellular domain [130]. 
The latter one consists of the carbohydrate recognition domain (CRD), and a 
stalk or neck region that is involved in protein oligomerization and anchors the 
CRD to the membrane (Figure 1.12). The length of this neck is widely variable 
among different members.  
In particular, the extracellular domain (ECD) of DC-SIGN (CRD + neck) is 
tetrameric. The neck region comprises 176 amino acids grouped into seven 
highly conserved 23-residue repeats, and an additional truncated 15-residue 
repeat at the N-terminus [172]. CRD and neck are structurally independent 
from each other, in contrast to other lectins like collectins, with a more 
packed architecture [173-174]. In fact, DC-SIGN tetramerization is also CRD-
independent and crystallographic models have suggested that the CRD is 
flexibly linked to the neck, thus enabling local CRD motions and increasing the 
ability of DC-SIGN ECD to target complex branched oligosaccharides in a 
multivalent fashion [175].  
 





Figure 1.12. Schematic representation of the oligomeric ensemble that DC-SIGN 
adopts at the cell membrane. The top box displays the globular structure of the CRDs. 
The bottom box shows a cross view of the four neck domains associated through 
hydrophobic contacts from the stalk core (highlighted in grey) and salt bridges 
between external Glu and Lys sidechains (indicated with arrows). Adapted from [177]. 
The short cytoplasmic domain consists of an YXXФ motif [178]. 
Each 23-amino acid repeat forms an α-helix and the four necks tightly pack 
between them constituting a robust bundle primarily stabilized by 
hydrophobic interactions arising from the hydrophobic residues buried into 
the stalk core. Otherwise, the existence of the tetrameric ensemble requires 
at least the presence of six amino-acid repeats (78% of the neck sequence). 
Removal of more repeats leads to equilibrium between tetramers and dimers, 
and with two repeats or less the tetramer is no longer stable and only dimers 
and monomers are detectable [179]. Subsequent studies revealed that the 
ECD stability might not exclusively depend on the hydrophobic core, as the 
ECD undergoes a deep loss of its secondary structure under acidic conditions. 
Low pH values not only preclude ligand binding at the CRD, but also promote 
the loss of the helical structure of the neck, eventually causing the tetramer 
destabilization. Then, salt bridges between exposed Glu and Lys residues have 
been postulated to maintain the bundle assembly, and hence Glu re-
protonation at acidic pHs would explain the loss of stability [177]. However, 




this explanation is still controversial, as the tetramer remains totally stable at 
high ionic strengths.  
Through diffusion and sedimentation coefficients, in combination with 
modeling, several models have been proposed for the ECD architecture 
(Figure 1.13). Apart from the parallel packing of all the α-helices, a different Y-
shaped structure has been proposed, with the last two repeats associated in 
antiparallel hairpins. The parallel distribution allows CRD flapping between 
closed and open forms, although SAXS analyses have shown that DC-SIGN 
might tend to maintain a more packed, closed CRD distribution. 
 
Figure 1.13. The three tridimensional models of the DC-SIGN ECD that better fulfill the 
experimental data from sedimentation and diffusion studies. Adapted from [177,179]. 
On the left, a TEM image of the ECD used in this work (See Chapter 4.1). 
 
At the cell membrane, DC-SIGN tetramers freely diffuse throughout the cell 
surface and randomly cluster forming heterogeneous nanosized domains with 
different protein densities [180].  The formation of these nanodomains is 
driven by intermolecular interactions between the four-helix stalks. This 
nanoclustering could be aimed at maximizing the docking of DC-SIGN to big 
pathogens on larger scales [181].  
1.4. DC-SIGN and carbohydrate recognition 
DC-SIGN is the paradigmatic case of receptor binding promiscuity. Its broad 
specificity has been described for years. Akin to other C-type lectins, DC-SIGN 
specifically recognizes a plethora of simple monosaccharides with affinities in 
the mM range (Figure 1.10). D-Man is the best binder among D-sugars (Ki ≈ 13 
mM), as expected from a lectin with the EPN sequence motif. In addition, the 
axial stereochemistry of the OH2 group seems to favor binding in N-acetyl 
derivatives, whereas the equatorial disposition is nearly irrelevant, as seen in 
Glc and derivatives (Ki ≈ 20-30 mM). On the contrary, the interaction with L-
Fuc (OH2 is equatorial) is slightly better than D-Man (Ki ≈ 7 mM). Gal binding is 
extremely weak (20-fold worse than Man) and this sugar was actually 




As mentioned in the previous section, reaching a global understanding about 
DC-SIGN specificities towards complex oligosaccharides must not be limited to 
the simple sugar-mediated Ca2+ binding, but a thorough analysis of many 
other factors should be carried out, namely: 
 Three-dimensional geometry of oligosaccharides: large glycans exhibit a 
great flexibility, and hence, a broad conformational space [182-183]. The 
frequencies of the different conformers may influence the accessibility of 
certain residues to the binding site, either due to possible steric clashes 
arising from nearby branches or to thermodynamic aspects like 
desolvation or loss of flexibility (enthalpy/entropy balance) [184-187].  
 Multivalence mechanisms: on the one hand, large branched glycans 
typically contain several monosaccharides that can be independently 
recognized at the binding site. This gives rise to the so-called “statistical 
rebinding” effect, such that all possible modes of interaction 
synergistically improve the global binding constant [188-189]. On the 
other hand, complex oligosaccharides, if large enough, are able to 
simultaneously target several near CRDs originating “chelating or 
clustering effects” [190-192], which raise the affinity as well (Figure 1.14). 
 
Figure 1.14. Representative multivalence mechanisms involving complex glycans with 
multiple epitopes.  
 Secondary interactions on the protein surface: the suitable binding to the 
primary site is strongly influenced by the position of the interacting 
monosaccharide in the oligomeric structure. Namely, the glycosidic 
linkages define the spatial arrangement of the immediately linked sugars, 
determining which sugars could correctly accommodate at the binding 
site [162,193] (Figure 1.15).  





Figure 1.15. Two examples of carbohydrate-lectin recognition events in which the 
primary sugar-lectin interaction (hexose circled in purple) is assisted by favorable 
secondary contacts arising from the surrounding sugar moieties (circled in green) or 
even from remote ligand groups that target other distal protein pockets (highlighted in 
yellow). On the left, E-selectin interacting with a peptidic chain containing the sialyl-
LeX epitope (PDB: 1G1S). On the right, mincle recognizing a glycolipid bearing a 
trehalose disaccharide (PDB: 4KZV). Adapted from [31]. 
In particular, DC-SIGN has a fairly flat, solvent-exposed area around the 
calcium ion. This plateau is essentially composed of acidic amino acids (Asp, 
Glu) and several other non-charged or basic residues (Ser, Asn, Gln, Lys). 
Flanking this area, three protruding hydrophobic residues can be found: 
Val351 at the long loop, quite near to the binding site and very important in 
fucose binding; Phe313 at the edge of the three-stranded β-sheet, which may 
play stabilizing roles in the recognition of long Man-containing branches in 
mannans; and Leu371, less important and further away from the calcium site. 
This architecture is crucial to understand the different specificities between 
related lectins, for instance regarding L-SIGN, Langerin and MBPs, three C-
type receptors usually studied alongside DC-SIGN (Figure 1.16):  
 The CRD of L-SIGN (or DC-SIGNR) shares a lot of similarities with that of 
DC-SIGN [194]. However, the position equivalent to Val351 in L-SIGN is 
occupied by a serine residue (Ser363) [156]. This switch from an apolar 
residue to a polar one abrogates the binding to the Fuc-containing Lewis 
X motif, while Man recognition remains unaffected [195-196]. Other 





 Langerin CRD shows two important differences in comparison with that 
of DC-SIGN:  firstly, an alanine (Ala289) lies close to the binding site 
instead of Val351 [197-198]. Even so, the hydrophobic nature of the 
sidechain has not changed and Fuc binding is possible yet. Secondly, the 
binding site is less acidic and there are two protruding lysine sidechains 
(Lys299 and Lys313) closely flanking the metal ion, opposite to the loop. 
The presence of these residues has marked consequences: Fuc binding is 
limited (some Lewis-type antigens do not bind) [199]; the interaction with 
high-Man glycans is preferentially driven by the outer non-reducing 
residues, due to a smaller extended binding site compared with that of 
DC-SIGN [200]; and interestingly, the exposed amino groups can 
accommodate sulfated groups by means of a double salt bridge, opening 
the door to the recognition of sulfated sugars (like 6S-Gal), only described 
for this lectin so far [201-203]. 
 Mannose-binding proteins (MBPs or MBLs) belong to the group of 
collectins (Group III), but are another illustrative example of subtle 
structural modifications underlying notable differences in specificities. 
Many structural data about these lectins has been obtained from the rat 
homologues MBP-A and MBP-C. The CRD of MBP-A is more polar and 
devoid of relevant exposed hydrophobic residues [204]. It has a couple of 
protruding charged sidechains (Asp200, Lys182) which participate in 
binding to oligomannans, rather than hydrophobic amino acids. Indeed, 
Phe313 and Val351 positions on DC-SIGN are respectively substituted by 
a shorter serine sidechain and a bulky histidine residue close to the 
calcium ion (Ser154 and His189). The accommodation of mannans is 
thereby constrained by the presence of all these residues, and binding to 
long sugar chains preferentially takes place through the non-reducing end 
[205]. Instead, MBP-C has a valine residue and hence a binding behavior 
very similar to DC-SIGN [147]. Interestingly, not only MBP-C but also 
MBP-A can recognize Fuc, although the stabilizing role of His189 in the 
latter case is unclear yet [157]. 
Overall, all these factors should be taken into account for exploiting this 
receptor as a therapeutic target for drug development. In this line, the next 
and last sections summarize the current knowledge about DC-SIGN-mediated 
recognition of natural ligands, as well as related mimetics and other 
compounds that have successfully exploited secondary interactions and 
multivalency to achieve strong affinities and compete with PAMPs.   





Figure 1.16. Structural comparison between DC-SIGN and three closely related C-type 
lectins: DC-SIGNR (PDB: 1K9J), MBP-A (PDB: 2MSB) and Langerin (PDB: 3C22). Those 
sidechains that notably influence the glycan arrangement at the recognition site are 
detailed in each case. The underlined residues are those positions structurally 
equivalent to Phe313 and Val351 in DC-SIGN. 
1.4.1. Mannose-based binding 
Given that most of pathogens interact with DC-SIGN through Man-containing 
antigens, the recognition of this sugar has been extensively studied from a 
structural point of view. 
Early research immediately evidenced the structural versatility of the DC-SIGN 
CRD when binding to complex mannans. Hence, it is known to recognize both 
outer and inner Man residues linked by different glycosidic bonds while 
perfectly accommodating the surrounding mannoses by means of secondary 
intermolecular interactions. Starting from the architecture of the prototype 
mannan, Man9, many studies have shed light into the structural preferences of 
DC-SIGN using fragments derived from the original Man9 scaffold, thus 




From a broad perspective, DC-SIGN exhibits a marked preference for the 
reducing moiety of the Manα1-2Man disaccharide unit. This interaction is 
fairly favorable regardless the glycosidic linkage that attaches the disaccharide 
to the core structure (α1-2, α1-3 or α1-6). Additionally, DC-SIGN binds to both 
non-reducing mannoses of the core Man3 trisaccharide (Manα1-3[Manα1-
6]Man), although the binding to the α1-3-linked Man seems to be slightly 
favored [206].  
 
 
Figure 1.17. The four available X-Ray models describing the interaction of DC-SIGN 
with different oligomannose fragments, namely, Man4 (PDB: 1SL4, purple box), Man2 
(PDB: 2IT6, orange box) Man6 (PDB: 2IT5, red box) GlcNAc2Man3 (PDB: 1K9I, blue box). 
Only the major binding poses are represented. The sidechains of Phe313 and Val351 
are detailed. 




In this scenario, X-Ray models as well as NMR analyses have provided 
extensive data about the molecular basis underlying this fine selectivity [207-
208]. Crystal structures containing the Man3 core always display the α1-3-
linked residue directly coordinated to the calcium ion. The central and the 
outer α1-6-linked mannoses lie along the polar surface defined by β3 and β4 
strands, flanking the aromatic ring of Phe313 without originating steric clashes 
(Figure 1.17). In the X-Ray model with GlcNAc2Man3, one GlcNAc residue is 
located onto the long loop, presumably establishing favorable hydrophobic 
contacts with the methyl groups of Val351, whereas the other one fits into a 
hydrophilic pocket defined by the β-sheet turn and the α2-helix [207]. 
Interestingly, the further elongation of these glycans, for instance with Gal or 
sialic acid, negatively affects the recognition of the core Man3 [209] (Figure 
1.18). Moreover, the binding ability seems to be partially recovered when the 
GlcNAc moiety is bearing GalNAc rather than Gal [210] (Figure 1.18, entries 12 
and 15). Unfortunately, there is not a structural basis to explain that yet. 
Figure 1.18. Relative affinities determined by glycan arrays for 17 Man-containing 




Notably, the CRD-Man4 complex demonstrates that the central unit of Man3 
should be always α-linked to the upstream scaffold to make the binding 
possible through this trimannoside core. The β-anomer would place the linked 
sugar too close to Phe313, whereby residue accommodation would not be 
viable (Figure 1.17). This presumably explains why DC-SIGN is completely 
unable to bind to the Man3GlcNAc2 fragment, and also underlines the double 
role of Phe313 as a structural element for surface complementation and for 
discrimination between the inner and the outer Man3 cores present in 
complex oligomannans [196]. Very interestingly, recent array studies with a 
large library of Man3-containing complex N-glycans have raised new issues 
about the cooperative influence of all the surrounding residues in the binding 
to this trimannose core [211]. As highlights, it has been shown that the 
binding of β1-4-linked Man3 is actually possible whether the Man3GlcNAc2 
pentasaccharide is elongated with two additional GlcNAc units (Figure 1.18, 
entries 1 and 10), and also, further asymmetric galactosylation seems to be 
solely tolerated at the α1-6 arm (Figure 1.18, entries 12-14). 
The Manα1-2Man fragment can be efficiently inserted in many ways onto the 
binding site region, opening the door to multiple plausible binding poses. Both 
X-Ray and NMR data have pointed out the preferential coordination of the 
inner mannose, while experimental STDs (in combination with CORCEMA-ST) 
using the simple disaccharide have actually proven that there must be an 
additional minor binding mode co-existing at the same time, in which the Ca2+ 
ion is targeted by the outer Man [212]. Fittingly, crystallographic models with 
the same fragment support that the non-reducing Man can perfectly pack 
against the aromatic ring of Phe313, thus justifying the NMR data (Figure 
1.17). Alternatively, the crystal containing the Man6 fragment also reveals that 
the Man can adopt the opposite presentation, with the ring rotated 180º. In 
this case, the terminal Man points towards Val351, and the core is placed 
similar to those of Man4 and GlcNAc2Man3 fragments [213]. All these binding 
modes are compatible with the Man9 architecture, as assessed by docking 
models. 
In regard to the mannan affinities, the low M dissociation constants 
observed for Man9GlcNAc2 and other highly-mannosylated N-glycans are now 
reasonably explained whether considering the expected statistical rebinding 
effects: the presence of several Man residues that, in some cases, could 
display two ring orientations. Accordingly, these effects justify that mannan 
fragments usually exhibit larger binding constants as their size increases 
(number of Man residues) [196,214-215].  




However, even considering the favorable statistical re-association, more 
complex spatial factors should be taken into account in the recognition of 
high-Man glycans, especially those regarding sugar accessibility and sugar 
density. These factors strongly depend on the glycan flexibility and 
conformational space, and may explain some discrepancies found when 
comparing affinities between oligomannans [215-216], namely changes in the 
global affinity that do not correlate with the expected effect derived from the 
addition or removal of available Man residues. Three-dimensional effects 
affecting glycan recognition become more evident in biological studies, when 
considering the whole carbohydrate-containing entity, either the isolated 
pathogen glycostructures or the entire organism in “in vitro” studies. As an 
example, dissimilar interactions between DC-SIGN and Mycobacterium species 
have been ascribed to the variable number and distribution of Man caps on 
the surface-exposed ManLAMs [217]. Alike, it is well known that Candida 
species target DC-SIGN through their N-linked mannans, whereas O-linked 
mannans and phosphomannans barely participate in the pathogen uptake 
[112]. Despite their irrelevant role in binding, phosphomannans are thought to 
influence the conformational space of the N-linked mannans, as depletion of 
the former affects the binding strength of the latter [218]. Unfortunately, 
addressing a detailed structural analysis from such a high level of complexity is 
unrealistic and unworkable for now. Also, each glycan scaffold adopts a 
suitable binding mode and may trigger local conformational changes in the 
receptor that are transmitted to distal regions, what will eventually have 
biological implications like influencing intracellular lectin signaling. There are 
examples in the literature related to DC-SIGN with gp120 [219] and L-SIGN 
with GlcNAc2Man3/Man9GlcNAc [220]. 
1.4.2. Fucose-based binding 
DC-SIGN binding to Fuc also drew attention of researchers since the biological 
importance of this receptor was uncovered. This sugar naturally appears in a 
wide range of self- and non self-antigens with different scaffolds, mainly in 
Lewis antigens and Blood group antigens (See Chapter 4). In comparison with 
mannans, these fucosylated motifs display a greater structural variability 
regarding the surrounding residues (usually Gal, Glc, their N-Acetyl 
derivatives, sialic acid and other fucoses) and the type of glycosidic linkages 
existing between them. Over the years, research data have evidenced highly 
variable affinities for fucosylated antigens. Often, due to the lack of enough 
structural data, these results have exposed unexplained discrepancies and 




factors. Overall, the recognition of Fuc-containing glycans perfectly reflects 
the strong influence of the ligand presentation in the binding process. 
Mostly from array data [196,214-215,221], DC-SIGN CRD is an acknowledged 
receptor of Lewis-type antigens (LeX, LeY,  LeA , LeB, LDN-related scaffolds) in 
which the fucose is α1-3 or α1-4-linked to a central GlcNAc residue (Figure 
1.19). It also interacts with blood group antigens (BgA, BgB, BgH) with a core 
galactose bearing an α1-2-Fuc moiety. By contrast, the negative effects that 
sialylation and sulfation frequently exert in modified Lewis-type scaffolds are 
well documented: the elongation of the non-reducing end with a sialic acid 
unit almost completely abrogates the binding in most of cases, whereas the 
presence of sulfate groups can entail either negligible or negative 
consequences for binding, depending on the sulfated position and the type of 
fucosylated scaffold (Figure 1.19, entries 7-8 and 13-14).  
From now on, these general guidelines occasionally fail to explain some other 
differences found between related structures, especially when considering 
elongated fragments with more neighboring sugars. Some noticed patterns 
are: 
 Sequential repeats of a Lewis antigen (e.g. di-LeX, tri-LeX, di-LDNF) 
expectedly lead to increased affinities, likely contributed by additional 
“statistical rebinding” effects. However, the depletion of individual fucose 
moieties in these oligomers has an unclear effect: in LeX-containing 
structures, the removal of the terminal Fuc sharply decreases the affinity, 
suggesting a minor role in the lectin recognition from the fucoses located 
at inner positions. On the contrary, the same affinity drop is observed in 
LeA repeats when an inner Fuc residue is cleaved while maintaining the 
outer one (Figure 1.19, entries 4-6 and 10-12). 
 In Lewis-type antigens, the substitution of the non-reducing Gal moiety 
by GalNAc is nearly irrelevant for binding, but it has a noticeable effect 
when it comes to the interaction with the blood groups, as the B antigen 
(BgB, contains Gal) exhibits a better affinity than the A antigen (BgA, 
contains GalNAc) (See Chapter 4).  
 The complete absence of the terminal Gal in blood group antigens (as in 
the H antigen, BgH) gives rise to a poor binding, suggesting that the role 
of this non-reducing sugar may be more relevant for the blood groups 
than for the Lewis groups. In fact, structural modifications affecting to 
this residue, such as changing the anomer (α-Gal/β-Gal) or the type of 




glycosidic linkage (α1-3/α1-4) have a negative impact on the interaction, 
as a general rule (Figure 1.19, entries 16-21). 
 The type of glycosidic bond that attaches the central sugar to the glycan 
scaffold may condition the sugar accommodation at the binding site. 
Roughly, the most preferable linkage for both Lewis and BG antigens is 
β1-4, as those glycans bearing β1-3-linked ones tend to show lower 
affinities. 
 
Figure 1.19. Relative affinities determined by glycan arrays for 21 related Fuc-
containing oligosaccharides. Adapted from [215]. 
Obviously, all these queries are meant to have a structurally supported 
reasoning, but there are still very few pieces of information about the 
molecular recognition of Fuc-containing oligosaccharides by DC-SIGN. 
Essentially, X-Ray and NMR techniques have been applied to unveil the 
molecular basis for the recognition of the LeX antigen [196,222]. Both sources 
of data agree that the Fuc residue is coordinated to the metal ion through its 
OH3 and OH4 groups, while the Gal ring is placed into the flat area defined 
between Phe313 and the Ca2+, establishing a secondary H-bond interaction 
with Asp367 through OH6 (Figure 1.20). Additionally, a thorough analysis of 
the sugar positioning has allowed hypothesizing about the recognition of 
related structures: 
 The presence of GalNAc instead of Gal does not presumably produce 
severe changes in the binding, as the N-Acetyl group at carbon 2 would 
be expected to point away from the protein surface. Also, the attachment 
of an additional Fuc moiety to the same position could be likewise 
tolerated. Taken together, these observations support the binding of 




 In the same line, the recognition of sialyl-LeX (sLeX) would be expected to 
fail due to foreseeable clashes between the sialic acid moiety and 
Phe313. Strikingly, the mutant F313A neither recognizes sLeX, supporting 
that the stabilization of the sialic acid ring in selectins [223], for instance, 
requires the existence of additional specific electrostatic and vdW 
interactions arising from the protein environment. These interactions 
might not be present in DC-SIGN.  
On the other hand, the NMR results have highlighted the crucial role of the 
hydrophobic interactions involving Val351 in the stabilization of DC-SIGN-
fucose complexes. The H2 of Fuc establishes a tight van der Waals contact 
with the Val sidechain, as assessed by STD experiments. In parallel, 
mutagenesis studies have underlined the role of this aliphatic residue in Fuc 
selectivity [195-196]: replacing Val351 by a glycine residue abrogates the 
recognition of fucosylated ligands, whereas Man can still bind. Instead, the 
swapping of Val by Ser turns DC-SIGN selectivity into that of L-SIGN (Ser363), 
and LeX can be no longer bound. Besides Fuc protons, the N-Acetyl group of 
the core GlcNAc lies close to Val351 and the experimental STD values have 
confirmed that it notably contributes to the hydrophobic stabilization as well.  
Moreover, the models built using experimental NMR constrains (STD and 
ligand transferred NOEs) have shown discrepancies with the crystal structure. 
Specifically, STDs agree with closer contacts between the Gal ring and the 
protein surface while the N-Acetyl group of GlcNAc should be located fairly 
close to Val351. Both observations point out the importance of these 
secondary interactions for the binding stability. In addition, the bound 
conformation of the Lewis-type trisaccharide interestingly seems to be slightly 
more “opened”, different from that in solution. This is partly surprising given 
the known conformational rigidity of histo blood groups [224-226] even when 
bound to their receptors [9,184,227]. 
Other fucosylated oligosaccharides, like LeA or pseudo-LeY (the second Fuc is 
attached to OH3 of Gal), have been investigated to a lesser extent, only 
making use of docking models. In the LeA-DC-SIGN complex [195], the central 
GlcNAc is rotated 180º because of the different configuration of glycosidic 
linkages. Thus, Val351 would be now contacting the CH2OH group rather than 
the N-Acetyl group, and the hydrophobic interaction would be maintained yet, 
although expected to be weaker due to the presence of the polar OH6 end 
(Figure 1.20). Interestingly, this polar group would contact Ser363 in L-SIGN, 




explaining why this C-type lectin still recognizes LeA and LeB. Nevertheless, this 
arrangement does not support LeY recognition by L-SIGN.  
 
Figure 1.20. On the left, the DC-SIGN-LNFP III complex (1SL5) displaying the 
accommodation of the Lewis X antigen at the primary binding site. On the right, a 
simulated model of the interaction of DC-SIGN with the Lewis A trisaccharide. The Le 
structure has been modeled with the GLYCAM server [228] and manually docked into 
the calcium site by superimposing both interacting Fuc moieties. As noted, the GlcNAc 
residue is rotated 180º in the latter case. Color code: Fuc: red. Gal: yellow. GlcNAc: 
blue. 
The interaction of DC-SIGN with pseudo-LeY is as strong as with LeY [229]. 
Therefore, the protein-ligand complex is thought to be similar to that of LeX 
and LeY, although the docked models suggest that the attachment of the 
second Fuc to Gal C3 instead of Gal C2 would force the aromatic ring of 
Phe313 to adopt a different conformation, avoiding possible steric clashes.  
1.4.3. Artificial receptors: towards the development of 
therapeutics 
DC-SIGN has become a very promising target for the development of 
therapeutic methodologies against diseases in which this receptor takes part. 
Aside from anti-glycan vaccines or cell immunotherapy, one of the most 
employed strategies in medicine consists on blocking the receptors directly 
involved in the pathologic disorder [230]. Indeed, nature itself has provided 
mammals with a plethora of oligosaccharides in the human milk to block or 
modulate C-type lectin-driven interactions and protect the breastfed infants 
from external microorganisms [231]. Actually, human milk contains 
glycoproteins with the LeX motif which are able to block DC-SIGN, hence 




There are few recent examples about glycan-containing biostructures, like 
immunomodulators, nanoparticles or liposomes, which have successfully 
worked as anti-glycan vaccines to simultaneously target DC-SIGN and 
stimulate DC activation [234-236]. Apart from those, the rational design of 
glycomimetics keeps being the major methodology to address the quest for 
better substrates than the natural ones. In spite of the aforementioned 
structural limitations that are common for C-type lectins, good inhibitors have 
been developed along this decade, surpassing the affinity of natural 
monosaccharides above 3 orders of magnitude. Then, these improved 
mimetics can be arranged into a multivalent presentation, eventually yielding 
incredibly potent inhibitors [237]. 
 Exploiting secondary interactions 
The design of Man-based mimetics has been essentially oriented to exploit 
additional van der Waals contacts around the binding site, using the Man 
scaffold to drive the coordination to the calcium ion and bear other groups or 
modified sugars. The earliest research already proved that a simple structural 
modification at position 2, like introducing a methylamino group, can increase 
the affinity for Man more than one order of magnitude (Ki = 0.35 mM) [238]. 
Mostly, the use of carba-analogues (cyclohexane instead of pyranose) has 
accompanied this research drift in order to enhance the drug-like character of 
designed mimetics (increased lipophilicity) and their metabolic stability 
against enzymatic degradation [239-240]. 
In this line, a great deal of work has focused on improving the structural 
features of the Manα1-2Man disaccharide (Figure 1.21A). The substitution of 
the reducing Man by a functionalized cyclohexane ring provided one of the 
first and most studied mimetic scaffolds [241].  Interestingly, X-Ray and NMR 
studies confirmed that it adopts a completely new binding pose where the 
inner cyclohexane is stacked on top of Val351 rather than lying near to 
Phe313, as seen for the natural disaccharide [242] (Figure 1.21B). Moreover, 
this alternative hydrophobic stabilization would explain the improved 
selectivity for DC-SIGN as compared to Langerin (4-fold better). In this 
scenario, the subsequent substitution of the ester moieties by arylamide 
groups reinforced the binding with additional contacts on the back part of the 
long loop [243-244], providing higher affinities in the M range. Additionally, 
these modifications hampered the recognition by Langerin, increasing the 
selectivity towards DC-SIGN even more. Recently, a total selectivity for DC-
SIGN has been achieved by combining these arylamide groups and positively 




charged groups in the same molecule [245]. The presence of a positive 
substituent in the interacting Man ring precludes the binding to Langerin as a 
result of repulsive electrostatic contacts with nearby lysine sidechains.  At the 
same time, this positive functional group has been subsequently modified to 
also provide stabilizing contacts with the neighboring sidechains of DC-SIGN 
(near to Phe313),  yielding more potent mimetics [246]. 
 
 
Figure 1.21. A) Structural modifications progressively performed on the Manα1-2Man 
scaffold over the last decade to improve its inhibitory potency and enhance its 
selectivity towards DC-SIGN, minimizing its recognition by Langerin. B) 
Crystallographic models of DC-SIGN in complex with the pseudodimannoside and the 
pseudotrimannoside mimetics (PDBs: 2XR5 and 2XR6, respectively), as compared with 
the major binding pose reported for the Manα1-2Man fragment. As can be observed, 






A similar line of research tried to target the opposite secondary pocket with an 
elongated mimetic bearing a third natural Man residue at the reducing end 
[247]. The resulting compound was one order of magnitude more potent than 
the previous dimannoside mimetic, but surprisingly, the major binding mode 
was again identical and the affinity upgrade simply came from the existence of 
a minor additional binding pose involving the inner Man residue [248] (Figure 
1.21B). Indeed, at low ligand/protein ratios, this mimetic has been noticed to 
target two independent binding sites, bridging two separated DC-SIGN 
tetramers in solution [249]. 
The design of multivalent systems containing these improved analogues has 
developed in parallel. A tetravalent presentation enables additively combining 
the individual affinities of the monovalent mimetics with multivalence effects 
[250]. Furthermore, these dendrons were readily affordable and displayed 
better biological properties, including high inhibitory potencies against HIV, 
selectivity for DC-SIGN and low cytotoxicity [251]. However, the global 
affinities become less predictable in higher order glycoconjugates, since 
additional effects like sugar density/accessibility or CRD chelation begin to 
take effect [252]. Specifically, the individual contribution of each epitope is 
diluted, and similar affinities have been reported for 32-mer dendrons 
containing the dimannoside and the trimannoside mimetics, respectively 
[253]. A different design with a rigid rod-shaped core and flexible spacers has 
enabled exploring those multivalence factors in a controlled fashion, using a 
hexavalent presentation [254-255]. Longer rod-like cores contributed to 
diminish the entropic penalty, while the spacers of variable length allowed 
modulating the epitope accessibility and the ability to chelate several CRDs.  
Other works have directly attempted to create stabilizing hydrophobic 
contacts with Phe313 dispensing with the neighboring sugar residues [256]. 
Using a glycerol chain as a spacer, Kotar et al [257] have attached aromatic 
moieties to the anomeric carbon to develop a series of mimetics with affinities 
in the low micromolar range. Experimental STDs, assisted by docking models, 
have assessed the good interaction provided by a naphtyl moiety contacting 
the aromatic ring of Phe313 (Figure 1.22), while another aromatic entity 
(napthyl or benzyl) is meant to be placed into a different pocket close to 
Asn344/Arg345. 





Figure 1.22. Most potent inhibitor obtained through the introduction of non-sugar 
substituents at the anomeric position of the recognized Man. On the right, modeling 
based on measured STD effects. The Ca2+ ion is shown as a green sphere. Some ligand 
protons whose STDs have been measured are indicated and colored based on ligand-
receptor inter-proton distances (from red to blue). Adapted from [257]. 
 
 
Figure 1.23. Some LeX analogues and their relative inhibitory potencies as compared 
with those of natural Fuc and Le
X
 antigens. The best designs are those of 1 and 3, 
reflecting the importance of the aromatic moiety mimicking the Gal unit (better than 
2). Adapted from [260]. 
Regarding Fuc mimicking, few works have described the synthesis of Lewis X 
analogues with similar inhibitory potencies, in which both GlcNAc and Gal 
residues are substituted by cyclohexane rings [258]. According to 
crystallographic data, the Gal mimetic seems quite important for assisting Fuc 




affinity positively [259]. Remarkably, the best mimetic has been achieved after 
substituting the cyclohexane stereochemistry of the Gal residue by a planar 
aromatic ring [260] (Figure 1.23). NMR data (STD) have confirmed the 
involvement of this phenyl group in close contacts with the protein and 
docking analyses have strongly suggested that this moiety actually contacts 
the sidechain of Phe313 [261]. 
 Exploiting multivalence 
As mentioned at the beginning of this section, multivalent effects are crucial 
for enhancing the poor affinities of monosaccharides or small oligosaccharides 
for DC-SIGN, and for any C-type lectin in general [191,262]. Notably, this is a 
field of intense research since the factors that govern multivalent effects are 
not so straightforward, and the design of potent inhibitors require a thorough 
analysis of geometrical and thermodynamic aspects including the type of core 
or skeleton, the chemical nature of the spacers, as well as their rigidity or 
flexibility; the closeness between interacting epitopes (sugar density and 
accessibility), and the nature of the proper glycan moieties. This issue is even 
more complex whether considering that binding potencies are not necessarily 
correlated with internalizing capabilities: the best multivalent ligand may not 
be suitable for DC activation after being recognized [263]. 
At last, the multivalency enhancement of a glycoconjugate is given by the so-
called “affinity per residue”: how higher the affinity of an individual epitope in 
a multivalent scaffold is as compared with the single epitope itself. 
The first Man-containing glycoconjugates already proved to be effective for 
avoiding pathogen attachment in “in vitro” studies, efficiently competing with 
the natural viral glycoproteins (IC50 = 0.34 μM for EBOV; 50 μM for HIV) *264-
265]. In principle, this affinity improvement came exclusively from chelating 
effects when interacting with DC-SIGN tetramers, as the multivalent effects 
disappeared in the presence of the single CRD [266] (Figure 1.24). The 
distribution of the sugar epitopes throughout the glycoconjugate surface also 
affects the global potencies, and many designs have reported such effects 
[267].  Polyamide scaffolds bearing alkyl oligomannans (alkyl-Man4, alkyl-
Man9) have provided increasing affinities according to the rising number of 
mannoses from the first (3 mannoses) to the second generation (9 mannoses). 
However, there was not a significant change from the second to the third 
generation (27 mannoses), whereby the second generation was good enough 
to imitate the glycan density of gp120 on the surface of the array plate [268]. 
Similarly, the best affinities reported for golden core glyconanoparticles 




coated with mannosides have been achieved for a 50% of ligand occupation 
[269-270]. Simultaneously, these systems also illustrate the relevance of the 
monovalent epitope in regard to its accessibility. Thus, although Man5 is 
expected to better bind DC-SIGN than the linear Manα1-2Man disaccharide, 
the last one provides higher potencies in a multivalent presentation, likely 
because it preserves all its binding modes whereas Man5 is spatially more 
constrained. A potential solution to this problem consists of using longer 
spacers to increase the ligand dispersion, as has been suitably applied for the 
preparation of PEG-based polymannosides with very high affinities per Man 
residue (12000-fold) [271] and glycofullerenes with subnanomolar affinities 
[272-273] (Figure 1.24). 
 





The presentation of the ligand strongly modulates the affinities as well.  For 
instance, the alternative coupling of sugar monosaccharides through its C6 
position instead of the anomeric carbon seems to be irrelevant when building 
large glycoconjugates [274]. On the contrary, the substitution of the O-linkage 
by a C-linkage can exert either negative or positive effects, depending on the 
specific case.  Roughly, C-fucosides have been reported to be beneficial for 
binding [275], whereas C-mannosides usually produce less relevant or even 
negative changes in the affinities [276]. In certain cases, sugar clusters located 
at a focalized point of a rigid glycoconjugate help to enhance the binding, 
increasing the probability of statistical rebinding phenomena and easing the 
targeting of two or more neighboring CRDs at once [277]. As an example, 
glycolipids with long enough aliphatic chains can trigger the formation of 
micelles by self-association and display multivalent behaviors [278] (Figure 
1.25A).  
Globular neoglycoproteins and linear glycopeptides constitute another source 
of multivalent architectures extensively exploited for many years [32,279]. In 
fact, these tools have remarkably contributed to the recent development of 
very potent inhibitors (nM-pM) to prevent the DC-SIGN-mediated binding of 
the envelope GP of EBOV and gp120 of HIV [280-281]. In the last case, DCs can 
internalize gp120 yet due to the participation of the co-receptor CD4. 
Nevertheless, these results are promising for expanding and optimizing their 
applications in the biological scope. An important advantage of linear 
glycopeptides is that the amount of residues can be increased without 
affecting the sugar density, just elongating the peptidic chain. The same 
benefit has been also exploited by employing DNA/RNA templates instead of 
peptidic chains [282-283]. Thus, a linear dependence between the degree of 
sugar coating and the affinity is readily achievable, and the best potencies 
have been reported in most of cases for 100% of epitope occupancy [284-285] 
(Figure 1.25B). Moreover, the linear geometry enables the creation of 
chelation effects more easily. Interestingly, in glycopolymers with 
intermediate percentages of glycan substitution, the distribution pattern may 
affect the affinity [286]. 
 






Figure 1.25. A) Most potent glycoclusters developed to target DC-SIGN. From left to 
right, the shown structures have as base scaffold a lipid chain [278], a calyx[4]arene 
[277] and a β–cyclodextrin [287], respectively. B) Linear glycopeptides with different 
epitope distributions designed to disrupt the DC-SIGN-gp120 interaction *286+. The “S” 
block corresponds to the starter structure (no epitope). Each block bears a unique 
monosaccharide. The first two designs on top are made of 23 and 27 blocks, 
respectively (only a fragment shown).  
Finally, it is worth mentioning liposomes as multivalent scaffolds carrying 
multiple sugar copies. Liposomes are commonly used as carriers for 
intracellular drug delivery and, in this regard, glycoliposomes have been also 
employed for this purpose aimed at targeting DC-SIGN, among other lectins 
[288-289].  Strikingly, the ligand presentation plays here an unclear role, since 
both DC-SIGN and Langerin recognize LeY-coated liposomes, but whereas DCs 
can internalize them via DC-SIGN, Langerhans cells cannot do so via Langerin. 
Instead, glycopolymers are actually effective for drug delivery in Langerhans 
cells [290]. This work well reflects how subtle variations in the glycan 
presentation and accessibility can trigger deep differences in the recognition 






branches have been under study as well [287] (Figure 1.25A). However, 
although the attached branches improve the potencies of these cyclodextrins 
below the micromolar range, the carrier capability remain limited due to the 
additional difficulties to load the tested drugs into the small, hardly accessible 
hydrophobic core. 
 Other non-sugar inhibitors 
Finally, in spite of the low druggability featuring most of C-type lectins, several 
research groups have efficiently found out non-carbohydrate inhibitors by 
ligand screening (Figure 1.26). Some of them, like those based on the shikimic 
acid scaffold, exhibit affinities very similar to these of the natural 
monosaccharides (Figure 1.26, right). Further structure improvements have 
yielded better inhibitors which display low micromolar potencies (about 3 μM) 
when loaded onto a heptavalent polymer [291]. NMR studies have assessed 
that these mimetics specifically interact at the primary Ca2+ site, and the 
conjugation of multiple copies to a bovine serum albumin (BSA) scaffold allow 
them to promote cell signaling by DC-SIGN targeting [292]. Another set of 
interesting non-natural inhibitors have been discovered by solid phase arrays. 
Curiously, none of the described inhibitors had polar groups with the right 
stereochemistry to chelate the calcium ion, but even so several of them 
reached low micromolar affinities [293] (Figure 1.26, left). Structurally, various 
candidates shared a common core composed of two fused rings (at least one 
aromatic and/or one heterocycle). The optimization of this core with other 
suitable aromatic functional groups at remote positions gave rise to very good 
inhibitors with submicromolar potencies [294] (Figure 1.26, top). 
 
Figure 1.26. Most relevant non-sugar inhibitors discovered for DC-SIGN. 





 Screen Kd (mM)a  Kd (mM)b Site 
 
NMR 0.3 ± 0.2 0.5 ± 0.1 I 
 




1.0 ± 0.1 1.8 ± 0.3 III 
 
SPR - 0.7 ± 0.1 IV 
 
NMR, array 0.4 ± 0.1 0.7 ± 0.1 V 
 
Figure 1.27. The five potential binding sites that can accommodate drug-like molecules 
in the DC-SIGN CRD, as indicated by computational docking. Below, five active 
fragments found by screening using NMR, SPR and/or arrays, and the site of 
interaction expected for each one as predicted by the docked models. Kds have been 
determined in the presence of EDTA (a) or Ca
2+
 (b). Adapted from [298]. 
 
More recently, fragment screening methods combining SPR, 19F-NMR and 
other techniques like reporter displacement assay (RDA) have been applied to 
the quest for new drug candidates [295-297]. In parallel, NMR-based titration 




the primary binding site. Instead, computational methods have suggested the 
existence of five different druggable sites distributed along DC-SIGN surface, 
where these compounds would presumably bind [298] (Figure 1.27). Thus, 
these findings have shed light into the design of new allosteric, non-sugar 
inhibitors to potentially control the glycan attachment to this lectin.  
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The primordial scientific aim of this thesis project is the characterization of the 
fine details of the interaction processes between DC-SIGN and carbohydrate 
antigens, especially those bearing Fucose units. From a biological perspective, 
these data will provide a better understanding of cancer, allergy and other 
autoimmune diseases in which DC-SIGN takes part through the recognition of 
endogenous fucosylated substrates.  
This scientific objective is intimately related to the training aims, focused on 
the acquisition of high-level knowledge in chemical biology, including 
synthesis, conformational analysis, and molecular recognition, especially 
focused in state-of-the-art NMR methods and their applications to problems 
of biological interest as well as in their combination with computational tools.  
Specifically, the first goal is to precisely describe the interaction of DC-SIGN 
with the histo blood group antigens A and B from a molecular point of view, 
thereby expanding the scope of the therapeutics development towards the 
rational design of Fuc-based mimetics.  
In addition, the second important goal, now from the methodological 
perspective, concerns the optimization of a robust NMR approach that can 
provide the key features of protein/glycan interactions at atomic resolution, 
demonstrating its potential for its application in future studies with different 
sugar antigens and lectins.  
As third and additional goal, the NMR protocol specifically optimized for DC-
SIGN has been applied to the analysis of its interaction with two distinct 
fucosylated ligands, LDNF and LDN-DF, thus demonstrating the effectiveness 
of the NMR methodologies and providing insights into the interaction of DC-

















































































Nowadays, the range of biophysical techniques and spectroscopic 
methodologies applicable to the study of protein-ligand interactions is 
tremendously wide. Many of these approaches directly rely on the 
observation of a measurable variable manifested by one entity (ligand or 
receptor) whose value is somewhat related to the presence (concentration) of 
its counterpart.  This variable is usually derived from a spectroscopic property 
affected by the interaction. Thus, a great deal of the analytical biochemistry 
assays (lectin arrays [1], glycan arrays [2-3], ELISA *4+…) would be classified 
into this category, since they are generally based on measuring the 
absorption, transmittance, emission or dispersion of electromagnetic 
radiations with different frequencies (fluorescence emission [5], UV/Vis 
absorption, interference patterns *6+, radioisotopes *7+…).  Clearly, the 
configuration of an array is very versatile, as the measured parameter can be 
monitored directly arising from the studied system or indirectly from other 
sources (a third molecular entity behaving as competitor or probe, a 
subsequent chemical reaction providing active species, etc.). However, in most 
of cases, the scope of these techniques ends up at this point. They can be very 
potent tools to quickly screen protein-ligand interactions and infer the 
corresponding affinities. However, on the other side, no further information is 
obtained at atomic level, setting aside crucial structural factors that may 
explain the differences or similarities between the calculated affinities and 
better understand the global recognition event. 
In the context of protein-carbohydrate interactions, Surface Plasmon 
Resonance (SPR) [8] or Isothermal Titration Calorimetry (ITC) [9] are common 
examples of methodologies employed, besides the aforementioned analytical 
assays. Again, they both entail the same limitations in the kind of information 
that they provide, although ITC stands out by offering additional kinetic and 
thermodynamic parameters to better describe the binding event.  From a 
strict structural point of view, NMR and X-Ray are the most widely known 
methodologies to gather information from the molecular perspective [10-11]. 
Nowadays, cryo-Electron Microscopy should be added to this list, as it is an 
emerging tool in the analysis of protein-sugar interactions [12]. Undoubtedly, 
although X-Ray keeps being the reference technique for describing protein-
ligand complexes with a high degree of detail (atomic resolution) [13], cryo-
EM is also becoming a powerful tool [14], whereas structural determinations 
by NMR are mainly limited by its low intrinsic sensibility. Even though, NMR 
provides two crucial advantages that complement those drawbacks normally 






 The type of information: both X-Ray and cryo-EM approaches require the 
sample to be immobilized (low temp., vitrified) to generate the 
experimental dataset [16-18]. In terms of molecular dynamics, the 
protein-ligand complex is “fro en”, what means that the built model 
exclusively represents a “frame” of the real system, ignoring molecular 
motions (rotations, torsions, bond vibrations). Otherwise, these 
techniques are blind to additional phenomena which only take place 
when considering a true dynamic system (cooperative effects, entropic 
effects from flexibility changes or enthalpic effects from dynamic 
interactions…). In this regard, solution NMR fully addresses the study of 
protein-ligand interactions from a dynamic perspective, getting closer to 
the real biological conditions. 
 Secondly, the versatility of NMR provides several descriptive parameters 
(chemical shifts, couplings, NOE, relaxation…) that can be exploited in 
many ways depending on the studied nuclei and the configuration of the 
pulse sequences. In turn, such versatility has given rise to tens of 
experiments designed for distinct purposes [19]: characterization of 
unknown molecules (organic synthesis, natural products…), structure 
elucidation [20-21], ligand screening in drug discovery [22], estimation of 
affinities [23-24], conformational information [25-26], reaction kinetics 
[27], description of interactions at a molecular level [28-29]… 
As mentioned above, X-Ray methodologies are frequently employed to quickly 
obtain a descriptive model of the system of interest, given that the dataset is 
directly translated into spatial coordinates of the heavy atoms (C, O, N, S...), 
whereas the interpretation of NMR data is not so straightforward but can 
likewise lead to the same kind of details. Consequently, the current practices 
often make use of both techniques at once, as they nicely complement each 
other [30]. 
In this work, NMR has been used as the reference technique to derive the 
essential data, assisted by theoretical calculations made by computational 
methods (Molecular Dynamics). The already existing X-Ray structures of DC-
SIGN and related receptors have been suitably applied to provide the proper 
framework for the spatial interpretation and justification of the NMR data. 
Now, the NMR methods used along this thesis are briefly summarized in the 
next sections prior to the detailed analysis of the results. Also, a quick 






3.1. NMR basics 
Nuclear Magnetic Resonance (NMR) is a spectroscopic technique firstly 
described in 1938 by I. Rabi, although F. Bloch and E. M. Purcell were the first 
ones who applied it to the observation of liquids and solids (1946). For such a 
contribution, they were awarded with the Nobel Prize in Physics six years later 
(1952).  
The physical phenomenon of NMR comes from an intrinsic property of the 
atomic nuclei: the nuclear spin [31-33]. Each spinning nucleus has an 
associated magnetic moment (µ), whose value is quantified by means of the 
nuclear spin quantum number (I) (Figure 3.1).  This parameter takes integer 
values for those nuclei with an even mass number and half integer values for 
odd mass numbers. Moreover, when both mass and atomic numbers are even 
(12C, 16O), then I = 0 and these nuclei are consequently not observable by NMR. 
For other nuclei with non-zero I values, there are 2I+1 possible magnetic 
moment states, represented by the quantum number “m” ranging from –I to 
+I. Hence, the “ ” component of each state is described by Eq. 1: 
   
    
  
                          
 
Figure 3.1. Schematic representation of the two possible orientations of the magnetic 
moment for a nucleus with I = ½ that precesses with a Larmor frequency ω0. On the 
right, the differentiation of both spin states in terms of energy after applying an 
external B0. 
Where “h” is the Plank constant and “γ” is the so-called gyromagnetic ratio, a 
constant value characteristic for each particular nucleus (Figure 3.2). All these 
states are degenerate in energy and therefore indistinguishable a priori. 
However, under the influence of an external magnetic field (B0), the 





depending on their “m” values. Consequently, this hyperfine distribution of 
the spins becomes asymmetric since more nuclei will tend to preferentially 
occupy the lowest energy levels. NMR is aimed at promoting changes in the 
spin populations by means of electromagnetic pulses and observing the 
emission of radiofrequencies from those nuclei which are trying to reach the 
equilibrium again.  The energy of each magnetic moment state is:   
              
 
  
                            
For a dipolar nucleus with I = 1/2, the application of Eq. 2 allows to calculating 
the difference in energy between the two possible states (mI = +1/2, mI = -1/2) 
(Eq. 3). Such a difference corresponds to an electromagnetic frequency that 
turns out to be the precession frequency of the magnetic moment vector, also 
called the Larmor frequency (ω0): 
             
 
  
             
   
  
                              
 
Figure 3.2. Properties of some common active isotopes employed in NMR. Their 
resonant frequencies correspond to a field strength of 11.74 T, which confers the 
1
H 
nucleus a Larmor frequency of 500 MHz. Adapted from Ref [34]. 
 
Noteworthy, the ΔE term is remarkably low and the Boltzmann distribution 
predicts an incredibly small difference between the populations of both 
possible spin levels. Indeed, for a 400 MHz frequency, the gap created in the 
1H spin states leads to only a 0,0064% of the nuclei  staying at the high energy 
state. This is the main reason for which NMR is commonly regarded as an 
insensitive technique, as most of nuclei in a sample do not generate 
observable transitions. Apart, the 1H is the most sensitive atomic nucleus 
regarding its natural abundance (99,98%) and its particular gyromagnetic 















1H 1/2 99.98 26.75 500 1 
2H 1 0.02 4.11 76.75 0.00000145 
13C 1/2 1.11 6.73 125.72 0.000176 
14N 1 99.63 1.93 36.12 0.00101 
15N 1/2 0.37 -2.71 50.66 0.00000385 
17O 5/2 0.04 -3.63 67.78 0.0000108 
19F 1/2 100.00 25.18 470.39 0.83 





Excluding 1H, the active isotopes of other relevant biological elements, mainly 
13C and 15N, are very scarce in nature. Obviously, from Eq. 3 it can be deduced 
that the only way to achieve better resolutions (higher ω0) is to increase the 
external magnetic field. Though, the magnetic field enhancement is not 
enough for 13C and 15N observation in many cases and isotopically enriched 
samples are often needed for the study of such nuclei in biomolecules (see 
below).  
Without getting into detail, the work pipeline for performing an NMR 
measurement firstly requires the application of a set of radiofrequencies 
centered on a reference ω0 value. Thus, the bulky magnetization of the sample 
(MZ) is perturbed and subsequently treated with sequential pulses aimed at 
transferring the magnetization (coherence) between nuclei close in space and 
permitting certain “properties” of the perturbed nuclei to evolve in different 
ways. Finally, the system is allowed to relax, emitting a complex signal that 
decays along the time: the Free Induction Decay (FID) signal. Afterwards, this 
time-domain signal is transformed into another function in the domain of 
frequencies (Fourier Transform, FT), yielding what we know as an NMR 
spectrum.  
Noticeably, an NMR experiment would not have sense whether all the nuclei 
are affected by the external field in the same way. Actually, the applicability of 
the NMR methodologies lies in the particular Larmor frequency that every spin 
displays depending on its chemical environment in a given molecule. This local 
influence is manifested through several of the aforementioned “properties” 
which each spin externalizes and whose nature elicits different noticeable 
effects. In this regard, the common NMR parameters describing these 
phenomena are the chemical shifts [35], the scalar couplings [36], the nuclear 
Overhauser effects (NOEs)[37] and the relaxation parameters: 
 The electron cloud that surrounds every nucleus is responsible for the 
observed chemical shifts. Literally, the basic Larmor frequency arising 
from the applied B0 is slightly tuned by additional small magnetic fields 
generated by the circulating electrons. These little fields oppose to the 
main B0, giving rise to subtle variations (less than a kilohert ) on the ω0 of 
the studied nuclei, originating the common signal dispersion observed 
around the reference frequency (B0 = hω0). Similarly, a reduction in the 
expected electronic density leads to the opposite effect. In the former 
case, the nuclei are said to be shielded (high field), while the contrary is 





The influence of the electron cloud strongly depends on how it is actually 
affected by the surrounding network of covalent and non-covalent bonds 
[34]. In general, the electronic perturbations transmitted through 
covalent bonds include inductive and mesomeric effects, both arising 
from asymmetric charge distributions originated at electron-withdrawing 
groups, electron-donating groups or ionic species. In biomolecules, like 
proteins or nucleic acids, the anisotropic effects are more relevant by far. 
These are chiefly caused by aromatic rings and carbonyl groups, 
unsaturated systems in which the circulation of the π electrons creates 
notable magnetic perturbations directly transmitted through space. 
Analogously, the presence of paramagnetic ions has similar effects with a 
remarkable strength: pseudocontact shifts (PCS) [38]. Particularly in the 
case of protons, chemical exchange from acidic or basic groups affects 
the chemical shift as well, as the signal is averaged with that from the 
solvent protons. 
 
In practice, chemical shifts depend on the specific B0 applied. Hence, the 
δ scale (in ppm) was created as an universal scale which always provides 
the same chemical shift value for a given nucleus regardless the external 
field: 
 
        
         
    
                          
 
 As stated before, atomic nuclei genuinely behave as little magnets, 
exerting a noticeable influence on its neighboring atoms. The existence of 
two spin states necessarily implies that a close nucleus is sensing two 
different environments, what in turn leads to a signal splitting in two 
peaks, jointly describing the two possibilities (Figure 3.3). This mutual 
interference through covalent bonds is known as scalar coupling, while 
the difference in Hz between the resulting peaks is called coupling 
constant. These couplings merge as long as the two considered nuclei are 
not chemically equivalent (isochronous). Usually, noticeable coupling 
constants are established between atoms separated by two bonds 
(geminal, 2J) or three bonds (vicinal, 3J). 
 
Vicinal coupling constants [39] are of special interest in interaction 
studies due to its usefulness for many purposes as ring puckering in 
carbohydrates [40-41], rotamers and stereoisomers in proteins [42] or 





values are determined by several factors (substituents, bond lengths, 
bond valence angles), being the dihedral angle (φ) the factor underlying 
most of the mentioned applications. The dependence between 3J and the 
dihedral angles was empirically established by Karplus at first [44], giving 
rise to the known Karplus curves that are widely used today for predicting 
torsional angles in biomolecules [45] (Figure 3.4). The parameters of the 
general equation (Eq. 5) depend on the particular nuclei pair studied:  
  
                                                  
 
Figure 3.3. The NMR signal given by an isolated proton (in red) compared with 
the signal that result from the presence of a neighboring nucleus with two 
possible spin states, whose influence is transmitted through the covalent bond 
network. The thick arrows represent the nuclear spins and the dashed arrows 
correspond to the electronic spins. 
 
Figure 3.4. Examples of empirical Karplus equations describing the dependence 
between the coupling constants from nuclei at the protein backbone and the 





 Apart from scalar couplings, direct perturbations may appear between 
atoms that lie very close to each other in the space. These perturbations 
originate the so-called dipolar couplings [46]. However, such couplings 
depend on the relative orientation of both nuclei with respect to the 
external B0, and hence, free tumbling of molecules in solution eventually 
averages all these effects, making them invisible in the NMR spectrum. 
On the contrary, when a given nucleus in a two-spin system is irradiated 
with its specific frequency, the system tries to reach relaxation by 
transferring the magnetization through dipolar coupling mechanisms 
(W0/W2, Figure 3.5A). As a result, the irradiated nucleus is no longer 
visible and the signal of the counterpart experiences an intensity change 
that is named the Nuclear Overhauser Effect (NOE) [47]. The 
quantification of this effect is fairly complex. Broadly speaking, the 
maximum magnitude of the NOE depends on the half of the difference 
between both gyromagnetic ratios, and its value rapidly decreases as the 
interatomic distance grows (Figure 3.5B). Moreover, the balance between 
the W0/W2 mechanisms determines the NOE sign. At the same time, the 
predominant mechanism is related to the correlation time (τC), which 
correspondingly depends on the molecular size. When W0 is the major 
process, the NOE is negative and reaches its maximum magnitude (Figure 
3.5B). 
 
 Finally, the specific relaxation pathways followed by the excited atoms 
can be likewise exploited to obtain useful information, essentially 
regarding dynamic aspects of the studied system. There are two main 
relaxation mechanisms: longitudinal and transversal relaxation [48-49]. 
 
The longitudinal relaxation (T1) is often said to be enthalpically driven, 
since it essentially comes from the loss of energy promoted by the 
fluctuating magnetic fields present in the surrounding lattice, which 
contribute to drive the excited nuclei back to the relaxed state. In 
contrast, the transversal relaxation (T2) is entropically driven due to the 
spin-spin interactions (chemical shifts, couplings) contributing to the loss 
of phase coherence in the resonating nuclei. This relaxation is then 
associated to the attenuation of the neat magnetization component 
existing in the transversal xy plane, according to the vectorial model 
(Figure 3.6). T2 is generally faster than T1, except for particular conditions 
that favor the latter mechanism, like the presence of radical species or 





monitoring the transversal relaxation component of the observed system 
(from an entire molecule or different parts of it). 
 
 
Figure 3.5. A) Diagram of the existing energy levels for a two-spin system. If the 
nucleus labeled as Hi is irradiated, the relaxation pathways depicted as orange 
lines are disabled. To reach the ground state, the system can evolve through cross 
relaxation mechanisms enabled by dipolar couplings, represented as black 
dashed arrows (W2 and W0). B) The dependence of the NOE magnitude and sign 
on different parameters like the correlation time (τC) or the interatomic distance 
(rij). 
In the biological context, also including this work, the often large size of the 
studied entities (oligosaccharides, proteins) precludes the sole utilization of 
monodimensional (1D) spectra for gathering the desired data. Signal crowding 
is a typical problem in 1D-1H NMR, whereas other nuclei like 13C and 15N offer 
a better spectral dispersion but entail severe sensibility problems when 
measured individually (low isotopic abundance, lower γ). Then, 







NMR correlations to additional dimensions [50-51]. Commonly, the pulse 
sequences incorporate an additional evolution step with a variable delay 
which prepares the system for a subsequent stage in which other components 
of the spin-spin interactions can develop (mixing time). At last, the FID is 
routinely processed by FT and then, a second FT is applied to obtain a planar 
spectrum (2D) containing the information. For more dimensions, the FID 
processing is analogous (nFT) although the complexity increases. The resulting 
experiments are classified as homonuclear or heteronuclear correlation 
depending on whether the correlated nuclei are respectively identical (2D-
COSY, 2D-TOCSY, 2D-NOESY…) or different (2D-HSQC, 2D-HMQC, 2D-HMBC, 
3D-HSQC-NOESY, 3D-HNCA…) *19+.  
 
Figure 3.6. The two relaxation mechanisms that contribute to take the neat 
magnetization of the nuclei (MZ) from the xy plane back to the z axis. 
Regarding protein-ligand interactions, there are two habitual strategies 
considered when making use of NMR approaches. The interaction can be 
independently studied from the point of view of each entity, analyzing how 
the recognition process affects their respective resonances [52-54]: 
 The receptor-based methods (in our case, the DC-SIGN CRD or ECD) are 
based on monitoring the perturbations on the protein NMR resonances 
occurring during the binding event. This method allows to delineating the 
binding site and differentiates between specific and non-specific 
interactions. In addition, there is not an affinity limit for the 
measurements and it is possible to observe interaction kinetics and 
thermodynamics. The most employed methodologies include HSQC-
based titrations, relaxation (15N, 13C) and diffusion editing (2D-DOSY). By 
contrast, the typical drawbacks associated to these methods arise from 
the size limit (< 40 kDa) [55]. Large receptors possess very efficient 
relaxation mechanisms (T2) and display profound signal broadening. 





overlapping necessarily demands the use of multidimensional NMR (2D, 
3D, 4D), what requires the use of large amounts of the receptor and 
isotopically labeled samples (13C, 15N) whose preparation is often 
expensive and time-consuming. 
 
 Ligand-based methods are aimed at extracting information from the 
ligands in the presence and absence of the receptor. A crucial advantage 
of these methods reside in overcoming the cited limitations regarding the 
receptor: in contrast to receptor-based methods, the molecular size is not 
limiting, even some experiments actually yield better ligand signals as the 
receptor is larger (e.g. STD). Additionally, the required amounts of 
receptor are considerably lower and isotopic labeling is not needed. 
Typical examples of such experiments are Saturation Transfer Difference 
(STD), Transferred-NOESY (TrNOESY), Water-LOGSY and relaxation (19F, 
13C). The extracted data allow to detecting ligand binding (ligand 
screening) as well as estimating affinities, in some cases. However, these 
methods usually rely on the sufficient difference in size between receptor 
and ligand, whereby the study of large ligands may entail measuring 
limitations. Similarly, the ligand is often observed in its free state after 
leaving the receptor, and then the study of high-affinity ligands (Kd < 10
-7 
M) is hampered by their intrinsic low koff rates. 
In the next sections, the main practical aspects about the experiments used in 
this work are detailed. 15N-HSQC-based titrations have been employed for the 
lectin analysis (CRD), while the oligosaccharides of interest (Blood Group 
antigens, monosaccharides) have been fundamentally analyzed by STD, 
TrNOESY and 19F-T2 relaxation (with fluorinated sugars). Also, the analysis of 
the CRD required the previous assignment of the protein signals by three-
dimensional NMR, as specified below. 
3.2. NMR assignment of the DC-SIGN CRD 
Proteins are the extreme case of signal crowding in routine 1D-1H NMR 
spectra. A single protein having 100 amino acid residues or more readily 
contains several hundreds of protons dispersed along 12 ppm as much. Thus, 
assignment of proteins is unworkable by only considering a single dimension. 
In the middle eighties, the Nobel Prize winner Kurt Wüthrich managed to solve 
by the first time the three-dimensional structure of a globular protein through 
NMR methodologies *56+. The Wüthrich methodology (known as “sequential 





2D-NOESY. The 2D-TOCSY (TOtal Correlation SpectroscopY) resembles the 
COSY experiment, but it permits to transfer the magnetization to all the 
protons connected by scalar couplings [57]. In the context of a protein, these 
connections remain isolated within each individual amino acid. Then, a specific 
correlation pattern is meant to fit with a specific sidechain, hence allowing the 
classification of the observed patterns by residue type [58] (Figure 3.7A). In 
principle, each amino acid will give at least one TOCSY pattern, except for 
those sidechains containing other isolated spin systems, for instance in 
aromatic residues (Phe, Tyr, Trp, His). As complement, the 2D-NOESY provides 
the spatial connections between close nuclei, enabling the sequential 
correlation between neighboring residues. Regardless the three-dimensional 
structure of the protein or peptide studied, some sequential NOEs always 
appear, as those between Hαi and HNi-1 [59-60] (Figure 3.7B). 
          
Figure 3.7. A) Average values of proton chemical shifts in proteins according to the 
BMRB database [58]. Red squares: Hα. Blue circles: Hβ. Empty black circles: H. Green 
triangles: Hδ. Orange triangles: Hε. B) Sequential correlations established through NOE 
effects observed in the amide region of the 2D-NOESY spectrum (6-9 ppm). In blue, the 
vertically derived TOCSY correlations. In orange, the NOE crosspeaks between HN(i) 
and Hα(i-1). 
In protein-ligand studies, the reference receptor-based method is the HSQC-
based titration [61]. The HSQC experiment (Heteronuclear Single-Quantum 
Correlation) is a 2D spectrum showing the correlation between proton and 






“residue isolation” as the 2D-TOCSY when applied to proteins: the direct H-N 
correlations essentially come from the amide bonds, and thereby each amino 
acid provides a single peak corresponding to its HN group. As exceptions, Trp, 
Asn and Gln do exhibit two HN peaks, with the additional one belonging to 
their particular sidechains. Similarly, His and Arg have exchangeable HN 
protons that occasionally appear under certain conditions (acidic). In contrast, 
Pro is devoid of amide protons in protein structures and therefore becomes 
invisible in the 15N-HSQC.  
Although effective for small peptides and proteins, the classical method of 
Wüthrich eventually fails as the protein size increases over 80-100 residues, 
because signal overlapping becomes extremely severe even in two 
dimensions. Three-dimensional spectra constitute the most practical solution 
in such cases [62]. Following the same methodology, the TOCSY and NOESY 
patters can be extended to a third dimension by referencing them to their 
respective HN groups in the 15N-HSQC, giving rise to experiments like 3D-15N-
HSQC-TOCSY and 3D-15N-HSQC-NOESY. However, the sensitivity of these 
experiments is deeply decreased by dipole-dipole relaxation affecting the 
homonuclear transference of coherence in large structures. Better, the recent 
development of pulse sequences based on triple resonance (1H, 13C, 15N) has 
given rise to a plethora of different spectra correlating vicinal carbon nuclei 
with amidic HN groups [63-64]. The configuration of the pulse sequence 
determines which carbons (Cα, Cβ, CO, Cγ…) receive the magneti ation. The 
key factor is that this transference of magnetization can be directed either to 
the proper sidechain carbons or to carbons from vicinal residues, thereby 
providing very few and clean signals which enable the unambiguous 
correlation of sequential residues [65]. For the particular work described here, 
four distinct experiments have been employed to establish such sequential 
correlations and identify as many residues of the DC-SIGN CRD as possible. 
These experiments are dubbed HNCA [66], HN(CO)CA, HN(CO)CACB [67] and 
HNCACB [68-69] (Figure 3.8).  
The HN(CO)CA experiment gives an only correlation between an HN i and the 
alpha carbon from the previous residue, Cαi-1. Similarly, the HNCA experiment 
shows two correlations in the carbon dimension, both with carbons at position 
α: Cαi-1 (the previous residue) and Cαi (the same residue). Given that the Cαi-1 
can be readily assigned in the HN(CO)CA spectrum, the remaining assignment 
(Cαi) is immediate. Theoretically, these assignments could be enough to 
establish sequential assignments. The main problem arises from the low 





ppm range (50-65 ppm) and being Gly the only exception (43-48 ppm) [70]. 
This reduced range often leads to many ambiguities, whereby two additional 
experiments, HN(CO)CACB and HNCACB, are likewise performed to add a 
second carbon nucleus (Cβ) as an exclusion rule for those ambiguous 
assignments. Besides a slightly higher spectral window (24-48 ppm), Cβ 
provides a great way to immediately identify four amino acid types: Gly (No 
Cβ), Ala (15-21 ppm), and Ser & Thr (very deshielded, 60-75 ppm). Specifically, 
the HN(CO)CACB displays two carbon correlations: Cαi-1 and Cβi-1. The Cβi-1 
resonance is unequivocally assigned as the Cαi-1 is already identified in the 
HN(CO)CA. Eventually, the HNCACB is the most complete experiment, giving 
four carbon correlations for each single HN crosspeak: Cαi-1, Cβi-1, Cαi and Cβi. 
Only the Cβi resonance needs to be assigned, as the other three nuclei are 
provided by the experiments mentioned above. 
 
Figure 3.8. Interresidue correlations deduced from the 3D NMR experiments 
HN(CO)CA, HNCA, HN(CO)CACB and HNCACB. The pulse sequences utilized are usually 
edited to show Cα and Cβ with opposite sign and ease their identification. 
Following this protocol, a complete assignment can be achieved by stepwise 
linking successive residues via the Cα and Cβ resonances. This sequential 
analysis may be uniquely stopped by prolines or highly flexible regions where 
undesired relaxation processes erase most of the signals. However, the 
recording of alternative available experiments (HNCO, HNCACO) in parallel 
might help to overcome these problems. 
As complementary information, chemicals shifts have been shown to be good 
descriptors of secondary structure elements in proteins [71]. Variations in the 





anisotropic effects and the hydrogen bonds. Instead, chemical shifts of Cα and 
Cβ strongly depend on the backbone torsion angles affecting the amino acid 
itself (φ, ψ) rather than through-space effects. On this basis, it has been 
noticed that Cα and Cβ resonances are good parameters to predict the 
presence of secondary structures (α-helix, β-strand) [72]. Their chemical shifts 
systematically change with respect to the expected values in “pure 
conditions”, like in solvent-exposed random coil peptides [73-74], without 
considering the existence of a folded scaffold. Through computational tools, 
like TALOS+ [75] or PREDITOR [76], the secondary structural elements can be 
predicted with reasonable accuracy jointly computing δCα, δCβ and also δHα 
and δHN. The same chemical shifts serve as indicators of the local flexibility as 
well: the higher the flexibility is, the closer the chemical shifts are to those 
exhibited in random coil peptides. Chemical shift processing is also 
accomplished by computational methods, like the Random Coil Index (RCI) 
server [77]. 
3.3. 15N-HSQC-based titrations 
Amongst the receptor-based methods, the analysis of perturbations in the 2D-
HSQC spectrum is the most representative technique, broadly applied to map 
the binding site, analyze the nature of the interaction (specific/non-specific 
[78], cooperativity *79+, binding stoichiometry *80+…), control protein 
dynamics, estimate dissociation constants or even for ligand screening in drug 
design (Structure-Activity Relationship -> SAR by NMR [81-82]). In spite of the 
limitations regarding the molecular size, the continuous development of new 
hardware and pulse sequences has led to expand the biological scope of NMR 
to more complex receptors. Among these advances, the most relevant in this 
regard are optimized HSQC sequences like TROSY (Transverse Relaxation 
Optimized SpectroscopY)[83], which yield better resolution spectra; improved 
cryo-probe technologies [84]; perdeuteration of large proteins to avoid 
relaxation issues [85-86] and non-uniform sampling (NUS) [87], which 
substantially reduces the time costs without affecting the resolution. 
In practice, two kinds of spectra are viable to perform these analyses: 13C-
HSQC and 15N-HSQC. The choice may depend on the type of system and its 
molecular size, but always looks for those nuclei efficiently sensing the ligand 
approaching [88-89]. From an empirical perspective, 15N, 13Cα and 1Hα 
resonances are the most affected by spatial factors like hydrogen bonding or 
near functional groups (for instance, from the ligand) causing local 
perturbations on the effective B0 [90]. In contrast, amide 





less altered or its variation depends almost exclusively on conformational 
changes (Cβ) or local hydrogen bonding (1HN). At last, the 1H-15N-HSQC is the 
most used for practical considerations (major amount of data in the shortest 
time). The 13C-HSQC of proteins displays rather higher signal overlapping 
problems that are mostly reduced by means of selective 13C-labeling [91-92], 
commonly applied to methyl groups in aliphatic residues (Leu, Val, Ile, Met). 
This methodology is better employed to carry out recognition studies 
involving very large receptors [93-94]. 
 
Figure 3.9. Evolution of crosspeak shifts and shapes along a titration process 
depending on the type of exchange regime in the NMR timescale. 
The primordial application of the 15N-HSQC is for depicting the binding site by 
detecting those amino acids that are the most influenced by the presence of 
the ligand. Nevertheless, an important consideration must be taken into 
account, which arises from binding kinetics: two different scenarios may show 
up two types of chemical shift drift [61]. If the chemical exchange between the 
free and the bound states takes place faster than the acquisition time, then 
we are facing a fast exchange regime in which the NMR signal from both 
states (free/bound) is averaged to a single crosspeak that progressively moves 
across the spectral window [95]. On the contrary, if the acquisition time is 
faster than the time the ligand needs to leave the binding site (tight binding), 
then the system is said to be in a slow exchange regime, and we will see how 
the free signal gradually vanishes as the ligand concentration grows, while a 
new signal (bound state) independently appears at another frequency [96] 
(Figure 3.9). In the limit between both kinds of events (intermediate 
exchange), peaks shift and broaden simultaneously [97]. In terms of kinetics, 
the comparison between the exchange rate (kex) and the chemical shift 
difference (in Hz) between free and bound states permits to distinguish the 
specific type of exchange regime. kex is directly correlated with the kinetic 





term of this equivalence (πΔω/√2) can be uniquely included when the system 
is near to a regime of intermediate exchange, in which the middle points of 
the titration show the maximal broadening, even disappearing [99]. This 
phenomenon is called “peak coalescence”. Usually, the exchange regime is 
directly correlated with koff rather than with kex. In general, large koff values (> 
105 s-1) correspond to fast exchange events and vice versa (slow exchange for 
koff < 10 s
-1). 
 
                         [ ][ ]      [  ]       
    




          
Where Kd is the dissociation constant at the working temperature and kon and 
koff are the corresponding kinetic constants for the formation and dissociation 
of the complex, respectively. 
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Where Δω is the difference in Hz between the starting point (free receptor) 
and the end position (bound receptor).  
For evaluating the chemical shift perturbations (CSP, Δδ), both the 1H CSPs and 
the 15N CSPs are treated within the same mathematical expression to calculate 
an averaged chemical shift perturbation value [100-101], which is then taken 
as reference for deciding whether the variation is significant or not (Eq. 8). 
Obviously, the weighing of each nucleus (αi) is different as its behavior upon 
ligand binding is so as well.  Considering the proton as reference (αH = 1), the 
αN factor can take different values depending on how the 
15N perturbation is 
compared with that of the 1H. Experimental values in literature commonly go 
from αN = 0.1 [102] to αN = 0.2 [103]. αN = 0.1 comes from strictly using Hz 
instead of ppm (15N = 0.11H). However, empirical observations have led many 
researchers to agree that the most suitable value is around αN = 0.14 [104], 
considering that for the amide groups in proteins, the spectral window of the 
15N is approximately seven times wider than that of 1H (1/7 ≈ 0.14). In this 
thesis, the standard criterion has been also adopted and a value of αN = 0.14 
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Regarding the threshold value, there is neither a specific rule, although the 
typical cutoff values for deciding the significance of the CSPs are the standard 
deviation, ς, or twice the standard deviation, 2ς [105]. In the fast exchange 
regime, the resulting Δδ is contributed by the corresponding molar fractions of 
the receptor in their bound and free forms, respectively. Thus, the affinity 
constants can be deduced from the binding isotherm built by plotting the CSP 
as a function of the total ligand concentration [106]: 
                                            
                                                         
Where xB is the molar fraction of the bound receptor: 
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And A = [P0]+Kd. [P0] and [L0] are the total concentrations of receptor and 
ligand, respectively, being [L0] the variable for the exponential fit. The 
parameter Δδmax is the chemical shift difference between the bound and the 
free state, and δB is taken from the observed chemical shift when receptor 
saturation has been reached ([P0+≈*PL+). Implicitly, the parameter A contains 
the value of the dissociation constant and the resulting plot is an exponential 
curve for a simple 1:1 binding event. For more complex binding events 
(induced fitting, multiple binding…), Kd cannot be accurately calculated since 
the CSPs suffer from other phenomena like non-linear drift [107-108] or 
uncommon broadening processes [109] (Figure 3.10). 
For interactions occurring within the slow exchange regime, the CSPs cannot 
be collected and instead the intensity variations on the peaks of the 
free/bound states provide a similar relationship to estimate the dissociation 
constants [110]. In the intermediate regime, Eq. 10 may be employed as well, 
but being aware that the Kd estimation is expected to be worse as the dynamic 
behavior is less predictable, sometimes leading to more “sigmoidal” trends 






Figure 3.10. On the left, curved trajectories observed for the stepwise recognition of 
several ligand molecules at different binding sites distributed on receptor´s surface 
(multiple binding). On the right, the distorted exponential growth (blue sigmoidal 
curve) observed when a binding process approaches to a regime of intermediate 
exchange. Adapted from [61,107].  
3.4. Saturation transfer difference (STD) 
 
The STD experiment was originally conceived as a technique for rapid ligand 
screening using mixtures of different compounds [112]. It takes advantage of 
the different relaxation properties existing between a small ligand and its 
large receptor. In large proteins, the mechanisms of cross relaxation that 
originate the NOE effects are particularly efficient due to the extensive 
network of nuclei that are coupled through space. Thus, a selective pulse 
applied on a given frequency range will affect a specific group of protein 
protons that will become saturated and hence attenuated. By cross relaxation 
(spin diffusion), this saturation is transferred to the nearby protons and 
propagated throughout the entire protein structure [113].  
Under these conditions, the proton signals of a compound that enters into the 
receptor binding site are susceptible to be also saturated, in this case through 
dipolar couplings transmitted by intermolecular mechanisms. On this basis, 
the STD setup is performed as follows (Figure 3.11A): 
 
Firstly, a 1H-1D spectrum is recorded while applying a train of selective pulses 
focused on a ppm region in which the protein exhibits NMR signals but the 
ligand does not. During this period, called saturation time (tsat), the ligand 
molecules attached to the binding site get saturated. After they have been 
released from the recognition site, the magnetization status is still preserved 
and the free molecule displays weakened peaks as a result. This experiment is 










Figure 3.11. A) The three individual spectra that constitute a complete STD 
experiment. On the top, the off-resonance spectrum, in which two ligands (structures 
on the right) show their corresponding proton signals. On the middle, the on-
resonance spectrum displaying attenuated peaks for that ligand recognized by the 
saturated receptor. The attenuation for each moiety is different according with its 
distance to the protein (highlighted in red). On the bottom, the STD spectrum obtained 
as the difference between the two previous ones. The circle moiety displays the 
strongest STD as it is the closest fragment to the protein and thereby the most 
affected. B) The process of saturation transference that enables the acquisition of an 
STD: after the protein gets saturated (tsat), the ligand needs to stay at the binding site 
for a specific time (τres) to be saturated. Eventually, after complex dissociation, the 
ligand still remains saturated if the dissociation rate is fast enough in the relaxation 
time scale, and exhibits sharp signals partially reduced due to that condition. 
 
In parallel, another 1H-1D spectrum (blank) is obtained with the same pulse 







(for instance, at 100 ppm). Thus, no signals are saturated at all, which is 
equivalent to record a routine 1D spectrum. This second spectrum is known as 
the off-resonance experiment and serves as reference. In the practice, the 
decrease on the signal intensities is very subtle and hence difficult to detect by 
directly comparing both spectra, on- and off-resonance. Therefore, a third 
spectrum is built by subtracting the on-resonance experiment to the reference 
1H-1D: the STD spectrum. As a result, the unperturbed signals totally 
disappear as their intensities are equivalent in both on- and off-spectra, while 
the affected peaks in the on-resonance spectrum are amplified even more as 
their intensities get weaker by transferred saturation. Remarkably, the 
adaptability of the pulse sequence enables the combination of this experiment 
with additional evolution steps, for instance allowing homonuclear couplings 
through a TOCSY scheme [114-116] or heteronuclear couplings through an 
HSQC sequence [117]. In turn, such versatility has enormously expanded its 
applications not only for ligand screening [118-119], but also in the study of 
ligand-receptor interactions from an atomic perspective [120]. 
 
With these features, the STD experiment constitutes a highly sensitive and 
robust tool to detect ligand binding [121]. Indeed, it efficiently avoids the 
detection of false positives since the compounds that do not interact with the 
saturated receptor are completely erased from the final STD. Noteworthy, the 
experiment relies on getting the highest possible percentage of saturated 
ligand molecules, while the bulky saturation is progressively lost in the free 
state by normal relaxation (T1/T2). Thus, the optimal scenario to record an STD 
demands the binding process to take place in a regime that is slow enough for 
the ligand to stay in the bound state the sufficient time (residence time, τres) to 
become saturated, but fast in the relaxation time scale to keep the saturation 
information in the free state during the acquisition [54] (Figure 3.11B). Under 
these requirements, the STD methodology has been demonstrated to be 
suitable for studying recognition processes with Kd values in the 10
-3-10-8 M 
range [122]. In the practice, good STD sensitivities depend on the amount of 
free saturated ligand molecules. Considering fast exchange regimes, this 
condition enables the utilization of large protein/ligand ratios, usually ca. 1:50, 
to get intense enough STD spectra, thus considerably reducing the amount of 
receptor needed down to 1 µM. In addition, STD methodologies are well 
suited for studying ligand recognition processes driven by huge receptors: the 
larger the receptor is, the more efficient the transference of saturation is by 
NOE mechanisms and the stronger the STDs will be. Hence, STD protocols 





compounds by very large systems, including liposomes [123] or viral particles 
[124].  
 
Additionally, the applicability of the STD has been quickly extended over the 
years to two additional tasks: ligand epitope mapping [125-126] and Kd 
estimation [53,127]. Apart from assessing ligand attachment, it is possible to 
map the binding epitope in a given compound due to the different closeness 
of the ligand groups to the receptor surface [128-129]. Thus, cross relaxation 
will better affect those protons lying nearer to the receptor ones. However, 
special care must be taken when STDs are applied to this purpose. The STD 
intensities are regulated by many factors besides spatial distribution, being 
the most relevant the koff, rebinding effects [130] and the individual T1 
relaxation of each proton [131].  
 
Experimentally, the longitudinal relaxation has a different impact on each 
atom of a given molecule. Consequently, the initial saturation gained by a 
particular proton evolves such that its relative intensity might change after a 
long saturation time. The T1 relaxation is therefore the main reason behind a 
biased interpretation of the STDs, which may lead to an incorrect epitope 
mapping.  One good solution can be afforded by using STD measurements at 
short saturation times (around 0.25-0.50 s), although the amount of saturated 
molecules is reasonably lower and the sensitivity would be expectedly worse. 
Strictly, the only way to efficiently minimize the bias effect of the T1 evolution 
is to use the so-called approximation of the initial slopes, based on plotting 
the STD evolution of each proton as a function of the saturation time (Eq. 11) 
and obtaining the slope for the exponential function when tsat approaches 
zero [132]: 
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Typical saturation times range between 0.25 s and 4 s as much. Larger tsat do 
not further improve the STD intensities as the saturation of almost all the 
ligand molecules has been nearly reached. The slope at tsat ≈ 0 is given by the 
product of the maximum achievable STD intensity (IMAX) and the constant 
saturation rate (ksat), as stated in Eq. 12. At the same time, the latter 





predicts their STD build-up speeds. By direct comparison of ksat values, it is 
possible to determine how a long saturation time will affect to the relative 
STD profile and therefore prevent erroneous interpretations. 
 
Regarding the calculation of dissociation constants, a quantitative STD-based 
approach is commonly applied that requires a different treatment of the 
experimental dataset. Mayer and Meyer [133] firstly proposed the 
amplification factor (STDAF) as a new parameter to better assesses the 
absolute magnitude of the STDs. This value consists of multiplying the STD 
effect by the molar excess of the ligand, and thereby the measured STD is 
exclusively determined by the fraction of bound protein [134-135]: 
 
      





                                        
Being L0 and P0 the total amounts of ligand and protein, respectively, and I0 
and Isat the corresponding peak integrals measured in the off- and on-
resonance experiments. Using this parameter, the build-up curves are 
represented as a function of the total ligand concentration rather than the 
saturation time. The fitting equation is analogous to that used for describing 
enzymatic processes through the Michaelis-Menten model [136]. To note, 
such a model is an approximation that becomes valid only if [L]free approaches 
the total amount of ligand, [L0], what normally happens in STD experiments.  
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Nevertheless, the Kd values have been checked to easily deviate from the real 
ones when using different saturation times, protons with distinct intrinsic STD 
effects or even different protein concentrations, in spite of using the same 
protein/ligand ratios [137-138]. Fortunately, the solution is fairly similar to 
that described above to evaluate the ligand epitope, but using the 
amplification factors at tsat close to zero (STDAF0) instead of the common STD 
effects. Briefly, the Langmuir-like isotherms are built by plotting the STDAF 
versus the saturation time, using different ligand concentrations. For each [L0] 
value, its corresponding STDAF0 is inferred from the initial slope obtained 
through the same exponential equation (Eq. 11). Subsequently, the 
amplification factors at tsat ≈ 0 are correlated with the increasing ligand 
concentrations by means of Eq. 14 again (Figure 3.12). Definitely, ligand 
competition experiments constitute a fairly faster alternative, which involves 





inhibition constant) has been already determined through other techniques 
[139]. In such a case, the unknown dissociation constant can be better 
approximated through a more complex mathematical expression, although 
some authors have also proposed the Cheng-Prusoff equation as a good 
estimation method [140]: 
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Where IC50 is the amount of inhibitor needed to reduce the intensity of the 
STD peaks from the unknown ligand “L” to the half. KI is the known 
dissociation constant for the probe compound. The inhibitor is titrated in the 




Figure 3.12. Quantitative assessment of dissociation constants by STD NMR. The 
amplification factors are formerly recorded at different saturation times and ligand 
concentrations (dashed curves). For each [L], its corresponding STDAF at tsat = 0 is 
calculated through Eqs. 11 and 12. Then, the STDAF0 values are plotted as a function of 
the ligand concentration (right graph) using Eq. 14, from which the Kd can be finally 
deduced. Adapted from [137]. 
 
Finally, it is worth mentioning the CORCEMA-ST software [141], which is 
capable of quickly assessing the veracity of theoretical structural models by 
using the experimental STDs as computing parameters. The theoretical STD 
values calculated with this tool are compared to the experimental ones 
through a statistical parameter called the NOE R-factor, which evaluates the 
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Where STDexp and STDcal are respectively the experimental and theoretical STD 
effects. Wk is a weighting factor specific for each “k” proton, proportional to 
1/ STDexp. Ideally, if the theoretical model perfectly fits to the experimental 
STDs, the R-factor would be 0. However, the real experiment is obviously 
subjected to inaccuracies and errors that will always preclude the exact fitting 
even though the theoretical model is correct. For this reason, the R-factor 
constitutes an essential tool to evaluate the model quality. To note, the 
evaluating criterion is rather subjective and the researcher must always 
analyze where the similarities or discrepancies between both datasets are 
coming from. A good way to do this consists of graphically representing the 
relative STD profiles, and comparing them from a qualitative perspective [143-
144]. Hence, disparate values can be individually analyzed to seek for 
reasonable explanations.  
 
Deviations could not only be originated by experimental errors, but they could 
also arise from other factors related to docking errors, wrong ligand 
conformations or complex recognition events involving the contribution of 
several binding modes. In most of cases, the fittings via CORCEMA are firstly 
improved by optimizing the theoretical parameters included in calculations, 
approximating them as much as possible to the real ones. These variables 
include kinetic and thermodynamic parameters (Kd, kon, koff, correlation 
times…) and other magnitudes related to experimental conditions (magnetic 
field, protein and ligand concentrations, selective saturation…). Additionally, a 
refinement protocol can be run in parallel to reduce the R-factor even below 
0.1 [145]. For this refinement, the same software has been designed to 
introduce other experimental restrictions like trNOEs, intra-ligand relaxation 
rates and torsion angles [146].   
 
3.5. Transferred-NOESY: unveiling the bound 
conformation 
 
The transferred NOESY (tr-NOESY) or exchange-transfer NOESY (et-NOESY) 
shares common features with the STD experiment. It is also based on the 
transference of magnetization though cross-relaxation mechanisms existing 
between spatially close nuclei, and then, it turns out to be particularly useful 





respective sizes. From a conceptual perspective, the experiment is fairly 
simple: a 2D-NOESY sequence with a mixing time optimized for the receptor, 
which is essentially a large protein in most of cases [130,147-148]. Thus, in 
contrast to the STD pulse sequence, the sample is not irradiated into a specific 
range of frequencies, but it is simply allowed to evolve along this mixing time 
in which through-space correlations develop as NOE crosspeaks. In this 
scenario, the cross relaxation rate of a given ligand is contributed by both 
mechanisms independently operating in the free and the bound state [149]: 
 




Figure 3.13. The possible events taking place in a 2D transferred-NOESY, depending on 
the specific values of koff, σB and T1. The ideal situation for observing tr-NOEs is that 
represented in the middle, where the koff is slow enough to firstly enable 
intermolecular cross relaxation (σB) and fast enough to allow the ligand to leave the 
receptor before complete relaxation (T1), thus exhibiting the transferred NOE 
information in the free state. 
 
As previously exposed, the NOE mechanisms deeply depend on the correlation 
time (τC), which is simultaneously ligated to the molecular size. Consequently, 
the contribution of the free ligand term is considerably lower than that of the 
bound ligand, even approaching zero for biomolecules like oligosaccharides, 
whose molecular sizes are within the 500-1000 Da range. In the bound state, 
the ligand is experimenting a correlation time remarkably higher, derived from 
its attachment to a large slow-tumbling protein. As a result, the NOE 
crosspeaks gain intensity in accordance with the expectedly favored W0 
pathway. Moreover, derived from this mechanism, the intensity improvement 
is always accompanied with a sign switch from positive (or zero) to negative. 
In conclusion, this change on the sign of the ligand peaks serves as an 






Similar to the STD, the tr-NOESY experiment becomes useful when applied to 
a system in the fast exchange regime (Figure 3.13). Under these conditions, 
the stronger NOE effects originated in the bound state are preserved when 
the ligand leaves the recognition site, giving rise to very sharp and intense 
signals upon longitudinal T1 relaxation [153]. Then, the tr-NOESY spectrum is 
routinely performed in the presence of large protein/ligand ratios, typically 
ranging from 1:5 to 1:40, to achieve good signal-to-noise ratios. However, in 
the STD experiment the saturation is exclusively originated at the receptor, 
whereas herein all the ligand molecules subjected to the 2D-NOESY pulse 
sequence are susceptible to evolve through the NOE relaxation pathways. As a 
result, lower protein/ligand ratios than these used for STD are often preferred 
to minimize the contribution of the predominantly positive NOE arising from 
the large amount of free ligand molecules.  
 
The aforementioned features underlie the key application of the tr-NOESY for 
interaction studies: the use of the transferred NOEs to deduce the ligand 
conformation in the bound state [154-156]. This application requires using 
peak integration to quantitatively determine inter-proton distances, and 
hence several warnings must be taken into account. As explained for the STD, 
the NOE intensities are affected by multiple factors whose influence may 
sometimes lead to a wrong description of the bound ligand conformation. 
Firstly, as mentioned above, the exchange regime is important as the NOE 
effect is attenuated for ligands that bind either very tightly (Kd < 10
-8 M) or 
very weakly (Kd > 10
-4 M) [149]. In the former case (koff << ςB), the NOE effects 
are notably reduced as the residence time inside the binding site is so long, 
where the tr-NOEs only become observable in the much less concentrated 
bound state and hence practically undetectable. Likewise, the latter case (koff 
>> ςB) leads to incomplete transference of the protein-edited NOE as complex 
dissociation is too fast. If the koff is approximately known, the efficiency of the 
NOE experiment may be valued by comparison with the cross relaxation rate 
(ςB), which can be roughly estimated as a function of the molecular size 
through the following empirical relationship (ignoring the ςF term) [153]: 
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Obviously, the mixing time (tmix) must be also carefully chosen to allow cross 
relaxation mechanisms to efficiently progress through the ligand structure. 





select a suitable tmix, the NOE is often overrated because of the effects of spin 
diffusion [157-158]. Briefly, spin diffusion is the transference of magnetization 
between two relatively separated nuclei through a third intermediate atom 
that is located near to both nuclei. As a result, the NOE crosspeak intensity is 
virtually enhanced (or reduced) and its integral value is consequently 
misestimated, whereby often concluding that those protons lie closer to each 
other than they really are. The negative effects of the spin diffusion have been 
repeatedly reported [159-160], and they can arise both from intramolecular 
and intermolecular dipolar couplings. The predominant effect (intra/inter) will 
depend on how the intermediate nucleus is spatially arranged respect to the 
other two (Figure 3.14). Graphically, the alternative ROESY sequence is the 
most suitable method to detect spin diffusion peaks in a 2D spectrum, since 
they appear as signals with opposite sign respect to the real NOEs [161-162].  
 
 
Figure 3.14. Effect of the spin diffusion mechanism on the evolution of the NOE, 
depending on different geometrical factors. On the top, the NOE build-up curves 
considering different locations of the intermediate nucleus (H3), represented on the 
bottom (red/blue/green). The black curves represent the ideal case of an isolated two-
spin system. The colored dashed and dotted curves respectively represent the NOE 
evolution in the presence of intermolecular H3 or intramolecular H3. Adapted from 
[159].   
 
From a strict point of view, the quantitative determination of H-H distances is 
usually made by applying the initial slopes strategy again. To completely erase 





pairs are related to the initial slopes extracted from the exponential fitting of 
the NOE integral versus the mixing time. Of course, the time cost is higher as 
several 2D-NOESY spectra at different tmix must be recorded. Apart from spin 
diffusion, other problems may still arise from the protein background and the 
non-specific binding phenomena at high protein-ligand ratios [163]. Even 
using a large ligand excess, the intramolecular NOEs of the protein may hinder 
the precise determination of peak integrals, introducing moderate mistakes in 
the estimated distances. In this regard, the application of T2 or T1ρ filters to 
suppress the protein signals is highly recommended if quantitative analyses 
are going to be performed. Non-specific binding is a minor problem that does 
not seriously affect the determination of bound conformations in most of 
cases. There are several options to prove whether a recognition process is 
specific, although the most straightforward method consists of adding another 
specific ligand to check by competition the NOE intensity decay in the 
compound of interest. 
 
3.6. 19F-based T2 relaxation 
Within the aforementioned ligand-based approaches, nuclei relaxation is 
likewise applied to the study of binding events involving two entities with 
different sizes [164-165]. The mathematical expressions that provide the 
expected relaxation rates (R1 and R2) for a given system are rather complex 
and include several parameters, including dipolar and scalar couplings, 
chemical shift anisotropy (CSA) and chemical exchange [166-167]. However, 
an important variable shared by most of these factors is the correlation time 
(τC), also understood as the time that a given molecule needs to complete a 
turn around its own rotation axis (Figure 3.15). This time usually ranges from 
0.1 ns for small molecules to several tens of nanoseconds for typical 
macromolecules (e.g. 41 ns for BSA [168]). Therefore, observable changes in 
the line broadenings of a small molecule after adding a large receptor can be 
attributed to a binding event. The experimental methodology is essentially 
based on recording two experiments with the compound of interest, in the 
absence and in the presence of the receptor [169]. Indeed, the relative 
simplicity of this experimental setup has made this technique a common 
choice for accomplishing high throughput screening (HTS) [170-172]. 
Nevertheless, the measurement of relaxation rates requires a clean 
observation of the attenuated signals, something often difficult in 1H-NMR, 
especially when applied to the screening of mixtures containing many 
compounds [173]. A described solution consist of subtracting one spectrum 





spectrum similar to the STD experiment, that erases the signals from the non-
interacting compounds, exclusively leaving those from the bound ones [174]. 
Other approaches have relied on including T2 filters in 2D experiments like 
COSY or TOCSY, thus alleviating the signal crowding for better observing line 
widths [175]. Apart, a popular method broadly used to improve the sensitivity 
of the experiment consists of incorporating paramagnetic tags (e.g. TEMPO) to 
enhance the transversal relaxation rates [176], either attached to the 
macromolecule [177] or to another ligand already known [178]. The latter 
approach is generally employed to detect binders at secondary sites, placing 
the tagged ligand at the primary binding site.  
 
Figure 3.15. The evolution of the transversal (R2) and longitudinal (R1) relaxation rates 
for 19F and 1H as a function of the correlation time, τC. On the left, the dependence 
originated by dipolar couplings, and on the right, the contribution arising from the 
chemical shift anisotropy (CSA). Adapted from [167]. 
Aside from these options, research has progressively pointed towards the 
utilization of the 19F nucleus instead of the proton. The 19F isotope is very 
similar to 1H in terms of natural abundance and gyromagnetic ratio, which 
makes it as good NMR probe as the proton. Moreover, it offers numerous 
advantages from a practical point of view [179], and specifically for relaxation 
studies: 
 Whereas protons are intrinsically present in every (bio)organic molecule, 
the biological compounds are completely devoid of 19F. Then, this nucleus 
is always intentionally introduced in the analyzed ligands by chemical 
synthesis. Since only one or few fluorine atoms are generally introduced 
per molecule, the resulting spectra are considerably cleaner, displaying 
one signal per compound and eliminating the background arising from 





 The fluorine atom is remarkably more sensitive to its electronic 
environment, whereby NMR signals are typically spread over several tens 
of ppms. Together with the previous point, these features allow readily 
working with large mixtures of fluorinated compounds avoiding signal 
overlapping problems. 
 As a result from the chemical sensitivity mentioned in the latter point, 
the 19F nucleus becomes an excellent probe in order to measure 
transverse relaxation rates (R2 = 1/T2) for two reasons: firstly, the 
contribution of the chemical shift anisotropy (CSA) of the 19F to its global 
R2 leads to notable differences in the line widths between the free and 
the bound states [181]. Moreover, this extreme sensitivity is accentuated 
as the chemical environment is more perturbed. Then, the detection limit 
of these experiments can be expectedly improved at higher fields [182]. 
Secondly, the chemical exchange between both possible states 
(free/bond) when a receptor is present also makes T2 faster [183]. The 
mathematical expression that determines the contribution of the 
chemical exchange to R2 is known as the Swift-Connick equation (Eq. 19, 
[184]). Usually, since [L] >>> [P] in ligand-based methods, the fraction of 
free ligand (xF) is considered as 1: 
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Where xF/δF and xB/δB are the molar fractions and chemical shifts of the 
free and bound forms, respectively, R2B is the transverse relaxation rate 
of the ligand in the bound state, and τres is the residence time in the 
bound state, also interpreted as 1/koff. 
The dependence of the exchange contribution on the residence time (or 
1/koff), taking into account the other parameters (R2B, δB - δF), has been 
evaluated in detail many times, especially by C. Dalvit and co-workers 
[167,182], and is crucial to determine the range of applicability of 19F-T2 
experiments in the analysis of molecular interactions (Figure 3.16). These 
studies have highlighted that the chemical exchange is certainly one of the 
most relevant effects regulating the ligand relaxation rates for most of the 
protein-ligand systems usually investigated. In fact, when the difference in 
chemical shifts (δB - δF) is large enough, the exchange contribution is notorious 
even at very high protein/ligand ratios (low xB). This implies a double 





use really low amounts of receptor, even reaching pM concentrations [185]. 
On the other hand, the upper affinity limit becomes higher since weak binders 
(Kd = 10
-3-10-2 M) can be also detected as long as their koff values are of the 
same order as |δB - δF|. In addition, as deduced from the Swift-Connick 
expression, the influence of the chemical exchange does not depend on the 
protein correlation time, thereby enabling its effective application to small 
receptors as well [182]. 
 
Figure 3.16. Contribution of the chemical exchange to the transversal relaxation rate 
(R2) as predicted by the Swift-Connick equation, depending on τres (the inverse of koff). 
The two graphs are calculated for two different R2B, and each graph displays the 
variation predicted for three different δB - δF, expressed in Hz (100, 500 and 1000 
Hz).The upper scale shows the expected value of the dissociation constant in two 
different cases, for kon = 10
6 (Ms)-1 and kon = 10
8 (Ms)-1. Adapted from [167]. 
Experimentally, the relaxation rates are normally determined by means of two 
experiments: a routine 1H-1D in which the intensity of the fluorine signal is 
measured after a 90º pulse and an additional R2-filtered 
1H-1D in which the 
intensity of the fluorine signal is modulated after the initial 90º pulse by a 
spin-echo scheme, based on applying a train of 180º pulses separated by a 
delay “2τ” [186-187]. As a result, the latter experiment is merely a 1H-1D with 
an additional element that makes the fluorine signal to get weaker 
proportionally to its specific T2. This particular spin-echo scheme, as depicted 
in Figure 3.17A, is commonly known as the Carr-Purcell-Meibom-Gill (CPMG) 
pulse sequence [188-189]. The relationship between the observed T2 (T2,obs) 
and the signal attenuation is established as follows: 
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Where I0 is the signal intensity in the normal 
1H-1D spectrum, and “n” is the 
number of times that the 2τ + 180º interval is repeated (number of echoes). 
This is the simplest version of such an equation, since the complete expression 
includes another exponential term that adds the contribution of translational 
diffusion (“D”) and the magnetic field inhomogeneities (ΔB0) to the signal 
decay [182]. However, these contributions only become really significant 
when the 2τ period is too long, and hence, the value of “τ” should be 
reasonably chosen to work without considering that term. Analogously, if the 
2τ interval is too short, the evolution of the chemical shift is not suitably 
driven and the effect of chemical exchange is partially lost [190], what may 
deeply affect to the experiment sensibility. Generally, the number of echoes 
(“n”) is adjusted through a previous evaluation of the T2,free and the T2 
observed in the presence of the protein (T2,obs). By recording several CPMG 
spectra at different values of “n”, both decay curves are jointly represented 
and compared (Figure 3.17B). The best values ranges within the intermediate 
zone where it is high enough to appreciate how the ligand signal has been 
differently affected in the presence and absence of the receptor [191]. At 
longer or shorter “n” values, both signals (free/bound) display similar 
percentages of attenuation and comparisons may become unrealistic. Of 
course, T2 can be roughly estimated by directly applying Eq. 20 with a single 
CPMG experiment (with “n” and “τ” well adjusted), but the most accurate 
procedure by far consists of fitting the data from the aforementioned decay 
curves to Eq. 20. This is undoubtedly the best method not only to calculate 
transverse relaxation rates but also to evaluate whether there is specific 
binding or not [191]. In this regard, the acquisition of an only CPMG 
experiment is often reserved for screening purposes, namely detecting 
potential binders (hits) for a given receptor through the direct observation of 
line width changes in a fluorinated probe (spy  molecule) [192-193], for which 
the experimental setup has been previously optimized as detailed above.  
Competition experiments using a fluorinated compound as “spy molecule” 
have been repeatedly employed in order to indirectly determine binding 
constants of other specific binders of the same receptor [194]. For this 
purpose, the Kd of the spy molecule (KS) must be known a priori. With the 
dissociation constant, it is possible to readily determine xB at a given [S]0 
through Eq. 10, as already explained. Then, different values of xB are 
determined at different [P]0, and correlated with the corresponding signal 
decays experimentally measured in each case. The resulting exponential fit is 
subsequently used to interpolate new values of xB when the tested compound 





these data, the KS of the probe is recalculated as an apparent KS (KS
app) for 
each concentration of “C” used, and both variables are finally adjusted to Eq. 
21, which yields the dissociation constant of the tested molecule, KC. 
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Figure 3.17. A) The CPMG pulse sequence which provides an R2-filtered FID. After the 
hard pulse (90x), the 2τ+180x segment (echo) is repeated “n” times. “τ” and “n” are 
parameters of the Eq. 20. B) The signal decays observed at different “n” values for a 
relatively small compound in the absence (blue) and the presence (orange) of a much 
larger receptor. The optimal value of “n” to differentiate both states (free/bound) is 
graphically determined. 
3.7. 2D-DOSY for estimating the protein size 
The random translational motion that every molecule experiences in solution 
due to its internal kinetic energy is referred to as self-diffusion [195]. The 
parameter used to describe this phenomenon is called the diffusion 
coefficient (“D”), which quantifies the translational speed of a molecule.  
Self-diffusion is influenced by the physical properties of both the proper 
molecule (shape, size, charge) and the surrounding milieu (temperature, 
viscosity). Analogously to T2-filtered experiments, these physical properties 







diffusion into an observable NMR parameter [196-197]. Specifically, diffusion 
coefficients are routinely evaluated by pulsed-field gradient (PFG) sequences 
[198]. Broadly speaking, these experiments are based on the application of a 
gradient pulse that generates a variable magnetic field along the NMR tube 
(the “ ” axis). Under the influence of this magnetic gradient, each molecule 
experiences a different Larmor frequency which depends on its specific spatial 
position. In other words, the phase of the measured spins turns out to be 
spatially encoded at this point (Figure 3.18A). After a certain delay (Δ, 
diffusion time), an echo pulse (180º) is applied to remove the contribution of 
the chemical shifts and then, another gradient pulse removes the effects of 
the first pulse by refocusing all the spins again. In the most ideal case, if all the 
molecules would remain static at their initial positions, the second gradient 
pulse would allow to fully recovering the initial signal. However, due to 
Brownian translational motion, the molecules have already moved randomly 
away from their positions, whereby the signal cannot be well refocused and it 
is inevitably attenuated due to self-diffusion. The higher the diffusion 
coefficient is, the faster the molecular displacement is and consequently the 
weaker the NMR signals will be. The peak attenuation can be expressed as an 
exponential function that essentially depends on the diffusion coefficient (D), 
the diffusion time (Δ, delay for allowing the spatially-driven encoding) and 
other parameters related to the gradient pulse (strength, “g”, and duration, 
“δ”) and the observed nucleus (): 
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In the practice, this sequence is carried out several times by varying one of the 
parameters related to the PFG scheme (usually, the gradient pulse strength, 
“g”), giving rise to a series of 1H-1D NMR spectra in which the signals from 
each compound have been differently affected by their diffusion coefficients. 
Subsequent data processing, based on Eq. 22, leads to a pseudo-2D spectrum 
in which the direct dimension shows the normal proton resonances, while the 
second dimension separates these resonances according to the diffusion 
coefficient, commonly represented in logarithmic scale. This experiment is 
better known as Diffusion Ordered SpectroscopY (DOSY) (Figure 3.19) [199-
200].  
The standard PGF scheme was firstly developed by Stejskal and Tanner [201] 
(Figure 3.18B), and was subsequently improved with modifications aimed at 
suppressing undesired artifacts arising from signal modulation caused by spin-





by the presence of a variable B0 [204]. More problematic than eddy currents 
are convection currents created by temperature gradients [205]. In both 
cases, the diffusion coefficients are overestimated since these currents 
increase the molecular motions throughout the NMR tube. In this regard, 
several practical solutions have permitted to easily compensate temperature 
gradients in most of cases, such as applying a faster gas flow, using solvents 
with higher viscosities or spinning the tube at certain speeds [206].  
 
Figure 3.18. A) Phase encoding based on the position of every nucleus along the 
variable B0, generated by a gradient pulse GZ. After the spin-echo (180º), the 
magnetization is refocused through an identical GZ. B) The Stejskal and Tanner pulse 
sequence. Parameters: τ, delay between pulses; Δ, diffusion time; δ, gradient pulse 
duration; g, gradient pulse strength. Adapted from [201]. 
 
 
Figure 3.19. The 2D-DOSY experiment, in which the normal 1H-1D containing signals 
from three different compounds is expanded along a secondary dimension, thereby 
separating every signal from each compound according to its diffusion-driven 
attenuation. The vertical projection of this experiment (right) will display the three 
compounds independently separated and ordered by their respective diffusion 







As stated above, diffusion coefficients can be related to certain physical 
properties. Under the same solution conditions, two or more compounds can 
be distinguished by their diffusion coefficients, which are closely correlated 
with their molecular sizes through the Stokes-Einstein equation (Eq. 23). 
Hence, 2D-DOSY NMR is applicable to the determination of molecular sizes 
[207-208] and indeed it is usually considered as a non-invasive 
chromatography [209], since the indirect dimension can be interpreted as a 
size-ordered spin chromatogram (Figure 3.19). Noteworthy, the separation of 
the observed nuclei in the indirect dimension is purely virtual, and those peaks 
from different compounds resonating at very close or identical chemical shifts 
will appear as a “mixed” peak at an intermediate value of the diffusion 
coefficient contributed by both compounds [210]. For these cases, if the 
analyzed molecules cannot be well recognized, the best practical solution is to 
extend the information to additional dimensions, thereby alleviating signal 
overlap. As examples, the DOSY methodology has been successfully combined 
with COSY (3D-DOSY-COSY) [211], TOCSY (3D-DOSY-TOCSY) [212] and even 
HSQC schemes (3D-DOSY-HSQC) [213]. Another potential solution, although 
more complex, would be a multiexponential fit of the recorded data.   
 
  
   
     
                           
 
In the Stokes-Einstein equation, the hydrodynamic radius (rH) gives an 
estimation of the molecular size under the assumption of a spherical shape 
and supposing that the solvent is a continuous medium. Several other authors 
have updated this equation with additional terms that account for the size of 
the solvent molecules [214-215] and the non-spherical shape of the studied 
molecules [216-217]. In any case, the direct determination of this term once 
the diffusion coefficient is determined by NMR is rather unpractical, as it 
requires the previous determination of the solution viscosity (η). To avoid the 
introduction of large errors derived from additional calculations or 
approximations, a more straightforward method consists of directly 
comparing the diffusion coefficients of the unknown molecule and other 
reference molecule, whose size features (rH, MW) have been already 
determined or reported [218]. As has been done in this work, such an 
approach, if applied to macromolecules, would imply adding at least another 
reference protein whose size is in the same range as the studied system (e.g. a 
commercial protein like BSA) and it has to be measured in the same 
experimental conditions as the problem sample. Assuming certain 





as a function of the molecular weight (MW) instead of rH, and thereby the 
unknown molecular weight can be directly estimated as follows: 
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Where D and Dref are estimated by 2D-DOSY, and MWref is the molecular 
weight of the reference protein. If several reference compounds are available 
(e.g. a small library of commercial proteins), a better alternative consist of 
fitting the data to an approximate linear regression that would correlate the 
log10 D with the log10 MW, and then interpolate the unknown molecular 
weight once the experimental diffusion coefficient has been determined [219-
220]. 
 
It is worth mentioning that the 2D-DOSY also works as a ligand-based method 
to detect binding, as it is likewise based on observing a size-dependent NMR 
parameter [221]. However, its application is fairly limited to systems in which 
the exchange regime is predominantly fast, and thereby the ligand will 
expectedly exhibit a much lower diffusion coefficient in the presence of a 
large receptor [222-223]. For slow and intermediate exchange, if the ligand is 
very small, detection of binding become problematic as the free and bound 
states may appear as separated signals, and therefore, the signal of the free 
ligand could be interpreted as absence of binding and the signal of the bound 
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CHAPTER 4: DC-SIGN RECOGNITION OF THE 






































Carbohydrates are undoubtedly the most abundant biomolecules in nature. In 
living organisms, these compounds play diverse roles that remain essential for 
the maintenance of homeostasis. Namely, they serve as energy source 
(glucose metabolism), as structural components of the cell wall, or as markers 
for ensuring the proper folding of newly synthesized polypeptides and the 
stability, solubility and trafficking of the final glycoproteins [1-2]. Additionally, 
as exemplified in Chapter 1, glycans are essential at the surface of all types of 
cells due to their role of molecular recognition elements in the establishment 
of cell-cell or host/pathogen dialogs, as well as many other processes 
including cell proliferation and differentiation [3-4]. 
 
From a structural point of view, simple carbohydrates work as building blocks 
in the assembly of highly complex glycan structures. Similar to proteins and 
nucleic acids, the number of “letters” that form this “sugar code” is limited to 
less than 15 monosaccharides [5-6]. However, the particular structural 
features of these molecules, such as the existence of two possible anomers 
and the functionalization with multiple hydroxyl groups (4 available in the 
most common pyranoses, Glc, Gal and Man), enormously increases the 
versatility of such compounds as essential bricks in nature [7]. Such a degree 
of complexity is actually observed in living cells, although not all the possible 
combinations are really found due to the limited availability and specificity of 
the glycosyltransferases in charge of catalyzing the formation of new 
glycosidic bonds [8]. The additional complexity comes then from other aspects 
regarding the accessibility of the glycan to the receptor and its conformational 
flexibility, which both finely determine the correct glycan presentation that 
makes the sugar-receptor interaction feasible [6]. Also indirectly, these 
properties influence the recognition event by affecting the enthalpy-entropy 
compensation already known for sugars [9]. Overall, glycan flexibility governs 
multiple factors concerning the affinity and significance of a given epitope, for 
instance, it determines how high the entropic penalty will be due to 
desolvation or loss of conformational freedom [10-11], or whether a terminal 
sialic acid moiety is an adequate substrate for a particular receptor depending 
on to which position of the preceding sugar is attached (e.g. the α2-3- or the 
more flexible α2-6 linkage) [12]. An additional level of complexity is finally 
reached when natural glycans are jointly considered as taking part in the 
extensive network of varied sugars that coats the cell membrane. This “sugary 
coating of cells” is commonly named as “glycocalix” *13-14], and all the 
existing glycoproteins and sugar-containing entities are perfectly organized 
and their density is strictly regulated [15]. Thus, they work in consonance with 




their corresponding receptors to maintain a fine equilibrium that allows the 
cell to suitably display unique molecular patterns, thereby communicating 
with the neighboring cells as well as with cells from the innate and adaptive 
immune system [16]. In fact, both an altered sugar composition and an 
abnormal amount of certain sugar receptors are known hallmarks of cancer 
and autoimmune diseases [17-18], and hence a potential source of biomarkers 
and targets for biotherapeutics [19]. 
 
As mentioned, glycosyltransferases (GnT) [20] are the enzymes responsible for 
elongating and branching the initial heptasaccharide precursor Man5GlcNAc2 
in mammals [21-22], increasing their glycan diversity. Usually, these GnTs 
carry out the elongations by attaching successive LacNAc disaccharides 
(Galβ1-4GlcNAc), and eventually, the branch is capped with a terminal 
characteristic motif [7,23]. Since the most accessible positions of these long 
sugar chains are commonly the terminal caps, these are often the target of 
specific protein receptors, and hence can be considered as “self” signatures. 
Among these “self” motifs, the most prominent and studied ones are sialic 
acid and histo blood group antigens. Sialic acid is a single monosaccharide 
recognized by diverse receptors, including host proteins like siglecs [24] and 
pathogen receptors like hemagglutinin from influenza virus [25]. In contrast, 
the term “histo blood group antigen” is applied to a series of several antigens 
that share a common feature: terminal fucosylation.  
 
Usually, two distinctions are done, namely the ABO antigens and the Lewis-
related antigens, although all of them are biologically generated from the 
same initial precursor (Figure 4.1A). Such a precursor is a disaccharide unit 
composed of Gal and Glu that is intercepted by specific fucosyl- (FT) and 
sialyltransferases (ST) [26]. The final architecture of a given histo blood group 
antigen will then depend on the specific set of GnTs that the individual 
possesses, which will determine the initial precursor (at least six types 
described), and the subsequent modifications driven on it. Thus, due to GnT 
polymorphisms [27], glycan composition and self-motifs vary among different 
individuals of the same species, what can be understood as a useful natural 
self-protection strategy to guarantee the surveillance of a certain population 
against carbohydrate-mediated infections or pathologies.  
 
As defining structural features, ABO antigens are α1-2-fucosylated, whereas 
Lewis-type antigens can be either α1-3 or α1-4-fucosylated (Figure 4.1A). 
Moreover, after the first fucosylation, the terminal Gal may be fucosylated 
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again (Lewis B/Y types) or alternatively sialylated (sialyl-Lewis A/X types) [26]. 
In contrast, ABO antigen biosynthesis is always ended up after the 








Figure 4.1. A) Biosynthetic routes that give rise to the different histo blood group 
antigens found in mammalian cells. For each particular transformation, the 
corresponding GnT is indicated in green. FT: fucosyltransferase; GT: 
galactosyltransferase; ST: sialyltransferase. On the right, the six types of disaccharide 
precursors are represented. B) Structures of the blood group antigens A and B type VI 
used in this work. 
 
The following chapter compiles most of the results achieved along this 
dissertation, focused on studying the recognition of the histo blood group 
A) 
B) 




antigens A and B (Figure 4.1B). Particularly, the tetrasaccharides used herein 
have their core Gal linked to a reducing Glc through a β1-4 bond, whereby 
they are both type VI antigens. The common denomination “blood group” 
applied to these structures was firstly coined by Karl Landsteiner, an Austrian 
physician and immunologist who firstly realized that the blood agglutination 
resulting from mixing blood samples provided by two different patients was 
provoked by the presence of specific molecular patterns, which he identified 
and named as blood group antigens (three different, A, B and O) [30]. Soon, 
these antigens were discovered to be also in other tissues like gut, skin, 
respiratory tract and even neurons; and in biological fluids such as saliva [26]. 
In this regard, the prevalence of the classical name “blood group antigens” 
simply comes from the circumstances concerning their discovery and their 
particular usefulness in transfusion medicine. 
 
4.1. Receptor production 
Nuclear magnetic resonance allows the study of molecular recognition 
phenomena in solution. Hence, for the studies carried out herein, a soluble 
form of the DC-SIGN protein had to be firstly afforded in a suitable buffered 
medium, supplemented with the corresponding oligosaccharides of interest. 
Given that DC-SIGN is a membrane protein, the full protein sequence only 
exists as a correctly folded and functional structure in the presence of a 
bilayer membrane constituted by amphipathic lipids. According to the existing 
literature [31-33], carbohydrate-protein interactions involving this kind of 
lectins are always investigated by exclusively making use of the extracellular 
soluble portions. Specifically, the carbohydrate recognition domain (CRD) 
constitutes the minimum relevant fragment needed to undertake molecular 
recognition studies, since in most of cases this region has its own structural 
integrity and its folding does not depend on the neck regions. In addition, the 
expression of the full extracellular domain (ECD: CRD + neck) is a common 
strategy usually employed as well. The main advantage of this latter method is 
that the oligomeric state of the protein can be maintained, as the neck regions 
often take part in the corresponding oligomerization processes. Thus, the 
native state of the receptor of interest is better reproduced as well as it also 
enables the study of other events affecting the binding, as clustering effects, 
for instance. Herein, both the CRD and the ECD of DC-SIGN were produced by 
protein expression protocols in living systems, in enough amounts for 
performing the NMR experiments. Additionally, the CRD was also expressed in 
isotopically enriched media to prepare samples uniformly labeled either with 
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only 15N or with 15N and 13C, which served for performing the corresponding 
heteronuclear NMR experiments.  
4.1.1. Protein expression 
The DNA fragments containing the CRD and ECD sequences were respectively 
inserted in a pET15b plasmid (Thermo Fischer Scientific). The CRD fragment 
comprised 151 amino acids, from His254 to Ala404, while the ECD sequence 
included 185 additional residues which constituted the neck segment, starting 
from Glu70 [34]. To note, in the native protein N80 is glycosylated, although 
the biological role of such a glycosylation is still unclear [35]. In either case, 
the presence of glycans at that position does not influence the structural 
stability of the ECD, and therefore there was not any drawback associated to 
the expression of this construct in bacterial media, completely devoid of 
glycosylation machinery. Apart, the CRD construct was initially designed with 
an additional His-Tag fragment linked to the N-termini 
(MGSSHHHHHHSSGLVPRGSHML). In principle, the purpose of this modification 
was to test whether a faster and more straightforward purification of the CRD 
was possible by means of a simple Ni2+-containing His-Trap. Unfortunately, the 
CRD could not be efficiently purified and other options were considered, as 
subsequently detailed.    
The corresponding plasmids were amplified in E. Coli cells (DH5α strain) by 
thoroughly following the standard protocol specified in the QIAprep® Spin 
Miniprep Kit (250), using the suitable buffers included in the kit. The final 
concentrations of the isolated plasmids were variable but always ranging 
around 100-150 ng/µL, as confirmed by UV absorbance measured at 260 nm. 
With these amounts, 2-3 µL of the plasmid were enough to inoculate a small 
aliquot containing BL21/DE3 cells. After the thermal shock at 42º, the 
transformed cells were incubated in LB medium at 37ºC to obtain competent 
colonies. Then, precultures of 100 mL in LB medium were prepared from 
single colonies, and grown overnight at 37ºC in the presence of 100 mg/l of 
ampicillin. Those precultures were then diluted up to 1 L of final culture in LB 
at 37ºC, and supplemented with 100 mg/L ampicillin. Under continuous 
shaking (180 rpm), the cells were allowed to grow until reaching an optical 
density of 0.60-0.65 (600 nm). At that moment, the protein expression was 
induced by adding 1 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG) and 
the exponential growth was prolonged for 2.5 to 3 hours, maintaining a 
constant temperature of 37ºC. Following this methodology, the final ODs 
achieved were about 4.0-5.0 for each liter prepared. These results were 
similar for the CRD and for the ECD. Eventually, the produced cells were 




harvested at lower temperature (4ºC) by centrifugation, and the resulting 
pellets were resuspended in the minimal amount of Tris 10 mM buffer (pH = 
8) and stored at -80ºC. 
The preparation of the isotopically labeled CRD was carried out through a 
different protocol. After obtaining competent BL21 cells expressing DC-SIGN, 
small pre-inocules of 5-10 mL were prepared in LB from single colonies. These 
precultures were grown overnight at 37ºC under gentle shaking. Afterwards, 
each preculture was directly diluted into 1 liter of sterile M9 minimal medium 
containing 100 mg/L ampicillin, as well as other supplements (biotin, 
thiamine) and necessary ions (Ca2+, Mg2+, Na+, Cl-, SO4
2-…). As expected, the 
cell growth was significantly slower for two reasons: the low starting OD (10 
mL of competent cells diluted into 1 L) and the intrinsically harder cell 
development in a M9 medium, containing limited nutrients. Even so, ODs 
close to 0.40-0.45 could be reached within 5-7 hours at 37ºC. This 
methodology permitted to skip the intermediate overnight preculture in 100 
mL of M9, such that the uniformly labeled protein could be efficiently 
expressed in two days as much. Of course, the initial amount of LB pre-inocule 
(without labeled components) had to be very small in comparison with the 
final volume, thereby guaranteeing a percentage of isotopic labeling above 98-
99%. In contrast to the normal methodology, this protocol was proved to be 
rather inefficient when the induced cultures were grown for few hours at 37º 
C. Thus, after reaching ODs between 0.40-0.45, the temperature was 
decreased to 24 ºC, and the cell induction with IPTG was carried out as soon 
as the OD surpassed 0.60, maintaining the constant shaking at every moment. 
Then, the exponential growth was allowed to progressing overnight at 24 ºC, 
thereby maximizing the protein overexpression and minimizing the adverse 
effects of protease-mediated degradations. By means of this protocol, the 
final ODs achieved were slightly lower (about 3.0-3.5), but still large enough 
for the preparation of NMR samples.  
4.1.2. Protein purification 
The purification protocol used herein was similar to those already reported in 
previous works [36-37], with some little modifications to adapt the protein 
production to the available equipment and to the final purpose of the 
prepared samples. For both the CRD and the ECD, the applied methodology 
was equivalent, and it basically consisted of two steps of protein separation 
and isolation through chromatography techniques, preceded by a refolding 
process using dialysis.   
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First, the stored pellets were thawed and quickly resuspended in a larger 
volume of Tris 10 mM, always maintaining the temperature below 4ºC and the 
pH at 7.8-8.0. To extract the produced protein from the bacteria, the cells 
were immediately lysed by sonication. Complete cell lysis was efficiently 
achieved after 18 cycles of sonication (30 seconds each, tburst = 1 sec., Amp. = 
60%) leaving 1 minute of resting between consecutive cycles. Then, the 
soluble components of the cell debris were subsequently separated from the 
insoluble fraction by ultracentrifugation at 30000 rpm (1 hour, 4º C). By SDS-
PAGE (4-12%), the protein was confirmed to remain unfolded at the insoluble 
fraction of the sonicated pellets, forming inclusion bodies as previously 
reported [36,38]. Once the inclusion bodies were isolated, the construct was 
primarily solubilized as completely unfolded linear peptide chains, in the 
presence of strong denaturing conditions, namely, urea 6 M and β-
mercaptoethanol 10 mM (~0.05% v/v). To note, the pH value along all the 
purification steps was always set to 8.0, using Tris.HCl to buffer the solution. 
The pellets were manually smashed and ground in a glass mortar while 
applying the denaturing buffer. Specifically, at least 8 mL of the solution were 
added per liter of cell culture present in the pellet. Once finished the 
resuspension (almost homogeneous opaque solution), the resulting mixture 
was quickly sonicated again (4-5 additional cycles using the same setup) and 
gently stirred overnight at low temperature, at least for 15-20 hours. After 
several tests, these guidelines were checked out to be optimal for recovering 
the maximal amount of protein from the inclusion bodies (Figure 4.2, cols. 1-
2). In particular, the sonication steps (also after the solubilization in urea) 
were key to extract notable amounts of protein from the cellular media and 
largely increased the final yields, whereby the duration of this stage was 
always thoroughly controlled by SDS-PAGE evaluation of the retired fractions. 
Once the solubilization was achieved, the residual insoluble cell components 
were sedimented by ultracentrifugation at 40000 rpm for 2.5-3.0 hours (4 ºC), 
and the supernatant layer containing the soluble protein was carefully 
decanted. In this regard, those liquid fractions located on the bottom of the 
centrifuge tube were preventively discarded, since they showed an increased 
viscosity as a result of high concentrations of nucleic acids, as checked by UV 
absorbance (260 nm). The subsequent dialysis in the presence of these 
impurities was noticed to somehow hamper the progressive folding of the 
protein, instead favoring intense re-precipitation phenomena and giving rise 
to an important loss of soluble protein. In these cases, when the residual 
pellet still displayed a marked amount of protein, the solubilization was 
repeated again to improve the protein yields.  




The final supernatants contained the soluble unfolded protein mixed with 
other soluble biomolecules from E. Coli. The liquid fractions collected were all 
placed into a semipermeable membrane, and stepwise dialyzed in three 
different buffers (pH = 8.0) containing decreasing amounts of urea (4 M, 2 M 
and 0 M respectively). Each dialysis step was performed for 24 hours at 4 ºC, 
under gentle stirring and against 5 L of dialysis buffer. Importantly, the 
structural integrity and functionality of the protein required the presence of 
fixed amounts of Ca2+ (10 mM) and β-mercaptoethanol (0.01% v/v) 
throughout the entire refolding process [39]. A moderate ionic strength (150 
mM NaCl) was also mandatory to hamper undesired aggregation phenomena 
promoted by the hydrophobic parts of the protein, which will constitute the 
core of the folded scaffold [40]. Under these conditions, the protein could be 
successfully folded into its functional three-dimensional shape after three 
days, and neither chaperones nor disulfide isomerases were further needed 
along this purification step [41]. To highlight, other authors have efficiently 
accomplished the protein folding in the presence of glutathione as molecular 
system to adjust the redox potential [38]. However, in our particular 
conditions, the β-mercaptoethanol provided the impetus to form all the 
disulfide bonds present in the CRD (three) and in the ECD (four) constructs.  
 
Figure 4.2. Purification steps monitored by 4-12% SDS-PAGE (1% β-mercaptoethanol) 
for the 15N-labeled CRD (from 12 L of M9 culture). Column legend: M) Marker. 1) 
Supernatant containing the solubilized inclusion bodies (6 M urea). 2) Remaining 
insoluble pellet in 6 M urea. 3) Residual pellet precipitated from the dialyzed solution 
of the protein. 4) Flow-through collected during the protein loading into the Man-
sepharose column. 5) Column wash (>100 mL) after protein loading. 6) to 9) First four 
fractions eluted from the affinity column (5 mL EDTA 10 mM). 10) Fraction collected in 
the 15
th
 elution (>75 mL EDTA). 11) Fractions collected from the AKTA containing the 
pure monomer. 12) Flow-through during the concentration steps (negative control). 
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During the last dialysis step, a residual precipitate was always observed, which 
presumably corresponded to the remaining aggregated unfolded proteins and 
other smaller components, whose solubility depended on the urea. Thus, 
whereas the times for the intermediate dialysis steps were rather flexible 
(around 20-30 hours), the last step (0 M urea) had to be carefully controlled, 
since the prolonged exposition of the functional protein to the unfolded 
components of the precipitate favored the progressive loss of the already 
folded protein. In this scenario, the dialysis membrane was routinely removed 
after a reasonable time (16-24 hours) while the percentage of insoluble 
precipitate was low enough yet (Figure 4.2, col. 3). In all cases, this precipitate 
was immediately separated by ultracentrifugation at 25000 rpm (30 min, 4 ºC) 
and discarded.  
The folded functional protein was subsequently purified by affinity 
chromatography, taking advantage of the natural ability of DC-SIGN to 
selectively recognize Man. Following the methodology already described [36-
37], a mannose-sepharose column was employed to separate DC-SIGN from 
the rest of soluble E. Coli biomolecules. The solution containing the folded 
protein was mixed with 10 mL of mannose-sepharose beads previously coated 
with the loading buffer (25 mM Tris-HCl, 150 mM NaCl, 10 mM CaCl2, pH = 8), 
and the resulting mixture was vigorously stirred overnight to ensure the 
maximal percentage of protein attachment. Afterwards, the stationary phase 
was allowed to depositing at the bottom of the cartridge, and the upper 
solution layer was fully passed through without applying vacuum or pressure. 
The beads were then washed with the same loading buffer (at least 100 mL) to 
remove any other protein attached in a non-specific fashion. In many cases, 
the amount of protein incubated with the beads was higher than the limit 
concentration that these beads could harbor. Then, the collected flow-
throughs and washes were stored at 4º C for subsequent loadings after 
checking, by SDS-PAGE, that they still contained important amounts of non-
retained protein (Figure 4.2, cols. 4-5). Once loaded and separated from the 
starting mixture, the DC-SIGN construct was eluted from the stationary phase 
by disrupting the Ca2+-dependent recognition of Man with EDTA 10 mM. The 
elution was performed stepwise by adding small amounts of the elution 
buffer, up to 5 mL (25 mM Tris-HCl, 150 mM NaCl, 10 mM EDTA, pH = 8). After 
each addition, the column was gently shaken for 15-20 min, and then the 
buffer was passed through and collected in fractions of about 1 mL. The 
protein concentration in these fractions was individually checked by UV 
absorbance at 280 nm. The first fractions often provided lower yields, since 
the added EDTA firstly sequestered the free calcium ions present in the 




loading buffer that coated the column beads. From this point, the amount of 
extracted protein exponentially decreased along successive elutions, and the 
process was stopped when the measured absorbances were close to the 
detection limit of the device (A = 0.05-0.10) (Figure 4.3). Then, the elution was 
considered as finished. The analyses of the recorded absorbances 
corroborated that the amount of extracted protein surely ranged within 96-
98%. After several purifications, these columns were proved to harbor a total 
amount of protein that could be eluted with ca. 50-60 mL of EDTA 10 mM (10-
12 elutions of 5 mL) (Figures 4.3 and 4.2, cols. 6-9). Additionally, the efficiency 
was checked to slightly increase when the added volumes of chelating agent 
were smaller than 5 mL (same number of elutions but a lower EDTA total 
volume).  
 
Figure 4.3. Absorbances measured at 280 nm (ελ = 52855 M
-1 cm-1, estimated from 
ProtParam) for the 60 first fractions collected along 12 successive elutions with EDTA 
10 mM (5 mL each).The displayed data correspond to the eluted fractions from the 
first protein loading (dark bars) and the subsequent re-loading of the remaining 
protein contained in the flow-throughs (light bars).  
Finally, the purity and the size of the isolated protein were assessed by size 
exclusion chromatography (SEC). Due to the partial misfolding experienced by 
the protein in the absence of Ca2+, a small amount of the protein was detected 
to form fine white threads, as a result of total unfolding. Although the 
percentage of lost protein was minimal (undetectable changes in the UV 
absorbance) these colloidal particles were preventively removed by 
centrifugation at 4000 rpm (4 ºC), thereby avoiding a synergic and faster 
progression of the unfolding process. For the SEC run, dextran-based columns 
(Superdex) were used for both constructs, CRD and ECD. Importantly, as 
previously reported [41], the protein cannot be eluted in native conditions 
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when these columns are employed in the presence of Ca2+. The stationary 
phase is basically composed of dextran, a polymeric carbohydrate containing 
Gal and Glc. Even though DC-SIGN exhibits a weak affinity for these sugars, the 
interaction is strong enough to preclude the elution of the protein, and it 
remains bound to the column in any case (Figure 4.5). Then, the collected 
fractions from the Man-sheparose column were directly injected to the 
Superdex column and eluted in the presence of EDTA as well (25 mM Tris-HCl, 
150 mM NaCl, 1 mM EDTA, pH = 8). Given the large total volume of the mixed 
fractions (50-60 mL), the most diluted ones (below A = 1) were primarily 
concentrated in membrane filters by centrifugation at 2500 rpm (4 ºC).  The 
consensus absorbance for the injected samples was set within the 1-2 range 
(below 50 μM), since higher protein concentrations in the absence of calcium 
favored a faster appearance of precipitated protein.  
 
 
Figure 4.4. SEC elution profiles for the ECD (Top, Superdex 200, flow rate = 2.5 mL/min) 
and the CRD (Bottom, Superdex 75, flow rate = 1 mL/min). 





Figure 4.5. Gel filtration profiles (Tris-HCl, pH = 7.4) obtained for the DC-SIGN CRD 
when eluted in the presence of either 1 mM EDTA (solid line) or 1 mM CaCl2 (dashed 
line). Adapted from [41]. 
The ECD was eluted in a Superdex 200 column, giving a single elution peak at a 
retention volume of 141 mL, which corresponded to the self-assembled 
tetramer (Figure 4.4, top). The corresponding fractions containing the pure 
tetramer were collected and mixed for further concentration. The scenario 
was remarkably different for the CRD, which was eluted through a Superdex 
75 column. In particular, the successive runs constantly allowed the 
visualization of two main elution peaks, appearing at retention volumes of 60 
and 72 mL, respectively (Figure 4.4, bottom). Interestingly, the second elution 
peak, corresponding to the smallest biomolecule, was always the most 
intense, while the other one was rather variable and usually displayed a 
concentration between 25-75% of the major component. The molecular sizes 
associated to these elution volumes were evaluated by means of a linear 
regression built from five standard patterns already provided by the column 
manufacturer (Figure 4.6A). The estimated size for the major peak was 20.6 
kDa, reasonably close to the expected molecular weight of the DC-SIGN 
monomer (19.9 kDa). Surprisingly, the other elution peak at 59.9 mL displayed 
a size of about 41,4 kDa, close to twice the molecular weight of the monomer, 
what suggested that this second component corresponded to a CRD dimer. At 
first, it was unknown why the formation of these dimers was possible, since 
the DC-SIGN CRD has been actually reported to exclusively exist as a monomer 
in the total absence of any amino acid repeat from the neck [35]. However, 
taking into account that the designed construct included an odd number of 
cysteine residues, the possibility that the remaining free cysteine was involved 
in the formation of disulfide bonds bridging two CRDs was considered. In fact, 
the counterpart cysteine of C384 was C253, which was not present in the 
expressed sequence. Both residues are located on the terminal unstructured 
regions of the CRD, and hence, presumably accessible to the solvent. This 
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hypothesis was quickly assessed by SDS-PAGE using a marker without β-
mercaptoethanol to preserve the cystin groups, which actually enabled the 
observation of two migration bands, instead of one (Figure 4.6B). Even so, the 
observation of two elution peaks was significantly reduced but not completely 
solved in the presence of β-mercaptoethanol (0.01%). In fact, several further 
tests showed that pure fractions of the monomer tended to reconstitute the 
dimer again when re-injected in the AKTA system. Certainly, the presence of 
EDTA somehow favored this process as well, since the ratio dimer/monomer 
markedly decreased as the time lapse between the elution from the Man-
sepharose column and the SEC run was reduced, whereby the time that the 
CRD was under non-native conditions was crucial. These findings suggested 
that the partial deconstruction of the loop regions in the absence of Ca2+ led 
to the unspecific association of the monomers, similar to the association 
phenomena observed for any unfolded protein. Therefore, an equilibrium 
monomer-dimer was being established and it seemed to be contributed by 











Aprotinin 92 6500 3.813 
Ribonuclease A 78 13700 4.137 
Carb. Anhydrase 66 29000 4.462 
Ovoalbumin 57 43000 4.633 
Canalbumin 52 75000 4.875 
    
Peak A 59.9 41444 4.617 
Peak B 71.7 20672 4.315 
*Aprox. values provided by the manufacturer. 
 
A) B) 




Figure 4.6. A) Verification of the molecular weights expected for the two species 
reported along the purification of the CRD construct in the Superdex 75 column. B) 
Fractions extracted from the Man-sepharose chromatography analyzed by SDS-PAGE 
in different conditions. Col. 3: fraction loaded with the normal buffer (1% β-
mercaptoethanol). Cols. 1&2: Fractions loaded in the absence of reducing agents after 
thermal denaturation. 
The nature of the described monomer/dimer equilibrium was further analyzed 
by NMR to try setting a series of experimental guidelines that could minimize 
the dimerization event during the interaction studies with ligands. Specifically, 
the ratio monomer/dimer was analyzed through Diffusion Ordered 
SpectroscopY (2D-DOSY) starting from a sample that remained several days at 
room temperature, in the sole presence of Ca2+ 4 mM, without either reducing 
agents or EDTA. Under such conditions, a 2D-DOSY spectrum of the sample 
was acquired at 310 K and its diffusion coefficient was determined from the 
indirect dimension. In parallel, the corresponding diffusion coefficients of 
three commercial proteins (BSA, Carbonic Anhydrase and Lysozyme) were 
estimated in the same conditions (310 K, buffer Tris with Ca2+ 4mM and pH = 
8) through independent 2D-DOSY experiments. The measured D coefficients, 
together with their respective known molecular weights, were used to build a 
regression function that correlated the experimental diffusion coefficients 
with the corresponding molecular sizes [42-43]. Then, the average molecular 
weight of the previous sample of DC-SIGN was interpolated through this 
mathematical function, and the resulting value suggested that the ratio 
monomer/dimer was about 40:60 (Figure 4.7).  
Interestingly, when the 2D-DOSY was recorded again in the presence of 10 
mM Man, the sample size was noticed to diminish below 24 kDa, what was 
indicative of an 80-85% of monomer in solution. Eventually, the addition of a 
little excess (0.5 mM) of dithiothreitol (DTT) sharply shifted the diffusion 
coefficient to higher values, suggesting the almost exclusive presence of the 
monomer and only marginal percentages of the dimer. On the basis of these 
findings, and given that the oxidation/reduction process was the major event 
contributing to this dimerization phenomenon, all further NMR measurements 
were always performed in the presence of at least 2 mM DTT to avoid the 
existence of several species with different sizes and minimize the impact of 
the monomer/dimer equilibrium in the protein degradation.  Although less 
pronounced, it is also worth noting that the carbohydrate binding event 
seemed to play a role in the self-association process, presumably improving 
the rigidity of the long loop close to the binding site and precluding the 
unspecific association that could be driven by these flexible regions. 












Lysozyme 14300 4.1553 -9.76 - 
Carb. Anhydrase 29000 4.4624 -9.88 - 
Bovine Serum Albumin 66200 4.8208 -10.06 - 
     
DC-SIGN  32522 4.5122 -9.91 0.37 
DC-SIGN + 10 mM Man 23252 4.3665 -9.85 0.84 
DC-SIGN + 0.5mM DTT 18485 4.2668 -9.80 ~1.0 
 
 
Figure 4.7. 2D-DOSY-based calculation of the average molecular weight of the CRD 
construct under different conditions. The experimental values of the diffusion 
coefficients (D) were taken from the vertical projection of the 2D-DOSY (D-based 
chromatogram), as shown on the bottom figure. The ratios monomer/dimer (last 
column) are estimated through the real molecular weights related to the monomer 
(19990 Da) and the dimer (39980 Da). 




The pure protein fractions collected from the AKTA system were mixed and 
concentrated by centrifugation at 2000-2500 rpm (4 ºC) in a membrane filter. 
Then, the protein was washed within the same filter with a non-deuterated 
buffer containing Tris-HCl and NaCl (pH = 8), as well as 4 mM CaCl2 and 2 mM 
DTT, thereby restoring the Ca2+ and removing the EDTA. At least four washes 
were performed in which a dilution factor of 1:10 was applied each time, thus 
leaving a residual concentration of EDTA below 1 μM in all cases. Eventually, 
the buffer was changed to the suitable NMR conditions following the same 
guidelines, and making use of deuterated compounds (25 mM Tris-d11, 150 
mM NaCl, 4 mM CaCl2, 2 mM DTT-d10, pH = 8). For the CRD assignment and 
the 15N-HSQC-based titrations with the uniformly labeled samples, the buffer 
was prepared in H2O/D2O 9:1, enabling the observation of the exchangeable 
NH groups, while the experiments from the ligand point of view were better 
recorded in the presence of high purity D2O (99.99%, [H]min = 10 mM). As 
described above, the buffer change took four concentration stages again, 
thereby applying a total dilution factor of 104 to the initial non-deuterated 
components, which reduced their concentrations below 5 μM and efficiently 
erased their NMR signals from the proton spectrum. The final pure and 
concentrated protein was eventually distributed in aliquots of a given 
concentration according with the planned experiments, and stored at -80 ºC. 
 
Figure 4.8. Control 1H-1D spectra of the purified monomeric CRD recorded at 310 K (25 
mM Tris-d11, 150 mM NaCl, 4 mM CaCl2, 2 mM DTT-d10, pH = 8) in the presence of 50 
equivalents of Man3 (blue), and after adding 10 mM EDTA to the same sample (red). 
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In average, the global overexpression and purification processes afforded 1.5-
1.7 mg of protein per liter of grown culture. Routinely, the integrity and 
folding of the protein were verified by NMR after finishing the purification, 
checking the peak broadening of the protein profile in the 1H-NMR 1D 
spectrum (except for those peaks from Tris or DTT, if visible) and specially 
monitoring the presence of several nuclei shifted below 0 ppm, which typically 
correspond to the aliphatic sidechains (Ile, Val, Leu) located on the inner parts 
of a folded scaffold (Figure 4.8). These peaks quickly disappeared after adding 
EDTA to the sample, suggesting severe changes in the protein folding when 
Ca2+ is absent. Also, the binding abilities of the purified DC-SIGN constructs 
were tested by STD NMR. Two STDs were acquired at 310 K in the presence of 
a large excess of the Man3 trisaccharide, a known ligand of this lectin. Either 
under aliphatic or aromatic saturation, an STD profile could be observed when 
the lectin was into the NMR tube, thus confirming the carbohydrate binding 
ability of the used construct (Figure 4.9). 
 
Figure 4.9. STD profiles obtained for the Man3 trisaccharide at 310 K in the presence of 
the DC-SIGN CRD (tsat = 2 sec.). As displayed, the ligand could be saturated (red dashed 
box) by applying the selective pulse at three different resonances (0.96 ppm (blue), 
0.00 ppm (red), 7.31 ppm (green)), thereby confirming the interaction of the 
oligosaccharide with the expressed construct.   




4.2. CRD backbone assignment 
To study the interaction of the blood group antigens with DC-SIGN from the 
receptor point of view, the CRD rather than the extracellular domain (ECD) 
was used to make the relaxation mechanisms T1 and T2 less efficient and then 
maximize the signal-to-noise ratio along the data acquisition [44]. Using the 
15N-labeled CRD samples, a series of quick tests were performed to choose the 
proper work temperature. At first, the studies performed by the groups of 
Prestegard [38] and Dixon [32], respectively using DC-SIGN and L-SIGN, were 
chosen as references. In both cases, the assignment and subsequent titrations 
were conducted at physiological temperature: 37º C. This is, in principle, the 
correct choice for getting realistic results in binding analyses, but not 
mandatory for the CRD assignment. In the latter case, it is better giving 
priority to seek for optimal acquisition conditions during the three-
dimensional NMR experiments.  
 
Figure 4.10. Overview of the 
1
H-1D spectra of DC-SIGN CRD recorded at three different 
temperatures. The regions where the signal broadening is easily seen are indicated by 
green arrows. 
Both 1H-1D and 15N-HSQC experiments showed a progressive signal 
broadening as the temperature was decreased from 310 K (37ºC). In the 1D 
spectra (Figure 4.10), this was specially noticed for the aliphatic resonances 
around 0 ppm and the NH region between 6-8 ppm. The 15N-HSQC at 298 K 
(25ºC) displayed multiple weakened peaks (Figure 4.11), and surprisingly, at 
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283 K (10ºC) most of the CRD backbone peaks were no longer visible, except 
for those from the disordered protein regions in the middle of the spectrum. 
Thus, local protein motions in folded regions were noticed to get slower, 
moving from a fast-exchange regime to an intermediate-regime in which many 
signals were notably reduced due to coalescence phenomena. Consequently, 
the three-dimensional CRD assignment was conducted at 310 K.    
 
Figure 4.11. Superimposition of the 15N-HSQC spectra of DC-SIGN CRD acquired at 310 
K, 298 K and 283 K, respectively. 
The group of Prestegard had already deposited the backbone assignment of 
the DC-SIGN CRD in the BMRB database, with the accession code 19931 
[38,45]. However, at the first sight, striking differences were detected 
between our protein fingerprint and some peak positions reported in the 
deposited file (Figure 4.12). Namely, several expected correlation peaks did 
not appear in our experiment (yellow diamonds), and conversely, we 
visualized additional spin systems not reported before (red dashed circles). 
The only differences between Prestegard´s conditions and ours were the 
concentrations of CaCl2 (2,5 mM/4 mM) and NaCl (100 mM/150 mM). In this 
scenario, a higher ionic strength might be triggering slight conformational 
changes, thus explaining such discrepancies. It should be mentioned that 
many of these cases involved residues from the N- and C-termini, highly 




flexible regions whose disordered structure is rather unpredictable, so 
attention was mainly paid to explain the most relevant cases. 
The CRD backbone assignment was achieved by employing the typical set of 
3D NMR spectra to gather information on 1H, 15N, 13Cα and 13Cβ nuclei 
resonances. These included HN(CO)CA, HNCA, HN(CO)CACB and HNCACB. In 
particular, the intensity of the correlation peaks in the HNCA experiment come 
essentially from the carbon adjacent to the nitrogen (HNi-Cαi), whereas the 
magnetization is poorly transferred to the 13Cαi-1 [46-47]. Therefore, the 
15N-
HSQC projection of this experiment was firstly used to quickly detect the Trp, 
Asn and Gln sidechains, since their peak intensities are expected to 
dramatically drop due to the lack of an adjacent Cα (Figure 4.13). The Trp 
sidechains usually appear at lower fields than the rest of NH crosspeaks 
(orange box on the bottom left corner) and the opposite happens for Asn/Gln 
sidechains (purple boxes on the top right corner). All the Trp NH groups were 
identified (nine), whereas the identification of the Asn/Gln terminal amides 
was limited by the intense signal overlapping. To note, a TROSY pulse 
sequence was used to record the 15N-HSQC spectra and thus reduce signal 
crowding by increasing the resolution.  
 
Figure 4.12. Main discrepancies found between the existing deposited assignment and 
our experimental 
15
N-HSQC (TROSY). Yellow diamonds: expected peaks (BMRB) that do 
not appear in our experiments; red circles and arrows: systems unlinked to published 
data. 




Figure 4.13. Identification of the HN-containing sidechains of Trp, Asn and Gln residues 
through superimposition of the routine 15N-HSQC (TROSY) with the same projection 
extracted from the 3D-HNCA. As noted, sidechains only show their crosspeaks on the 
original 2D (blue), but not on the 3D-derived plane (red). Also, signal splitting can be 
noticed for Asn/Gln sidechain correlations in the nitrogen dimension, as a result of the 
different evolution of the NH and NH2 correlations according to the TROSY sequence 
[48]. 
Overall, the 3D assignment of the free CRD was unsuccessful at first, as a great 
deal of lost signals were noticed, especially those from Cβ nuclei. Indeed, the 
relaxation mechanisms were observed to be so efficient that nearly all Cβ 
correlation peaks were missing during the acquisition of the HNCACB 
experiment. As a result, a first assignment was attempted by simultaneously 
using the information from 13Cα-13Cα-1 pairs and the deposited assignments 
to establish coherent sequential correlations. At last, the gathered 
information was roughly the same (Table on Figure 4.14) although the poor 
signal dispersion of the Cα resonances precluded the sequential connection of 
all found spin systems, whereby 14 systems remained with ambiguous or 
unclear assignments (Figure 4.14).  
 
As previously described in Section 4.1, the CRD stability was noticed to 
increase in two scenarios: after adding a reducing agent (DTT) and after 
binding to a natural ligand. Although not fully understood, it was clear that 
ligand binding improves the stability of the long loop, somewhat favoring the 
presence of smaller species (CRD monomers) that showed sharper NMR 




signals. Thus, the entire CRD assignment was repeated in the presence of a 
large excess of a natural ligand, being D-Man the chosen candidate. The 
experiments were recorded with a double 13C-15N-labeled sample of the CRD 






BMRB 19931 Free CRD 
Man-bound 
CRD 
%Assign 118/140 (84%) 104/140  (74%) 120/140  (86%) 
Cα 139/140 (99%) 119/140  (85%) 124/140  (88%) 
Cα-1  - 119/140  (85%) 126/140  (90%) 
Cβ 119/131 (91%) 2/131 (1.5%) 110/131  (84%) 
Cβ-1 - 50/131  (36%) 111/131  (85%) 
 
Total spin systems (residues). 151 
Prolines. 11 
Total expected spin systems. 
- Missing systems. 








Figure 4.14. A) Graphic summary of the first CRD assignment. Color code: black: not 
assigned/not reported; grey: prolines; green & red: reported in the BMRB; green: 
reported in this work as well; red: missed spin systems. B) Assignment statistics. 
Percentages of the Cα, Cα-1, Cβ and Cβ-1 resonances identified for the two used DC-
SIGN CRD samples compared with those of the BMRB file.  
 
Now, the standard triple resonance protocol successfully provided a good set 
of 13Cα and 13Cβ chemical shifts that served to certainly assign 120 spin 
systems. Luckily, almost all the amino acids from the long loop region near to 
the binding site could be unambiguously assigned, what would be 
A) 
B) 
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subsequently helpful for the titration analyses. In addition, some of the 
discrepancies with the deposited BMRB could be clarified. Fittingly, some 
mistakes were detected and justified as well (Figure 4.15):  
 
 
Figure 4.15. Distribution and analysis of those spin systems whose identification was 
problematic or controversial. Label color code: black: new crosspeaks not reported in 
literature; orange diamonds: position of those crosspeaks previously detected for the 
apo CRD, but vanished for the holo CRD; yellow diamonds: position of G325 and K295 
as described in the deposited data (the green arrow indicates the new position found 
in this work); red: old wrong assignments in the BMRB; green: corrected assignments. 
 
 After a closer inspection of the 1H-1D spectrum, a weak signal was 
detected at very low field (peak M, 11.53 ppm), but given that all the 
tryptophan sidechains had been already identified, the spectral window 
of the 15N-HSQC was enlarged to check whether this signal could be 
another spin system. Indeed, it actually was, and strikingly, the sequential 
analysis linked that system to peak N and V242. At the same time, V242 
was noticed to unambiguously precede the systems D and A, which was a 
priori impossible since the next residue type in the sequence is proline 
(P243). 
Other two connections with unidentified systems were found out (N-M-
V242-D-A-Q-O) and eventually, the peak O was discovered to be the 
amino acid prior to C356. Then, the identified fragment turned out to be 




the group of amino acids from the long loop surrounding the Ca2+ ion: 
peaks N, M, D, A, Q and O were respectively assigned to N349, N350, 
G352, E353, E354 and D355 (Figure 4.16 and Figure 4.17B). To note, G352 
had been already assigned but its position in the deposited file was rather 
shifted at high field in the 15N dimension with respect to our free CRD. 
Also obvious, the HN pair corresponding to V242 had been wrongly 




Figure 4.16. 13C-derived sequential correlations established between residues 
belonging to the loop segment N349NVGEEDC, located at the binding site. Composition 
made by combination of the carbon strips from experiments HN(CO)CACB and 
HNCACB. 
 
 As a result of the previous deductions, other two conflicts with the 
deposited data were identified: the peak supposed to be E353 was 
reassigned to G325, which was supported by its low Cα chemical shift 
(45.04 ppm) and the sequential connections with the flanking residues. 
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The signal of G346, an amino acid from the long loop, displayed an 
unusual Cα chemical shift, too high for a glycine (59.70 ppm), as well as a 
clear Cβ correlation. After a thorough analysis of the remaining 
unassigned pairs, it was assigned to V246 (His-Tag). Similarly, the 
sequence A382-S383 did not fit with their expected Cα and Cβ 
resonances. Instead, it was better identified as the K295-S296 fragment 
(Figure 4.17A). 
 
         
 
Figure 4.17. A) Analysis of the 13C resonances extracted from the fragment K295-S296: 
the strip of K295 shows both Cβ and Cβ-1 ranging around 30-40 ppm, which fits with 
the pair I294-K295 better than with two consecutive Ala residues (A381-A382). B) Top 
region of the DC-SIGN CRD in the PDB 1SL5. The black portions represent the regions of 
the long loop whose assignment was achieved.  
 
 Regarding the remaining unknown systems, T, R and S were identified as 
alanines by means of their Cβs resonating at high fields (18-21 ppm). R 
was presumably A397 due to its closeness to the position registered in 
the BMRB; S was the most intense peak in the 2D spectrum, and meant 
B) A) 




to be the C-terminus (A404) as its high flexibility surely underlies such a 
high peak intensity. By discard, peak T should correspond to A395. 
 
Apart, carbon resonances registered for peak H only fitted with H254. 
Most of the remaining peaks were noticed to disappear after adding D-
Man to the CRD sample (highlighted as orange diamonds in Figure 3.6.). 
Some of them were roughly identified as HN pairs already assigned by 
Prestegard´s group, but marginally shifted (B→S310, C→T398, E→E298, 
F→N311, G→Q390, J→E388, K→F391). The rest were left as unknown 
spin systems (I, L, P and U). Intriguingly, residues S310-N311 and the 
aforementioned K295-S296 pair are respectively located at the end and 
the beginning of the α2-helix. All of them deeply broadened and/or 
moved after the addition of D-Man, suggesting fine changes in their 
dynamics triggered by the presence of the monosaccharide. 
 
Considering all these corrections, 86% of the assignment was completed 
(Figure 4.18). Excluding the proline residues, 127/140 spin systems were 
identified in the amide backbone region, and 120 of them unambiguously 
assigned to specific residues of the CRD sequence. All the chemical shifts were 
arranged in an STR file and referenced using TSP as NMR standard. The 
resulting file was submitted to the BMRB database with the accession code 
27854 [49].  




Figure 4.18. Full CRD assignment performed at 800 MHz, 310 K and in the presence of 
133 equivalents of D-Man. 




Taking advantage of the finished assignment, the obtained chemical shifts 
could be further processed to assess the stability and the integrity of our CRD 
construct. A good feature to verify that a given protein is correctly folded is to 
check the existence of intramolecular disulfide bonds. As previously reported, 
the oxidized or reduced state of the sulfur atom strongly modulates the 
chemical shift of the nearby Cβ [50]. In the cysteine moiety, this carbon 
usually displays chemical shifts between 25-30 ppm, whereas the same atom 
shifts to lower fields when cysteine is oxidized to cystin (Cys-S-S-Cys), showing 
values within the 38-43 ppm range. For our construct, five out of seven 
cysteines could be completely assigned, and their Cβ chemical shifts ranged 
from 36 to 49 ppm (Figure 4.19). Consequently, they all were supposed to take 
part in the formation of disulfide bonds, forming the pairs C284-C377, C356-
C369 and C256-C267. Obviously, although C256 was not identified, its 
counterpart C267 displayed a much shifted Cβ, thus confirming the presence 
of a cystin unit. In principle, C384 remained free as reduced cysteine in a 
flexible region of the CRD, but without discarding the possibility that it could 
transitorily bind to another C384 from a CRD encountered in solution. 
 




Cys256 ?? Oxidized 
Cys267 43.06 Oxidized 
Cys284 36.10 Oxidized 
Cys356 49.26 Oxidized 
Cys369 46.49 Oxidized 
Cys377 40.32 Oxidized 
Cys384 ?? In principle, reduced 
 
Figure 4.19. CRD DC-SIGN cysteines and their oxidation state deduced from their Cβ 
chemical shifts.  
 
Apart, the backbone chemical shifts (H, N, Cα, Cβ) were analyzed by the RCI 
software [51] and the TALOS software [52] to check the protein flexibility and 
its secondary structure, respectively. The RCI analysis confirmed the evident 
high flexibility expected for the N-terminal and C-terminal regions. Moreover, 
another region with notable motion corresponded to the short loop segment 
situated behind the long loop and the primary binding site (Figure 4.20). 
Surprisingly, the long loop seemed to preserve a marked rigidity, which was 
expected to be caused by the presence of D-Man, and would confirm again 
that ligand recognition actually increases the structural stability of this loop.  
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In parallel, the secondary structure elements predicted by the TALOS+ tool 
fitted quite well with those identified in the deposited X-Ray crystals (Figure 
4.21). The unique discrepancies were detected for the β1’ and the β2’ strands: 
the registered chemical shifts pointed out that these regions could be more 
ordered than expected, compared with the previous existing data. However, 
the β2’ segment is located on the back part of the CRD, and the TALOS+ 
analysis would place the extended β2’ into a hinge region which establishes 
contacts with the calcium ions at sites 2 and 3. It cannot be ensured whether 
this is an artifact due to miscalculations or it is actually as rigid as predicted.   
 
Figure 4.20. On the left, the Random Coil Index (RCI) based on the H, N, Cα and Cβ 
chemical shifts of the assigned residues. On the right, the CRD of DC-SIGN showing 
those residues with the highest RCI values as CPK spheres. 
 
 
Figure 4.21. Expected secondary structure for the CRD based on the backbone 
chemical shifts. Comparison between predictions made by TALOS+ and the secondary 
elements present in the PDB 1SL5. 
 
 




4.3. HSQC-based tritrations 
To analyze the DC-SIGN CRD perturbations upon ligand binding, successive 
15N-HSQC spectra were recorded at increasing amounts of the 
oligosaccharides of interest. As explained in the Methods section, the working 
data set is constituted by the 1H and 15N backbone resonances of the protein, 
one from each amino acid residue, originated by their corresponding α-amino 
groups. The resulting 2D spectrum is called the protein “fingerprint”, as the 
correlation pattern distribution is characteristic and unique for each protein or 
peptide. 
15N-HSQC-based titrations are suitable [53-54] for describing binding 
processes with affinities that are weak but still relevant in the biological 
context (from 10 μM to 10 mM). Usually, the upper limit of this technique is 
set around 10 mM, what includes the system studied herein. In fact, 15N-
HSQC-based titrations have been already performed by other research groups 
to study related lectins, like Langerin [55] or L-SIGN [32], as well as DC-SIGN 
[38,56].  
To collect a good set of experimental data, the peak intensities and the 
spectrum resolution were maximized by recording the titration points at 800 
MHz, in a spectrometer equipped with a cryo-probe, and using the TROSY 
pulse sequence for the acquisition of the 15N-HSQC spectra.  
Firstly, the binding site on the lectin CRD surface was mapped for each 
tetrasaccharide independently, making use of the same 15N-CRD batch with a 
concentration of 120 μM. Apart from the two blood group antigens, L-fucose 
(Fuc) was included in the analyses to account for possible differences in the 
binding processes arising from the surrounding sugars. Noteworthy, from the 
equilibrium constant, it can be easily deduced that the total ligand 
concentration at the middle point of the titration is almost equivalent to the 
dissociation constant as long as [L0]>>>[P0]. At this point, the half of the total 
amount of protein is forming the complex ([P]=[PL]), while the ligand 
concentration can be approximated to [L0]: 
       
[ ][  ]
[  ]
      
           
→             [ ]  [  ]       [  ]                          
Taking into account the low affinities expected for Fuc and related antigens 
[36,57], the middle points of the titrations were expected at ligand 
concentrations ranging around 6 mM (Fuc), what implies using a 
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concentration of about 50-60 equivalents with regard to the 15N-CRD. To 
achieve almost complete protein saturation and observe the maximum 
chemical shift perturbations (Δδmax), sequential 
15N-HSQC experiments were 
acquired until reaching 140 eq. of ligand (16.8 mM). The data were processed 
by employing Eq. 8 described in the Methods section, with α = 0.14 [58]. The 
resulting CSPs are summarized for Fuc and the A and B blood groups in Figure 
4.23.  
 
Figure 4.22. Front and side views of the DC-SIGN CRD showing those amino acids 
which yielded the strongest CSPs. In green, the residues shifted the most upon titration 
with the B antigen (16 AA). In blue, the three additional residues which were notably 
shifted by the A antigen as well. In orange, D366 (very shifted for the B antigen and 
not observed for the A antigen). Red labels indicate those perturbed amino acids 
placed away from the binding site.  
Comparing both tetrasaccharides, few differences could be detected, as they 
displayed very similar CSP patterns. In both cases, the most affected amino 
acids were those directly contacting the calcium ion at the primary binding 
site, belonging either to the top part of the flexible long loop or to the β4-
strand that goes in parallel. Some residues located on the hinge between 
strands β3 and β4 were likewise shifted (S360, G361, G363). On the long loop, 
perturbations were notably propagated from N344 to the beginning of the β3-
strand (C356), including few residues which also established coordination 
bonds with the calcium ions at sites 2 and 3. Immediately, the localized 
distribution of the most intense CSPs allowed confirming that both binding 
processes are taking place in a specific fashion, by chelating the metal ion at 




site 1 (Figure 4.22). Interestingly, there were several amino acids which lay 
further away from the most affected area. Some of them, like F313, T314 or 
L371, are placed into the secondary binding surface defined by strands β2, β3 
and β4 where other sugar residues have been described to establish stabilizing 
VdW interactions [59-60]. On one hand, these findings suggested that both 
ligands can make additional contacts through other sugar residues, although 
this cannot be fully demonstrated by receptor-based methods. On the other 
hand, CSPs at remote positions can simply come from the primary 
perturbations triggering long-range effects propagated through the network 
of H-bonds [61]. The latter case could explain certain long-range CSPs 
detected in other parts of the CRD construct, like those observed for G325 and 
D320. 
In absolute terms, the collected CSPs were slightly higher for the B antigen 
than for the A antigen, and there was a notorious difference between them in 
the data dispersion assessed by the standard deviation (Figure 4.24A). Even 
so, the blood group A showed marked perturbations at residues F359, K368 
and V351 (Figure 4.22), not noticed for the B antigen. In constrast, E353 was 
largely less affected by the presence of the blood group A, although the 
observation of this residue was rather difficult due to the intense signal 
overlap, and an accurate measure of the CSP was impossible. Surprisingly, the 
CSP pattern obtained after titrating the CRD with L-Fuc was very similar to 
those reported for the blood groups. Moreover, L-Fuc seemed to trigger larger 
CSPs at V351, E353 and D367, all of them located on the same side of the 
binding site (Figure 4.24B).  




Figure 4.23. CSPs for the Fuc-containing fragments measured in 15N-CRD samples at 
120 μM containing 140 eq. of each ligand respectively (310 K). 
 
 











Blood Group A 16.6 23.0 39.6 18 
Blood Group B 21.7 35.4 57.2 16 
L-Fucose 20.9 28.8 49.7 19 
D-Man 18.9 22.1 41.0 14 
Man3 19.6 33.7 53.2 15 
 
Figure 4.24. A) Statistical analysis of the data collected from 15N-HSQC spectra for the 
three Fuc-containing and the two Man-containing ligands. The values are expressed in 
CSP*1000 (ppm). B) Most meaningful differences noticed during CSP data analysis. In 
red, those residues more shifted by Fuc than by the antigens A and B. In green, some 
amino acids notably perturbed by Man and Man3 that remained less affected in the 
presence of Fuc-containing fragments. 
In parallel, other two 15N-HSQC titrations were carried out in the presence of 
the Man epitope instead of Fuc. Man and Man3 (core trimannoside) were 
tested and compared with the fucosylated fragments (Figure 4.26). At first 
sight, Fuc and Man seemed to share very similar CSP patterns, although Man 
displayed an overall reduced effect on the protein chemical shifts. The only 
significant difference between Man-containing and Fuc-containing ligands was 
the particularly strong CSP caused in K368 by the presence of Man. There 
were other minor differences regarding nearby residues in the β-sheet like 
(E358, N365) and the long loop (E354, D355) (Figure 4.24). However, the 
intriguing point here arose when the monosaccharides were compared with 
their respective related oligosugars: Man and Man3 caused analogous 
perturbations on the CRD, as Fuc and both blood groups did as well. The fact 
that Fuc and Man likewise contributed to the existence of long-range CSPs 
A) 
B) 
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suggested that all the reported perturbations are exclusively triggered by the 
residue that binds to Ca2+. Consequently, it should be thought that the 
surrounding sugars do not establish tight stabilizing interactions with 
additional amino acid residues exposed on the CRD surface, but they would 
presumably play minor roles in the slightly improved affinities reported for the 
oligosaccharides. This hypothesis was reasonably supported by the already 
existing crystal structures of DC-SIGN CRD in complex with Man4 and Man6, 
both fragments containing the Man3 core [59-60]. In both models, the Man at 
the primary binding site targets the closest amino acid sidechains by means of 
multiple H-bonds through its OH3, OH4 and OH6 groups. In contrast, there are 
no more H-bonds arising from the other Man residues in spite of lying very 
close to the surface, except for an isolated H-bond established by the α1-6 
linked Man (Figure 4.25). In principle, the same would be expected to happen 
in the case of the blood group antigens, but additional information is needed 
to accurately delineate the binding mode and explain the possible lack of VdW 
contacts through sugar residues flanking the Fuc moiety. 
 
Figure 4.25. DC-SIGN CRD-Man4 complex (PDB: 1SL4). The binding Man is highlighted 
in dark green. The amino acids involved in VdW contacts with the ligand are shown as 
stick bars, and H-bonds are indicated by dashed light green lines. White spheres 
represent the calcium ions. 
 





Figure 4.26. Comparison between the CSPs collected in the presence of L-Fuc and after 
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Apart from mapping the binding site, the dynamic behavior of the CRD was 
investigated and the affinities were estimated by means of building the 
corresponding binding isotherms.  As mentioned above, the middle points of 
the titration are reached when the ligand concentration approaches to the Kd 
value. To minimize the experimental errors during the curve fitting, it is 
advisable that many points are acquired within this range, using ligand 
concentrations close to the theorical Kd [62]. In total, ten points were 
recorded for each ligand, and given that the weakest sugar was expected to be 
Fuc, most of them corresponded to protein/ligand ratios below/around 1:60 
equivalents.  
Firstly, the titration spectra were scrutinized to analyze the type of exchange 
regime. Interestingly, for both tetrasaccharides many residues were noticed to 
remarkably broaden immediately after adding the ligand (10-20 eq). In fact, 
N349, N350 and D366 cross peaks were almost lost during the middle points 
of the titration (Figure 4.27 and 4.28). In the case of the blood group B, the 
peak intensity could be subsequently recovered at high ligand ratios, even 
exceeding in some cases the initial intensities corresponding to the free state, 
as observed for N350 or G325. This sharp broadening process followed by 
signal recovering could be reported for almost any shifted peak, either 
belonging to the primary binding site or placed further away (F313, G325). 
Clearly, the observed behavior was indicative that an intermediate exchange 
process takes place upon binding of the B antigen (Figure 4.27). For the blood 
group A, a slightly different scenario was found: in general, signal broadening 
affected to many shifted peaks, but intensities were marginally or not 
recovered when the ligand concentration increased. After initial intensity 
decay, the broadening was maintained without progressing or reversing. For 
some residues located at the long loop, as N349, N350 or D355, a slight signal 
recovery was detected as well, thus suggesting the same intermediate 
exchange regime as that documented for the B antigen. In contrast, other 
amino acids showed no relevant changes in the broadening along their 
evolution (G325, N365), and their cleaner drifts better suggested the existence 
of a fast exchange regime (Figure 4.27).  
In either case, the peak displacements always followed linear trajectories, and 
therefore the possible binding of two or more ligand molecules to the DC-
SIGN CRD was discarded. Nevertheless, the existence of non-specific binding 
could not be ignored, although its effect in CSPs is usually negligible since 
these transitory interactions at the receptor surface are extremely weak [63]. 
For the blood group B, there was a clear intermediate exchange derived from 




an exchange rate very close to the experimentally measured CSP values (in 
Hz), while the binding of the blood group A seemed to take place in a transient 
regime ranging from intermediate to fast exchange. Considering that both 
tetrasaccarides are almost structurally identical in terms of molecular size and 
diffusion, binding processes were expected to take place under the same kon, 
and therefore, these results would point out that the B antigen exhibits a 
slower koff than the A antigen, what means that the former would have a 
slightly better affinity for the CRD. 
 
Figure 4.27. Crosspeak evolution reported for six representative amino acids. The box 
on the left shows the observed shifts in the 2D-HSQC (orange: free CRD; red: 20eq; 
pink: 60eq; dark blue: 100eq; orange: 140eq), and the picture on the right shows the 
1D profile to better compare peak intensities (blue: free CRD; purple: 20eq; pink: 40eq; 
red: 60eq; orange: 80 eq; pale orange: 100 eq; green: 140eq). 
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In accordance with reported data [64], the existence of progressive signal 
broadening can be related to the presence of a higher number of receptor 
conformers derived from ligand recognition, although other feasible reasons 
can also explain this phenomenon, including multiple or non-specific binding 
[53]. However, and specially for the blood group A, it is unlikely that these 
processes were actually occurring, as multiple binding events usually lead to 
exaggerate and crescent signal broadening, eventually causing that correlation 
peaks vanish at high ligand concentrations. Instead, for the A antigen, signal 
broadening remained almost constant even in the presence of very large 
amounts of ligand. This behavior is more likely to arise from subtle 
conformational changes triggered into receptor´s structure and/or from 
complex effects of the fast-intermediate regime itself. To note, weird line 
shapes were also noticed for few residues alongside extreme broadening, 
sometimes giving rise to very wide signals with irregular patterns, which 
probably come from protein conformers that coexist at low protein-ligand 
ratios (N350, D355) and finally converge to an unique and stable conformer 
(bound receptor) when the ligand amount increases. At the same time, as 
mentioned before, some correlation peaks became sharper signals at the 
saturation point when titrated with the B antigen, what suggested that the 
area around the primary calcium ion (specially the loop regions) gains stability 
upon sugar attachment. 
Experimentally, the exchange rates could be roughly estimated by using the 
titration data from residues N349 and N350. D366 was also a good candidate, 
since it was the most prone to reach coalescence. However, it disappeared in 
most of the recorded points for the titration with the blood group B, and in 
fact, the intense line broadening provoked by binding of the A antigen 
precluded at all the observation of that residue at the saturation point (Figure 
4.28A). Applying the Eq. 7 described on the Methods section, the exchange 
rate kex was estimated around 100 Hz (Figure 4.28B). As reported, the kinetic 
constant koff commonly takes values between 10
2 and 104 s-1 for processes 
occurring within an intermediate exchange regime [65]. This means that the 
product kon[L] must never surpass two orders of magnitude to fulfill the 
equivalence stated in Eq. 7 for kex. Given that the ligand concentration around 
the coalescence point is about 10-15 eq (~1-2 mM), the expected kon would 
stand within the 103-105 M-1 s-1 range, what suitably fits with reported kinetic 
constants for other carbohydrate-binding lectins [66-68]. Also, this estimation 
underlines the otherwise false assumption on supposing a diffusion-driven 
recognition process and considering a kon of about 10
8 M-1 s-1 [69]. Certainly, 
the estimations done highlighted that the binding of both antigens is very 




similar from a kinetic point of view. Indeed, the on and off rate constants were 
within the expected range of values in each case. The kon rates took values 
around 104 M-1 s-1, although the binding process seemed to be slightly faster 
for the B antigen. There are many factors that may account for slowing down 
the on rates under the diffusion control limit. Often, productive collisions 
between receptor and counterpart are hampered by processes of 
conformational selection [70]. According with our gathered data so far, it is 
likely that the conformational flexibility of the binding site region on the DC-
SIGN CRD is behind these kon values. Likewise, both koff values perfectly fitted 
with an intermediate exchange regime, ranging around 102 s-1. It is worth 
mentioning that the calculated kon and koff were very approximate, and 
additionally, the coalescence is probably reached below 10 eq, although the 
exact position could not be determined with enough accuracy. Then, it was 
difficult to conclude where the difference in affinity between both 
tetrasaccharides is arising from, although the most probable reason might be 
the magnitude of their on rates rather than the koff, as thought at first.  
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10eq BgA   
Kd ≈ 7.1mM 
87.68 2.3·104 1.7·102 93.94 2.5·104 1.8·102 
10eq BgB 
Kd ≈ 2.3mM 
106.97 6.8·104 1.6·102 93.97 6.0·104 1.4·102 
Figure 4.28. A) Different CSP patterns reported for D366 in the presence of both 
tetrasaccharides and L-Fuc. B) Estimation of the binding kinetics through CSP from 
N349 and N350, assuming that peak coalescence is achieved at 10 eq for both sugars 
(1.2 mM). As can be noted, the off rates are very close in all cases whereas the kon 
values seem to be slightly higher for the B antigen.  
A) 
B) 
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Finally, the binding isotherms were calculated by adjusting the titration data 
to Eq. 10 described in Methods. Very interestingly, a notable difference was 
noticed between both oligosaccharides when plotting the evolution of the CSP 
as a function of the ligand concentration. The blood group A yielded normal 
isotherms in all cases, as expected for a simple binding event, with a 1:1 
stoichiometry (Figure 4.29).  However, a completely different scenario was 
found out for the B antigen: the data did not adjust to a unique crescent 
curve, but it reached an intermediate plateau around 40-50 eq of 
tetrasaccharide, and grew again until protein saturation (120-140 eq). 
Noteworthy, it was impossible to detect this marked difference exclusively 
through the visualization of the 2D-HSQC spectra due to the low magnitude of 
the collected CSPs, but it became clear when representing the data in 
separated graphs. In principle, this kind of staggered curve is typically 
observed for receptors with several binding sites that are occupied in a 
stepwise fashion [71-72]. However, the essentially linear displacement 
observed for every residue in both cases unequivocally discards the binding to 
other regions in the CRD surface. Thus, the only plausible possibility was to 
consider an additional recognition process governed by a weaker Kd, but this 
minor binding mode would be taking place at the same primary binding site. In 
summary, there would presumably be a major binding mode for both 
tetrasaccharides, while only the B antigen would be able to target the primary 
Ca2+ site through two binding modes co-existing at high protein-ligand ratios. 
In addition, the existence of two modes of interaction could explain the higher 
kon estimated for the B antigen (better rebinding).  
According to previous deductions, the estimated affinities agreed that the B 
antigen (Kd = 2.3 ± 0.6 mM) is a better binder than the A antigen (Kd = 7.1 ± 
1.4 mM) (Figure 4.31). Surprisingly, Fuc turned out to have an intermediate 
affinity compared with both tetrasaccharides (Kd = 3.7 ± 0.5 mM). In any case, 
the three affinities were of the same order (mM), as expected for this kind of 
fucosylated oligosaccharides. The better affinity of the B antigen would be 
explained by the aforementioned existence of two binding modes (major and 
minor), whereas there was not an immediate explanation about why the A 
antigen displays less affinity than Fuc. Certainly, the titrations with Fuc were 
performed by using the mixture of anomers (α/β) in which all hydroxyls 
groups are free. As reported both for Man and DC-SIGN [60,73] and for Fuc 
with other lectins [74-75], the receptor attachment to simple 
monosaccharides with many sterically available hydroxyl groups may easily 
take place through multiple binding modes. In fact, the binding isotherms 
obtained for Fuc resembled, in many cases, the staggered shapes noticed for 




the B antigen. Moreover, the evolution of some peaks did not seem to follow 
a linear trend, but a marked change in their CSP trajectories was not observed 
either (Figure 4.30). These smooth deviations from linearity could arise from 
little differences in how each binding mode modifies the CRD chemical shifts, 
but in no case it can be said that the sugar is bound to another site on the CRD 
surface. Therefore, the existence of several possible binding modes for Fuc 
could perfectly account for its lower dissociation constant compared with 
blood group A.  
 
Figure 4.29. Binding isotherms built by using CSP data from residues V351, E358 and 
N365. The blue lines represent the experimental data and the red lines correspond to 
the theoretical curve adjusted by means of the CCPNMR software [76]. 
 
 




Figure 4.30. Chemical shift perturbations monitored for residues E347, N349 and N350 
along the titration of the DC-SIGN CRD with L-Fucose. In contrast to the blood group 
antigens, there was not a deep change in the signal broadening for any peak, what 
suggested that the interaction of Fuc takes place in a fast exchange regime and hence 
it will be expected to have faster kinetic constants (kon & koff). 
 
 Blood group A 
Kd (mM) 




Met316 7.1 ± 0.9 2.0 ± 0.5 3.1 ± 0.5 
Gly325 5.4 ± 0.6 2.3 ± 0.5 3.3 ± 0.3 
Glu347 7.0 ± 0.1 3.4 ± 0.5 3.5 ± 0.3 
Asn349 5.2 ± 0.9 - - 
Val351 9.0 ± 0.8 1.7 ± 0.4 3.1 ± 0.2 
Gly352 8.1 ± 0.8 3.4 ± 0.2 3.7 ± 0.3 
Glu354 10.0 ± 1.0 2.1 ± 0.5 4.6 ± 0.6 
Asp355 7.2 ± 0.4 - 3.8 ± 0.2 
Glu358 7.8 ± 1.0 1.6 ± 0.3 3.5 ± 0.5 
Phe359 5.4 ± 0.4 2.2 ± 0.3 - 
Asn365 5.8 ± 0.3 2.2 ± 0.5 4.1 ± 0.1 
Lys368 7.7 ± 0.7 - 3.4 ± 0.3 
Trp364 7.5 ± 0.6 2.0 ± 0.4 4.3 ± 0.4 
Leu371 5.7 ± 0.3 2.9 ± 0.7 3.3 ± 0.4 
Average 7.1 ± 1.4 2.3 ± 0.6 3.7 ± 0.5 
 
Figure 4.31. Estimation of the binding affinities for Fuc and the antigens A and B. The 
equation applied was y = A(B+x-[(B+x)2-4x]0.5), with A = Δδmax/2[P0] and B = [P0] + Kd. In 
the case of the B antigen, K368 was not used as its CSP was negligible, and the 
extreme broadening affecting N349 and D355 shifts precluded the accurate 
determination of their CSPs. For Fuc, N349 and F359 were not either employed since 
the curve fitting could not be suitably done due to very large errors in the estimated 
parameters.   




4.4. STD and tr-NOESY 
The results derived from the HSQC-based titrations essentially pointed out 
that both tetrasaccharides were specifically recognized through its Fuc moiety 
and there might be a minor contribution from the surrounding sugars to the 
binding. Interestingly, different affinities and binding isotherms for both 
ligands were unexpectedly noticed at the same time. As mentioned in the 
previous section, the crystal structures of DC-SIGN harboring Man-containing 
fragments (2IT5 (Man6), 2IT6 (Man2), 1SL4 (Man4), Refs. [59-60]) always show 
the Man residue targeting the Ca2+ ion establishing the major contacts, mainly 
H-bonds with the neighboring polar sidechains.  The only available X-Ray 
model of DC-SIGN interacting with a Fuc-containing fragment is the PDB 1SL5 
[59], which contains the CRD bound to Lacto-N-fucopentaose type III (LNFP III) 
(Figure 4.32).  
 
Figure 4.32. DC-SIGN-LNFP III complex (PDB 1SL5). The reducing Glc is not modeled. 
The sidechains of the CRD involved in VdW contacts with the ligand (green dashed 
lines) are detailed as brown sticks. As noted, all the H-bonds are established through 
the Fuc residue, except for a single H-bond that Gal forms with D367.  
Both NMR and crystallographic data support the proximity of the non-
reducing Gal moiety to the β-sheet plateau next to the metal ion, although the 
X-Ray structure does not display any direct Gal-CRD contact, except for an 
isolated H-bond between OH6 and D367. Certainly, the NMR models have 
suggested that the intermolecular distances are likely shorter than those 
described by X-Ray, but in either case the presence of close surrounding 
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sugars seems to play an additional role in the recognition event, although it 
has not been well clarified yet. In this scenario, the results reported herein for 
the blood antigens are actually fairly interesting since clear differences have 
been noticed between them. Intriguingly, although the interaction is 
exclusively driven by the Fuc moiety, each antigen is somehow triggering a 
distinct dynamic behavior which affects their affinities as well. Obviously, 
these findings have immediately raised the question about whether those 
discrepancies could be related to the only structural element that 
differentiates both blood groups: the non-reducing Gal/GalNAc moiety.  
To shed light into this question, the ligand-based approach was put in practice. 
Namely, additional analyses were conducted by means of STD and tr-NOESY 
experiments. The primordial aim was to gather enough data to propose a 
suitable 3D-model which would be subsequently evaluated by computational 
simulations.  
 
Figure 4.33. Typical 1H and 13C chemical shift ranges found in carbohydrates. Adapted 
from [77]. 
Previously, the NMR chemical shifts of the two tetrasaccharides had to be 
assigned. Only isolated monosaccharides can be readily identified in solution 
NMR, since the spectral window for the pyranose protons is highly reduced (3-
4.5 ppm) and 1D spectra quickly become too crowded as the number of sugar 
residues increases. Then, the normal routine for assigning relatively simple 
oligosaccharides includes the acquisition of at least 2D-13C-HSQC and 2D-
TOCSY spectra. The former one provides every C-H pair better dispersing the 
protons along the 13C dimension, while the latter one permits to identify and 
assign each independent pyranose ring. Similar to proteins, the glycosidic 
linkages stop the transference of correlations, whereby the 2D-TOCSY 
commonly displays as many patterns as residues the oligosaccharide has. 




Additionally, 2D-HMBC experiments provide 13C-1H correlations at longer 
distances (several covalent bonds) and allow to establishing the connectivity 
between adjacent sugars.  
Figure 4.34. Intrarresidue spin system correlations established via 2D-TOCSY for the B 
antigen. Each isolated pattern is detailed in a different color and corresponds to a 
specific residue. Blue: β-Glc; light blue: α-Glc; orange: β-Gal; light orange: α-Gal; red: 
α-Fuc. 
For the studied case, the three cited experiments (2D-13C-HSQC, 2D-TOCSY 
and 2D-13C-HMBC) were recorded at 298 K in D2O. In both cases, the region 
containing the anomeric protons at low field (4.5-5.5 ppm 1H; 90-100 ppm 13C) 
showed five cross-peaks. Moreover, the chemical shift also permitted to 
distinguish the type of anomer (Figure 4.33): equatorial H1 protons (α 
anomers) are always more deshielded than axial H1 (β anomers). On this 
basis, three α and two β anomers were unambiguously identified. Reasonably, 
the additional peak was expected to arise from the Glc reducing end, whose 
C1 position is free in both tetrasaccharides, thereby enabling the anomeric 
equilibrium that gives rise to both configurations. Starting from the anomeric 
positions, the five correlation patterns were easily deduced from the 2D-
TOCSY spectrum, in spite of the intense signal overlapping (Figure 4.34). The 
intensities of the TOCSY crosspeaks were primarily used to recognize the 
farthest positions from the reference proton (H1), thus reaching H6, which 
could be immediately assigned by means of their different peak signs in the 
13C-edited-HSQC (Figure 4.35). Only the two H6 from α-Glc turned out to be 
overlapped with H3 and H4 from the same residue and hence could not be 
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assigned in the 2D-TOCSY at first. Even so, the 2D-HMBC was more suitable for 
this task, especially in order to distinguish H2 and H3, which gave similar 
intense correlations when regarded from H1. In contrast to the 2D-TOCSY, in 
the 2D-HMBC the adjacent proton clearly gives the strongest correlation in 
most of cases. H4 was easier to correlate given that its signal in Gal rings 
usually appears broadened and displays very weak or no visible couplings.  
 
Figure 4.35. 13C-HSQC full assignment of the blood group B tetrasaccharide. Blue: β-
Glc; light blue: α-Glc; orange: β-Gal; light orange: α-Gal; red: α-Fuc. 
In summary, the 2D-TOCSY and the complementary 2D-HMBC were enough to 
assign every peak in the discerned correlation patterns. The locations of the 
crosspeaks along the spectral window were almost identical for both 
oligosaccharides, whereby both assignments were run in parallel. At this 
point, two particular spin systems led to eventually finish the assignment: 
firstly, the only set of signals that displayed correlations with the aliphatic 
methyl group at 1.5 ppm could be immediately recognized as the Fuc residue. 
To note, the anomeric equilibrium at the Glc moiety also affected to the 
nearby Fuc H5, giving rise to two related crosspeaks and pointing out how 
close this proton should be to the Glc ring. Analogously, H2 distinctively 
appears shifted when attached to an N-Acetyl group, as could be noticed for 
GlcNAc in the case of the blood group A. By discard, the remaining spin system 
supposed to be a Gal moiety (broad H4 singlet) was identified as the central 




Gal pyranose for both antigens. Finally, the identification of the different 
sugars according to their glycosidic bonds was likewise checked out by means 
of the 2D-HMBC: each H1 could be correlated via the glycosidic oxigen with 
the proton attached to the opposite carbon, placed at the adjacent residue, 
what eventually permitted to verify the full assignment. 
With this information, the saturation transfer difference experiments were 
carried out at 293K using the standard protein buffer prepared in D2O (Tris-d11 
25 mM, NaCl 150 mM, CaCl2 4 mM, DTT 2 mM, pD=8).  After several tests, the 
STD intensities were checked out to not significantly improve when using the 
EC domain of DC-SIGN, and the same experimental setup than that used for 
the HSQC-titrations was maintained, making use of the CRD. For a maximum 
ligand concentration of 4.2 mM, the CRD was added in a concentration 70 
times lower (60 μM), enough to record good STD intensities while rebinding 
problems were conveniently suppressed. The working temperature (293K) 
was chosen in order to optimize the signal dispersion observed at the 
anomeric region, avoiding as much as possible overlapping issues with the 
water signal. At 298 K, the H1 protons from the β-anomers resonated too 
close to the water peak, but they could be efficiently pulled down to lower 
chemical shifts by decreasing the temperature. Conversely, the H1 of α-Gal, 
which is less shifted in the A antigen, approximated too much to the water 
signal at 288K (Figure 4.36). Noteworthy, even using commercial D2O 99.99% 
pure, the remaining amount of visible water protons is predictably about 10 
mM, which was within the same order than the amounts of ligand used. Of 
course, the only practical solution is to make use of water suppression pulses 
(e.g spin-lock), but no water filters were eventually included since its 
application was noticed to bias the STD effects of the close anomeric peaks, 
modifying their relative intensities.  
Regarding the type of saturation, two resonances were chosen for applying 
the selective saturation pulse, where the CRD NMR profile contained a high 
percentage of signals: 7.05 ppm (aromatic) and 0.76 ppm (aliphatic). In the 
latter case, a good set of STD effects were reported and subsequently 
analyzed, whereas no clear perturbed signals could be detected when using 
aromatic saturation (Figure 4.37). From a structural point of view, the area 
surrounding the primary calcium site on DC-SIGN CRD is mainly composed of 
negatively charged and non-charged polar amino acids that are essential for 
the stabilization of the positive Ca2+ and the establishment of polar contacts 
with carbohydrates. Then, since aromatic and aliphatic residues are 
necessarily placed far away from the binding site (Figure 4.37), the direct 
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transference of saturation was in general more hindered than expected for 
other proteins. It seemed that aliphatic saturation was still good in such a 
scenario, which was attributed to the sole presence of the Leu371 and Val351 
residues, close enough to the primary binding site.    
 
 
Figure 4.36. Off-resonance experiments performed with a non-labeled CRD sample (60 
μM) at three different temperatures. The spectra at 288 K and 293 K were recorded in 
the presence of the A antigen, while the other spectrum (298 K) shows the B antigen 
peaks. Water suppression was only applied in the first test (288K) to check its effect in 
the close ligand peaks. 
 
The assignment of the observed STD signals was better accomplished from a 
qualitative point of view. Unfortunately, the extremely intense signal 
overlapping observed for the studied blood groups in the recorded spectra 
precluded the precise observation of isolated peaks. In particular, only six 
protons (β-Gal H1, β-Glc H1, Fuc H1, Fuc H5, β-Glc H5 and β-Glc H2) were 
separated enough to be accurately integrated. Then, peak intensities were 
employed rather than integrals to delineate the binding epitope, as the 
approximation of initial slopes was considered unrealistic for our particular 
system. Accordingly, the relaxation issues could not be properly monitored as 
the build-up curves were neither determined in most of cases. To our 
knowledge, deviations from reality have been previously checked out not to 
be so severe for pure carbohydrates in many cases if saturation times are not 
excessively large [73,78-79]. The only warning in these reported cases mainly 
concerns the STDs of H6, which usually evolve rather differently. Then, the 
qualitative interpretation of the spectra was performed in those STD 
experiments recorded with selective saturation prolonged for 2 seconds, an 
intermediate delay to afford enough sensitivity without deeply biasing the 
relative STDs intensities. In any case, it is worth mentioning that the purpose 
of these experiments was exclusively descriptive, and they were meant to 
provide informative data that will subsequently serve for the ultimate 
objective, that is to assess novel theoretical binding models for describing the 
interaction of the studied blood antigens with DC-SIGN.  






Figure 4.37. A) STD profiles acquired at 293 K with two different saturation 
resonances. Top (black): aliphatic. Bottom (red): aromatic. B) Spatial distribution of 
aliphatic (left) and aromatic (right) residues in the DC-SIGN CRD structure. The Fuc 
residue from the PDB 1SL5 is represented in red. 
The global analysis of the STD spectra is detailed on Figure 4.38. Both 
oligosaccharides provided similar saturation profiles, sharing few 
characteristic STD effects that could be clearly associated to the existence of a 
binding epitope: the Fuc residue undoubtedly gave the strongest STD 
intensities, in which Fuc H2 was the most perturbed nucleus followed by Fuc 
H1 in both cases. This latter atom seemed to be more affected in the B antigen 
than in the A antigen. In absolute terms, the STDs reached 1% of intensity as 
much, what was rather low. Nevertheless, sensitivity issues were not a 
complication as acquisition was prolonged enough to improve the signal-to-
A) 
B) 
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noise ratio and obtain measurable signals. Indeed, the peak overlapping was 
the major problem, instead of the sensitivity.  
 
Figure 4.38. Comparative analysis of the STD intensities obtained for both blood 
groups in the presence of the DC-SIGN CRD. In both cases, the Fuc H2 proton was taken 
as the reference proton and its relative intensity was assigned to a 100% of STD. 
Taking Fuc H2 as the reference atom (STDrel = 100%), the rest of protons were 
noticed to display weak relative STDs, always below 30%. H3 and H4 from Fuc 
also gave weak but meaningful STDs, whereas no relevant contributions were 
detected for H5 and the methyl group. Similarly, a significant set of notable 
STDs were distributed on the Gal moieties (Figure 4.39): the non-reducing Gal 
residue seemed to be systematically perturbed at H2, H3 and H4, and also the 
N-Acetyl group received an important amount of saturation in the blood group 
A. In addition, the central β-Gal ring showed a relatively intense STD peak for 
its H2 proton. Conversely, both reducing Glc anomers were almost devoid of 
observable STDs: for the A antigen, all the proton signals of the β-anomer 
were practically erased in the STD and the same was reported for H1 and H2 
atoms of the α-anomer. Unfortunately, protons from H3 to H6 could not be 
well distinguished due to the severe signal crowding, and their exact positions 
could not be checked out (not measured). For the B antigen, H6 was noticed 
to be weakly saturated in both Glc anomers, but it is worth mentioning that 




the experimental determination was very imprecise and probably 
overestimated in such a case, as the H6 of the β-anomer was partially 
overlapped with α-Gal H4 (which was more likely to yield that STD 
percentage), while in the α-anomer both H4 and H6 resonated at equivalent 
positions, and hence the STD estimation was jointly contributed by both 
atoms. In general, the individual STDs could be well inferred from those 
crowded regions since every peak displayed at least a non-overlapped region 
of the multiplet that could be taken to measure the peak intensity. 
 
Figure 4.39. Most relevant STD effects detected for each blood group tetrasaccharide 
(Top: A antigen. Bottom: B antigen). The STDs from the Fuc residue are highlighted in 
red. 
Overall, these STD effects probably encode the closeness of the ligands to the 
only aliphatic sidechains on the surroundings, namely V351 and L371. Indeed, 
the results strongly pointed to the almost exclusive participation of the nearby 
methyl groups from V351 on the saturation of the interacting antigens. The 
highest STD percentages measured for Fuc H2 and Fuc H1 perfectly match the 
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binding pose described in PDB 1SL5 for the Fuc ring. In fact, the direct vdW 
contact between Fuc H2 and this aliphatic sidechain has been already 
underlined as a key contact to form stable complexes with Lewis-type antigens 
[38,59,80]. Analogously, the STD values reported herein suggest that the 
binding pose adopted by the blood group antigens may be established in the 
same way than that described for the Lewis epitope, in which the calcium ion 
at site 2 is targeted via Fuc OH3 and OH4, such that H1 and H2 point towards 
Val351. 
Additional information in regard to the neighboring sugars indicated that the 
non-reducing Gal might be rather close to the protein surface as well, while 
the reducing end would be presumably placed far away. As stated before, the 
speech related to “surface proximity” may not be strictly certain given that the 
Val351 is probably the main contributor to the observed STDs. Therefore, the 
previous reasoning could be also valid by supposing that the α-Gal moiety was 
close to Val351, while the reducing end could be simply contacting the protein 
surface at another point, far away from Val351, as reported for Man-
containing oligosaccharides. However, since the configuration of the glycosidic 
linkages is different to that of the Lewis-type scaffolds, no straightforward 
conclusions could be extracted at this point on the orientation and location of 
the surrounding sugars. Nevertheless, the collected information turned out to 
be essential to further complement the data from tr-NOESY experiments, 
which are subsequently detailed.   
To unveil the binding pose of the oligosaccharides studied in this work, tr-
NOESY spectra were performed in order to derive distance restraints in the 
presence of the DC-SIGN CRD. At 600 MHz, the free ligand 2D-NOESY spectra 
displayed extremely weak positive cross peaks. This fact was actually expected 
since the molecular weights of the studied tetrasaccharides are within the 
range close to zero NOE (650 Da). At higher magnetic fields, the Larmor 
frequencies are larger and the relative NOE intensities may improve according 
to the relationship between the NOE mechanisms and the ω0τC product (See 
Methods). However, although the spectra significantly improved at 800 MHz 
and several negative peaks were now observable, it displayed rather few 
signals yet, notably attenuated in many cases. In such cases, the 2D-ROESY 
variant constitutes the best alternative since it always provides positive 
correlation peaks regardless the molecular correlation time [81]. As starting 
point, at 298K and 800 MHz, the ROESY experiments performed for the free 
ligands displayed a larger set of positive peaks that could be thoroughly 
examined.  




The key inter-residue contacts were carefully checked as they are essential to 
describe the free conformation of the tetrasaccharides (Figure 4.40A). In 
parallel, both ligands were modeled by means of the GLYCAM-Web online 
server, using the Carbohydrate builder tool. This online platform allows the 
prediction of the 3D structures of carbohydrates, making use of the 
“GLYCAM06” force field (latest update) developed and optimized by the team 
of Prof. R. J. Woods [82-83].  
The NOE distances were estimated and compared to those measured in the 
modeled structures. Experimentally, there are several methods to establish 
the relationship between NOE intensities and inter-protonic distances [84], 
being the full relaxation matrix approach one of the most rigorous ones.  
However, this method is usually employed when studying large molecules in 
which spin-diffusion effects can easily lead to erroneous estimations. Instead, 
the approaches based on relative distances are approximate but still precise 
enough to provide interatomic distances in small relatively rigid molecules 
[85-86]. Using a known distance, the unknown one is deduced from the 
expression on Eq. 2, which correlates the quotient between both distances 
with their respective cross relaxation rates (and therefore, indirectly with the 
NOE peak integrals):  
     
     
 
   
   
 
   
  
     
                            
Where “a” and “b” are the two spins whose interatomic distance is known a 
priori, and “i” and “j” form the other spin pair which is being evaluated. Thus, 
the collected interresidual NOEs were all processed by using Eq. 2 and three 
intrarresidual NOE effects: H1-H3 β-Gal, H1-H5 β-Gal and H3-H5 β-Glc. In β-Glc 
and β-Gal residues, these protons are all placed at the bottom plane of the 
sugar structure, and their relative distances have been taken as fixed values 
(ca. 2.4 Ǻ), given the exclusive 4C1 conformation adopted by these D-sugars in 
solution [87]. The resulting average interatomic distances are summarized in 
column 2 of Figure 4.41. All values were slightly underestimated compared to 
those predicted by the GLYCAM model. However, the relative errors were 
mostly ranging around 8-14%, what could be attributed to a systematic error, 
probably arising from the experimental determination of the peak integrals 
with the NMR software. Most importantly, from a qualitative perspective, all 
the interresidual NOEs found fitted to those expected for the modeled 
tetrasaccharides (Figure 4.40B), except for the αGal H5 - βGal H3 cross peak, 
whose NOE correlation could not be detected in any case despite the distance 
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in the GLYCAM model was quite short (2.5 Ǻ). Slight local angular motions of 
the corresponding lingakes could be responsible for this fact. In summary, the 
theoretical model was eventually taken as valid, after verifying that the 
glycosidic torsion angles were within the expected values for the exo-
anomeric effects. 
 
 A antigen  B antigen 
 φ ψ φ ψ 
α-Gal/GalNAc -51.4 -35.4 -69.0 -36.6 
β-Gal +53.8 +5.9 +85.7 -27.2 
 α-Fuc +49.8 -4.4 +68.9 +12.7 
A) 
B) 




Figure 4.40. A) 2D-ROESY spectrum for the blood group B antigen (1 mM/D2O, tmix=200 
ms), showing the assigned interresidual NOEs. B) The free conformation of the B 
antigen, as predicted by GLYCAM06. The experimental NOEs are depicted as dashed 
green lines. The red line with an asterisk points out the short distance H5 α-Gal-H3 β-
Gal, not found in the 2D-ROESY. The table below includes the corresponding dihedral 
angles φ and ψ observed for the three torsional glycosidic linkages in each 
tetrasaccharide. 
Subsequently, tr-NOESY spectra were recorded with both ligands in the 
presence of the lectin. Both experiments were acquired with a 1:5 
lectin:ligand ratio and 200 ms mixing time, enough to accumulate NOE 
without significant spin diffusion. At 298 K, a remarkable increase in the 
negative NOE intensities was noticed for both ligands, thus confirming their 








H1Fuc-H3αGal 2.5 2.3-2.4 8 %  - 
H1Fuc-H5αGal 2.8 2.5-2.6 10%  2.8-3.2 
H1Fuc-H2βGal 2.7 2.3 14%  - 
H1Fuc-H3βGal 3.9 2.9-3.0 25%*  2.6-3.0 
H1αGal-H3βGal 2.9 2.6-2.7 10%  2.5-2.8 
H1αGal-H4βGal 2.3 2.0-2.1 13%  2.1-2.4 
H5αGal-H3βGal 2.5 - -  - 
H1βGal-H4βGlc 2.7 2.3 14%  - 
H1βGal-H6βGlc 3.3 2.5-2.6 24%*  - 
H5Fuc-H3βGlc 3.3 2.5-2.6 24%*  - 
H5Fuc-H5βGlc 2.9 2.7-2.8 7%  2.8-3.2 
H5Fuc-H6βGlc 3.4 3.2 8%  - 
 
Figure 4.41. Proton-proton distances (Ǻ) derived from computational calculations 
(GLYCAM) and experimental data in free solution (2D-ROESY) and in the presence of 
0.2 eq of DC-SIGN CRD (Tr-NOESY). The relative errors (εR) are calculated respect to the 
values in the first two columns. The asterisks highlight the largest distances, for which 
the errors were higher. 
 
The strong negative NOEs were thoroughly scrutinized to search for 
substantial differences between the free and the bound antigens. 
Interestingly, the set of transferred NOEs was nearly equivalent to that 
obtained for the free ligands (Figure 4.41, last column). At least five peak 
integrals could be calculated and their values also resulted in distances (See 
Methods) within the same range as those of the free ligands, except for Fuc 
H1 - αGal H5, whose inter-proton distance significantly increased. To note, the 
DC-SIGN RECOGNITION OF BLOOD GROUPS A AND B 
193 
 
peak intensities improved but they turned substantially broader due to the 
free-bound exchange process, increasing the peak overlapping and precluding 
the proper quantification of more cross peaks. In any case, the obtained data 
strongly suggested that both ligands essentially maintained their respective 
free conformations in the complex with the DC-SIGN CRD, with minor 
variations in the inter-proton distances, and especially considering a slight 
torsional twist on the Gal-Gal glycosidic linkage to account for the change in 
the Fuc H1 - αGal H5 distance without altering the other ones. 
Apart from the information related to the inner correlations in the ligand 
structure, a more detailed inspection of the tr-NOESY spectrum revealed an 
interesting feature. H1 Fuc was noticed to present a new correlation with 
some nuclei at very high field, around 0.80 ppm. Such a correlation did not 
appear either in the 2D-NOESY of the free protein or in the 2D-ROESY of the 
free ligand, thereby corresponding to an intermolecular NOE effect arising 
from a close contact between H1 Fuc and some protein sidechain. 
Additionally, the tr-NOESY yielded two more correlations with the same 
unknown nucleus arising from H2 Fuc and, in a lesser extent, from H3 α-Gal 
(Figure 4.42). From the protein perspective, the only sidechains expected to 
have high shielded protons are those belonging to the aliphatic residues, 
namely Leu, Val and Ile [88]. Fittingly, the unique residue included in this 
group that was located close to the ligand in the CRD architecture was actually 
Val351. Indeed, the measured chemical shift fitted very well with those 
reported for methyl groups from valine residues [89-90] (Figure 3.7 on 
Chapter 3). 
Obviously, the veracity of the aforementioned conclusion could not be 
checked out exclusively through 2D-NOESY experiments with such a severe 
signal crowding. To prove the existence of these close contacts, a 3D-15N-
HSQC-TOCSY was performed with a sample containing the 15N-labeled CRD in 
the same experimental conditions, namely, 298 K and 5 eq of ligand. The 
experiment is equivalent to a 2D-TOCSY spectrum in which the individual 
TOCSY patterns are further separated in the additional nitrogen dimension, 
thereby notably reducing the signal overlapping. When positioning at 121.4 
ppm in the 15N dimension, the TOCSY plane showed a correlation pattern for a 
peak located at 7.15 ppm, which corresponded to the Val351 amide group 
(Figure 4.43). The TOCSY crosspeaks, from high to low field, were respectively 
identified as correlations with protons H (methyl groups), Hβ and Hα. Not 
only the H chemical shifts were in perfect agreement with those identified in 
the tr-NOESY, but also the other correlations could be unequivocally identified 




as intra-residue NOEs. Overall, although the signal crowding precluded the 
quantitative estimation of intermolecular distances, this piece of information 
provided strong spatial constrains to restrict the quest for a suitable binding 
pose, given that NOEs cannot be generally observed above distances around 5 
Ǻ. 
 
Figure 4.42. In black, the tr-NOESY of the blood group A in the presence of 0.2 eq of 
lectin CRD (tmix = 200 ms). In red, a 2D-NOESY of the free protein performed with the 
same experimental setup (tmix = 200 ms). As highlighted, the correlations not observed 
in the free NOESY involve contacts with the ligand protons.  
 
Figure 4.43. Sidechain assignment of the residue Val351 through 3D-15N-HSQC-TOCSY 
at 298 K, in the presence of 5 eq of A antigen (tmix = 80 ms). On the left, the 
15
N-HSQC 
projection, and on the right, the TOCSY plane extracted at δ(15N) = 121.4 ppm, showing 
a strip centered on 7.15 ppm in the 
1
H dimension. 
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At this point, the gathered information was enough to propose a first 3D 
model of the sugar/lectin complex. From the STD results, it was concluded 
that the Fuc residue was likely to be oriented such that H1 and H2 directly 
contact the methyl group of Val351. Following this reasoning, the Fuc moiety 
was supposed to interact at the canonical binding site through OH3 and OH4, 
as it does in the PDB 1SL5, thereby fulfilling these experimental findings. 
Moreover, as deduced from the tr-NOESY data, the spatial arrangement of the 
other sugar residues adopted in the structure of the bound histo blood group 
antigens corresponded to that described by the theoretical models presented 
above (Figure 4.40B). Then, the 1SL5 coordinates were employed to fit the 
structures of the bound tetrasaccharides by means of superimposing the Fuc 
ring of both antigens with the Fuc ring of the LNFP III oligosaccharide. The 
resulting binding poses are detailed in Figure 4.44.   
In general terms, for both antigens, the proposed model nicely fulfilled the 
ligand-derived information described above. The largest STD effects were 
almost perfectly distributed among those ligand protons surrounding the 
Val351 sidechain. According to the crystal model, the methyl groups of this 
residue are very close to Fuc H1 (3.4 Ǻ) and Fuc H2 (3.0 Ǻ). Fittingly, the α-Gal 
moiety was placed fairly close to Val351 as well, thereby supporting the 
observed saturation of this residue mainly contributed by H2, H3, and H4. 
Analogously, for the core β-Gal, H2 was the closest proton to this amino acid, 
what would justify the only relevant STD effect observed. Finally, the 
proposed arrangement would place the remaining Glc away from both the 
protein surface and specifically from Val351, supporting the almost complete 
absence of STDs. In regard to the tr-NOESY data, the interatomic distances 
between H of Val351 and Fuc H1, Fuc H2 and α-Gal H3 take values below 5 Ǻ 
in the models, thus fitting with the experimental NOEs reported. Such a 
finding constituted the strongest proof to support the modeled binding pose, 
as the insertion of the Fuc ring into the binding site through other contacts 
(OH2/OH3, as in Langerin [74], 180º-rotated OH3/OH4, as in DC-SIGN 
interacting with Man [60,73]), would inevitably place at least one of the three 
mentioned protons too far from Val351.   
Finally, it is worth mentioning that this approximation constituted a 
preliminary model roughly built by manual docking, which was subsequently 
refined by molecular dynamics (MD) simulations, as described in the following 
section. 
 






Figure 4.44. Binding poses proposed for the blood groups A (top) and B (bottom) on 
the basis of the collected STD and tr-NOESY data. Val351 is represented in blue. The 
protons are colored according to their respective relative STD percentages, from blue 
(100%) to red (0%). Relative STDs higher than 20% are directly indicated. The three 
transferred NOEs between Val351 methyl groups and the ligand are detailed as well 
(the protons of the Val351 residue are not represented to simplify the figure). 
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4.5. Molecular Dynamics 
Once a suitable description of the interaction had been proposed, the 
theoretical binding models were subjected to molecular dynamics simulations, 
aimed at assessing their stability and getting additional insights into the 
interactions. For both oligosaccharides, the starting geometry was built as 
detailed above, namely, by superimposing the Fuc ring from the ligands with 
the same residue from the LNFP III scaffold present in the PDB 1SL5 structure. 
After the two initial minimization steps, the MD simulations were run for 100 
ns. Along this time, structural data were extracted every 2 ps, collecting a total 
of 50000 frames that were carefully analyzed.  
 Figure 4.45. Values of the torsional angle φ observed for the three glycosidic linkages 
existing in each tetrasaccharide along the complete MD simulation (100 ns). In all 
cases, the φ dihedral is defined from the anomeric H1 to the opposite carbon (H1-C1-
O’-C’). The vertical axis represent the frequency of each dihedral value, in number of 
MD frames (total = 50000 points). 
Fittingly, both complexes remained stable along the entire simulation, and no 
ligand detaching was observed at any moment. The torsional angles φ and ψ 




were monitored for the three glycosidic linkages. In both cases, the observed 
values of the φ torsional reasonably accounted for the expected exo-anomeric 
effects. Specifically, the average values corresponded in the three cases to an 
exo-syn conformation, ranging around φ = -53º for the α-Gal/GalNAc, φ = +46º 
for the core β-Gal and φ = +53º for the α-Fuc (Figure 4.45). To clarify, the sign 
of the φ angle for the exo-syn α-Fuc is the opposite as it is an L-sugar. 
Noteworthy, as can be appreciated in Figures 4.46 and 4.47, the torsional 
angles related to the Fucα1-2Gal linkage were very low dispersed, with 
standard deviations below 10 degrees. Moreover, the Fuc moiety remained 
almost at the same position at every moment, showing a much restricted 
mobility as a result of the two coordination bonds established with the 
calcium ion. Both observations highlighted the marked rigidity of these two 
residues (α-Fuc and β-Gal), barely displaced from the initial positions along the 
simulation. For the reducing Glc ring, the φ angle also fluctuated within a 
reduced range, while the standard deviation for the other dihedral ψ was 
higher, thereby conferring to this residue a broader degree of mobility.  
 
Figure 4.46. Distribution of the φ and ψ torsional angles which define each glycosidic 
bond in the studied antigens. The φ dihedral is defined from the anomeric H1 to the 
opposite carbon (H1-C1-O’-C’) and the ψ dihedral, from the anomeric C1 to the 
opposite proton (C1-O’-C’-H’).  
Regarding the other terminal non-reducing moiety (Gal/GalNAc), the overall 
dynamic behavior was similar although some slight differences were noticed 
between the two tetrasaccharides. In both cases, the values of the φ angle 
were more dispersed, ranging from -25º to -75º for more than 95% of the 
collected frames. This variability led the Gal/GalNAc pyranose to show a more 
undefined location along the simulations (Figure 4.47, bottom), which could 
be explained by the existence of two preferred conformations of the 
Gal/GalNAc ring, as deduced from the asymmetric distribution of the φ values. 
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Indeed, such an asymmetry was better observed for the A antigen, which did 
not show a simple Gaussian distribution (Figure 4.45). In one of the 
conformations, the α-Gal ring displayed a φ value centered around -60º, 
which places OH3 and OH4 polar groups closer to the protein surface.  In such 
an arrangement, the α-Gal residue forms hydrogen bonds with the carbonyl 
group of Val351 and the amino group of Lys368, mainly through OH3 and 
occasionally through OH4 as well (Figure 4.48A). In the alternative 
conformation, the φ dihedral switched to a smaller value of -47º in average, 
similar to the torsional angle found in the free oligosaccharides. As a result, 
OH3 and OH4 were slightly moved away from the previous positions, getting 
closer to the long loop. However, in this case, only the OH6 group of α-Gal was 
directly involved in polar contacts with the protein sidechains, participating in 
a wider network of hydrogen bonds. These contacts mediated by OH6 were 
alternatively established with the carbonyl group of Val351 and the charged 
sidechain groups of Lys368 and Glu354. Frequently, an additional 
intramolecular H-bond with OH2 of Fuc  also bridged this residue to the 
mentioned amino acids (Figure 4.48A).  
 
Figure 4.47. Front and top views of the ligand trajectories (left: A antigen; right: B 
antigen) along the MD simulations. The bundle is constituted by 20 representative 
frames. Color code: blue: β-Glc; purple: β-Gal; red: α-Fuc; orange: α-Gal/GalNAc. The 
white spheres represent the calcium ions. The residue Val351 is detailed in black. 




Remarkably, the α-Gal/GalNAc moiety was the only residue as well as the α-
Fuc moiety that established stabilizing contacts with the protein, whereas the 
core β-Gal and the reducing Glc were completely devoid of direct 
intermolecular interactions. As indicated above, the non-reducing Gal/GalNAc 
was involved in transitory VdW contacts with the three aforementioned 
residues (Val351, Lys368, Glu354), while the Fuc pyranose, as well as 
coordinating the calcium ion, formed fixed hydrogen bonds with at least five 
amino acids located on the long loop and the opposite β4 strand:  Glu347, 
Asn349, Glu354, Asn365 and Asp367. All these residues simultaneously took 
part in the coordination sphere of the metallic atom and interacted with the 
hydroxyl groups OH2, OH3 and OH4 from Fuc (Figure 4.48B). Worth noting, H1 
Fuc and H2 Fuc remained notably close to the Val351 sidechain at every 
moment (2.0-3.0 Å), perfectly compiling with the intermolecular NOE effects 
previously reported for them. Similarly, the tr-NOE arising from H3 α-Gal could 
be explained as the distance to the Val351 methyl groups was always lower 
than 5 Å regardless the linkage conformation (Figure 4.49). The average inter-
protonic distances were 3.8-4.0 Å from H1 Fuc and H3 α-Gal, while H2 Fuc was 
undoubtedly placed nearer Val351 (3.0-3.2 Å). These measurements would 
explain why the average tr-NOE effects were much weaker for the former 
protons. Apart, H4 also lied rather close to Val351 (2.5-3.5 Å) in one 
conformation, but it was completely pushed away from the aliphatic sidechain 
in the other conformer, reaching distances much larger than 5 Å. Thus, the 
averaged transferred NOE, if it exists, would be expected to be even weaker 
than that of H3 Gal/GalNAc, and in fact, it was not observed for any antigen at 
all. Taken together, these observations fulfilled with the experimental NMR 
data. 
In addition, the corresponding MD trajectories were analyzed by using the 
CORCEMA-ST software, with the purpose ofevaluating the agreement 
between the theoretical STDs and the experimental ones. To reduce the time 
costs, a series of previous tests allowed to checking out that 100 structures 
randomly selected were enough to represent the binding of both antigens 
along the total MD time, since variations in the final theoretical STDs were 
actually negligible when more frames were included in the analysis. For each 
proton, its theoretical STD was calculated as the average of the 100 STDs 
estimated from the 100 respective computed frames. Thus, the final STD 
profile was built on the basis of the averaged values individually calculated 
and compared with the experimental profile (Figure 4.50).  





Figure 4.48. A) Detailed analysis of the molecular interactions (H bonds, dashed black 
lines) in which the non-reducing Gal/GalNAc moiety is directly involved. For each 
antigen, three representative frames are shown (top row: BgA; bottom row: BgB) and 
the corresponding φ angle is indicated on the top. Also, the three protein residues 
participating in these contacts are highlighted as tighter lines. B) Front and back views 
of the binding site displaying the molecular interactions provided by the Fuc residue. 
The coordination bonds are not represented. 
Several experimental variables were directly introduced as known parameters 
for running CORCEMA-ST, whereas other conditions could not be described 
exactly like in the experiments and had to be estimated considering some 
assumptions. For instance, as the sidechain assignment was not available for 
the DC-SIGN CRD, no chemical shifts could be used to simulate the selective 
saturation pulse, and instead, this pulse was considered as entirely applied to 
five aliphatic amino acids (Ile, Leu, Val, and also Ala and Thr).  Similarly, the 
A) 
B) 




correlation time of the bound ligand (τbound) was approximately determined 
through the empirical relationship described by Eq. 3 [91]. Finally, the chosen 
values of kon and Kd were those previously obtained from 
15N-HSQC-based 
titrations. To note, the on rate turned out to be rather important in the 
calculations, as the results significantly deviated when supposing a diffusion 
controlled kon of 10
8 M-1 s-1 (not shown).  
       
    
    
                             
Where “ρ” is given the value 1 for proteins with spherical (globular) shape, or 
alternatively 1.32 for other irregular geometries (ellipsoidal, lineal…). The 
molecular weight in this case corresponds to the sum of the respective protein 
and ligand MWs. 
 
Figure 4.49. Detailed analysis of the intermolecular distances between the two methyl 
groups of Val351 (blue/orange) and five protons of the blood group A. As can be seen, 
the distances to H1 Fuc, H2 Fuc and H3 GalNAc remain at fixed values below 4 
Angstroms, always contacting at least one methyl group. For H4 GalNAc and the N-
acetyl protons, the lowest distance to the Val351 sidechain systematically changes 
several times along the MD simulation, as a result of an important switch in the 
GalNAc arrangement. The red boxes indicate those time intervals in which the initial 
pose is modified (φ increases).    




Figure 4.50. Comparison between the CORCEMA-ST-derived STDs (orange) and the 
experimental STDs (green), expressed as relative values (Ref. H2 Fuc in both cases). 
Both CORCEMA-ST calculations were run with the following common parameters: Δsat: 
Ile, Leu, Val, Ala, Thr; tsat = 2 sec.; [P0] = 60 µM; [L0] = 4.2 mM; rholeak = 0.1; B0 = 600 
MHz; τfree = 0.5 ns; τbound = 8.33 ns; τintra = 0.01 ns. 
The resulting CORCEMA-ST profile described the experimental STDs in a 
satisfactory manner, although some discrepancies were found for both 
antigens. To highlight, the successive runs remarkably underestimated the 
STDs of H1 α-Fuc and H2 β-Gal, as well as the STD effect provided by the N-
acetyl group in the case of the A antigen. Even so, the main differences 
between both datasets were observed for the α-Gal/GalNAc moiety, whose 
theoretical values were rather overestimated for most of their protons in 
comparison to those experimentally collected. However, a thorough analysis 
of the computed frames revealed that such an overestimation essentially 
came from the contribution of those frames in which the α-Gal/GalNAc moiety 
adopted conformations with φ values smaller than -60º, thus placing H3 and 
H4 directly towards the Val351 methyl groups. In fact, when considering any 
of the other frames with the φ dihedral close to -60º or higher, the calculated 
profile improved for α-Gal/GalNAc, getting closer to the experimental STD 
effects (Figure 4.51): the contributions from H3 α-Gal and H4 α-Gal turned 
weaker, while the more flexible N-acetyl group (for the A antigen) approached 




to the protein surface, specifically to the Val351 sidechain region, providing a 
stronger average theoretical STD. In either case, the R-NOE factors (Figure 
4.50, see Methods) were acceptable considering that no experimental 
restrictions were imposed during the simulations and no further optimizations 
were applied to the CORCEMA-ST setup, except for kon [92-93].  
 
Figure 4.51. Comparison between the average theoretical STDs obtained for the A 
antigen (red dashed line) and CORCEMA-ST profiles calculated for two isolated frames, 
A and B, in which the GalNAc moiety displayed φ angles of -65.8º and -62.3º, 
respectively (blue solid lines). The black dashed line corresponds to the experimental 
profile. As can be noted, the predicted STDs for the two selected frames are notably 
lower for H3 and H4 GalNAc in comparison with the average values. In contrast, the 
expected STD for the N-acetyl group significantly varies among frames with similar 
poses.  
Therefore, the NMR results presented herein suggested that in the real 
scenario the α-Gal/GalNAc pyranose is likely to show a fixed conformation, 
exhibiting a φ angle close or higher than -60º, but not lower. The alternative 
conformer, in the most extreme cases, led this pyranose ring to pack against 
the nearby α-Fuc residue, thereby enabling hydrophobic contacts between 
both sugars as well as with the sandwiched aliphatic residue (Val351), what 
was not fully supported by the experimental NMR data. Hence, such an event 
was thought not to be actually happening, or it was only at very low 
percentages. Instead, the experimental evidences better supported that the α-
Gal/GalNAc unit is separated from the α-Fuc residue upon lectin binding, 
displaying slightly higher φ angles in comparison with those found in the free 
ligands. Besides the favorable corrections introduced on the CORCEMA-ST 
profile, the slight twist of the α-Gal/GalNAc glycosidic bond perfectly 
explained both the absence of a tr-NOE from Val351 for H4 α-Gal and the 
increased distance between H5 α-Gal and H1 α-Fuc upon binding, as observed 
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in the tr-NOESY and ROESY spectra of the bound and free ligands, respectively. 
Therefore, by virtue of these results, the binding geometry proposed for the 
histo blood group antigens A and B could be certainly considered as a robust 
3D structure, jointly corroborated by experimental and computational 
approaches.  
4.6. The 3D model of the complex 
The data gathered so far by means of ligand-based approaches has permitted 
to propose a binding model that describes different features of the interaction 
between the DC-SIGN CRD and the histo blood group antigens A and B. In 
analogy to the existing data for the recognition of the Lewis X motif [38,59], 
the Fuc moiety is placed at the canonical binding site, establishing direct 
coordination bonds with the metal ion through OH3 and OH4 groups and 
additional vdW contacts with the surrounding amino acids. Certainly, the 
neighboring sugars also play secondary roles during the formation of these 
complexes, slightly tuning the affinity and the interaction dynamics in 
comparison with the free monosaccharides. Interestingly, the configuration of 
the Fuc glycosidic linkage in the blood group antigens (α1-2 instead of α1-3) 
leads these ligands to display a totally different sugar arrangement in its 
interaction with the lectin. Thus, in the Lewis X trisaccharide, the other non-
reducing pyranose is placed into the secondary binding site formed by β-
strands 2, 3 and 4, pointing its more aliphatic face towards Phe313, while the 
N-acetyl group from the central GlcNAc moiety accounts for the additional 
stabilizing hydrophobic contacts with Val351. In contrast, in the blood group 
antigens, this latter role involves the non-reducing Gal/GalNAc, while the 
opposite ligand regions are located near the secondary binding site, but 
without participating in the interaction.  
At this point, some questions remained opened, especially concerning the 
differences detected by the protein-based NMR approach between both 
antigens. The non-reducing α-GalNAc moiety preferably displayed φ angles of 
ca. -60º, thereby enabling the formation of polar contacts with the protein 
through OH3 and/or OH4. In such an arrangement, the position 2 of the 
terminal α-GalNAc in the A antigen stays close to Val351 in a large percentage 
of the MD trajectories, suggesting the existence of an additional transient 
hydrophobic contact with the long loop. Strikingly, if this interaction exists, 
the affinity of the A antigen would be expectedly better. However, the 
experimental evidences pointed towards the opposite trend, since no tr-NOE 
effects were actually detected between the acetyl group and methyls from 




Val351. Hence, the proposed model did not fully explain why these 
oligosaccharides behave differently in terms of dynamics and affinities, 
considering that the structural requirements for binding are equally fulfilled 
for both sugars. Apart, although the stabilizing effect arising from the non-
reducing α-Gal is present in both cases, the affinity of the A antigen was 
slightly worse than that of the free monosaccharide (Fuc), as deduced from 
the binding isotherms built by 15N-HSQC-based titrations. In principle, this fact 
could be attributed to the existence of alternative binding poses for the Fuc 
monosaccharide. Indeed, as highlighted before, the existence of several 
binding modes enhances the affinity of a given ligand (statistical rebinding).  
Then, taking into account the promiscuous character exhibited by DC-SIGN on 
sugar recognition, the possible existence of additional binding modes was 
explored using T2-filtered NMR experiments and the 
19F nucleus as probe. As 
precedent, the results from 15N-HSQC-based titrations already supported this 
hypothesis in the case of the blood group B. As already detailed in the 
introductory section, the plasticity of the binding site is a common feature 
shared by C-type lectins and is the basis of their broad specificities. This ability 
not only enables the relatively easy accommodation of many different 
tridimensional structures, but also leads these receptors to recognize the 
same monosaccharide through alternative binding poses, as widely 
demonstrated for Man in DC-SIGN [60,73,79], and for Fuc between close 
lectins (MBP-C [75], Langerin [74] and DC-SIGN [59]) (Figure 4.52).  
 
Figure 4.52. Close view of the Ca2+-dependent binding site of three related lectins 
harboring different Fuc-containing ligands. Left: DC-SIGN with LNFP III (PDB 1SL5); 
Middle: Langerin with the blood group B trisaccharide (PDB 3P5G); Right: MBP-C with 
α-OMe-Fuc (PDB 1RDI). 
Considering that the major interaction is driven by hydroxyls OH3 and OH4 of 
Fuc, and that Gal and Glc are very weak binders of DC-SIGN as well [36], the 
other existing alternatives would include: 
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 Through OH2-OH3 of Fuc. 
 Through OH2-OH3 of the reducing Glc. 
 Through OH2-OH3 or OH3-OH4 of the non-reducing α-Gal, for the B 
antigen. 
 Through OH3-OH4 of the non-reducing α-GalNAc, for the A antigen. 
The possibility of targeting the calcium ion by means of the inner Glc was 
immediately discarded, given that there was no way to place the 
tetrasaccharide at the primary binding site without generating important 
clashes involving the core β-Gal. The remaining options were evaluated by 
means of 19F-T2 relaxation experiments using a small library of fluorinated 
monosaccharides, including 2F-Fuc, 4F-OMe-Fuc, 2F-Gal and 4F-Gal as probes, 
and 3F-Man as negative control (Figure 4.53). This last sugar has been recently 
reported to completely lack the ability to bind to DC-SIGN [73]. In addition, 3F-
Fuc was also included to directly compare its T2 rate in the presence of the 
lectin with those of the 2F-Fuc and 4F-Fuc. In principle, the 3F-Fuc was neither 
expected to be recognized given that blockage of position 3 would preclude 
binding through either the OH3-OH4 or the OH2-OH3 pair. The chemical 
syntheses of 2F-Fuc [94-95], 2F-Gal [96], 4F-Gal [97] and 3F-Man [98] were 
already achieved and optimized several years ago and they are currently 
commercially available compounds. The 4F-OMe-Fuc was de novo synthesized 
and provided by the group of Prof. B. Linclau at the Faculty of Chemistry in the 
University of Southampton (UK). Finally, the 3F-Fuc synthesis was 
accomplished in collaboration with the same group, by a novel method 
developed during the short term stay that is detailed in chapter 6.  
The relaxation experiments were performed at 298 K in the absence and the 
presence of 10 μM of lectin. To enhance the relaxation effects caused by the 
lectin and better evidence the binding events, the tetrameric extracellular 
domain of DC-SIGN (DC-SIGN ECD, 40 μM CRD) was employed rather than the 
CRD. The fluorine nucleus was individually assigned for each ligand through a 
simple proton-decoupled 1D-{1H}-19F (Figure 4.54). All the 12 fluorine signals 
(6 compounds, 2 anomers) were perfectly separated, and hence the time cost 
was reduced by only recording two T2-filtered experiments with the mixture of 
monosaccharides, containing 0.8 mM of each. Obviously, although the ligand 
ratio would be 1:20 under these conditions, the real ratios were actually lower 
after the anomeric equilibrium had been reached for the free sugars (all of 
them except for 4F-OMe-Fuc). Nevertheless, the final ratios were still large 
enough (between 1:5 and 1:20) to record the CPMG spectra with good 
experimental sensitivity. Indeed, as stated in the Methods section, the 




sensitivity of these experiments is fairly high and very weak interactions can 
be detected as well [99]. To avoid possible biasing arising from non-specific 
binding, a third control experiment was additionally recorded: a large excess 
of d12-EDTA (20 mM) was added to sequester the available calcium in the 
buffer (4 mM) and disrupt the specific Ca2+-dependent sugar recognition.  
 
Figure 4.53. Library of fluorinated monosaccharides used for performing 19F-based T2-
filtered NMR experiments.  
The CPMG pulse sequence [100-101+ was applied with a consensus τ = 2 ms 
and varying the number of echoes (“n”) from 2 to 1300 (24 points). The decay 
of each 19F signal was monitored for every “n” value, in the presence and in 
the absence of the lectin. From the individual graphs, the corresponding 
transverse relaxation times (T2) were estimated by adjusting the data to Eq. 4 
(Eq. 20 in Methods). To assess the binding ability of each ligand, the results 
were evaluated both graphically and also through the analysis of the 
percentage of T2 decay, calculated by comparing the difference between both 
T2 rates (free/bound) with the absolute T2,free, as described by Eq. 5. The 
overall results are summarized in Figure 4.55. 
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Figure 4.54. Monodimensional 19F-{1H} spectra acquired at a consensus echo time of 
1000 ms (n = 250) with the CPMG pulse sequence. The chosen echo time was optimal 
for the observation of large differences in the free/bound decays. Top: free ligands (0.8 
mM). Middle: ligands + 40 μM CRD. Bottom: ligands + 40 μM CRD + 20 mM EDTA. 
As expected, neither the 3F-Man anomers nor the β-3F-Fuc could bind to the 
DC-SIGN ECD, thereby highlighting the essential role that position 3 plays in 
the recognition of both sugars by this lectin. Analogously, α-4F-Gal displayed 
no visible changes in its decay profile after adding DC-SIGN, thus totally 
discarding it as a binder. Instead, the T2 decay was slightly faster for β-4F-Gal, 
as shown in Figure 4.55B, suggesting that the binding is negligible or 
extremely weak. The fact that β-4F-Gal preserves a residual binding character 
that does not exist for the α anomer is supported by the known ability of β-Gal 
to target the calcium site through its axial OH1 and equatorial OH2 when OH1 
is available (reducing end), in an alternative pose called “non-physiological” 
binding [75]. Surprisingly, for both 4F-OMe-Fuc the scenario was rather similar 
to that described for the previous ligands, namely, the variations in the 
corresponding relaxation times were remarkably low and actually not 
meaningful. In retrospect, these observations differed from those works 
reporting that the binding of Fuc to other lectins is also feasible through 




positions 2 and 3 [74-75]. Instead, regarding the results presented herein, it is 
clear that this OH2-OH3-based binding is much less favored in DC-SIGN. In 
contrast, the corresponding 2F-Fuc probes displayed a sharp drop in their 19F 
signals upon protein addition, quickly disappearing only after 40 echo cycles 
due to the fast protein-mediated relaxation, and thereby unequivocally 
confirming these sugars as binders. Finally, both 2F-Gal anomers stood out as 
binders of DC-SIGN as well, as displayed in Figure 4.55A. Interestingly, the 
signal decay was fairly strong in comparison with that of 4F-OMe-Fuc, and 
they were actually among the clear strongest binders within the studied 
library just after both 2F-Fuc anomers. It has been reported that Gal can be 
weakly recognized by DC-SIGN [36], and the findings reported herein have 
highlighted that such a binding is mainly established by means of hydroxyl 
groups OH3 and OH4, as shown for Fuc. Moreover, the recognition of the α 
anomer was clearly more favored than that of the β anomer. Finally, it is 
specially worth noting the particular case of the α-3F-Fuc. Certainly, it was 
reported to produce a noticeable decay in the presence of DC-SIGN. Taking 
into account the completely opposite scenario found for the β-anomer, the 
anomeric position is very likely to be involved in the binding together with 
nearby OH2. Indeed, the stereochemistry of OH1 and OH2 is exactly 
equivalent to that of OH3 and OH4, hence this observation could be 
reasonably justified as well as it also supports the slightly better affinity of Fuc 
found in this work in comparison with its corresponding methoxy-L-glycosides 
[36]. To note, in all cases, and especially for those fluorinated sugars that were 
clearly recognized by the ECD, the further addition of EDTA led to almost 
complete signal recovery, what eventually proved that for all the probes the 
binding was always taking place in a specific manner, at the Ca2+-dependent 
primary binding site.  
 
A) 




Figure 4.55. A) Percentage of T2 decrease calculated by means of Eq. 5. Each T2 value 
was individually obtained by fitting data shown in B) to Eq. 4. B) Signal decay curves 
reported for every single ligand. The intensity values are displayed in relative scale, 
giving the value 1.00 to the intensity measured at the first point (n = 2). Each graph 
includes three curves: the free sugar (light orange circles), the sugar in the presence of 
the lectin (dark orange circles) and after adding 20 mM of EDTA (grey diamonds). 
B) 




Overall, these results point out that the preferential interaction with the DC-
SIGN ECD is established by the Fuc moiety, chelating the calcium ion chiefly 
through hydroxyls at positions 3 and 4. Fittingly, this is the major mode in 
which DC-SIGN interacts with both blood group antigens A and B, as 
demonstrated in the previous sections. Regarding the other available residues, 
the existence of a secondary binding pose for the blood group B would be now 
supported by the additional participation of the non-reducing α-Gal, which 
would target the binding site through OH3 and OH4. In the same line, the 
contribution of any other binding mode involving calcium targeting through 
positions 2 and 3 is probably negligible. Taking all these observations together, 
the Fuc moiety would only enable the interaction of the blood group antigens 
by means of a unique binding mode. Additionally, the B antigen, but not the A, 
would have the ability to rebind to the DC-SIGN CRD through its terminal α-
Gal, thereby explaining its slightly better affinity and more complex binding 
isotherms. Of course, to fully confirm this hypothesis, the interaction through 
the GalNAc moiety in the case of the A antigen should also be discarded. Since 
a fluorinated GalNAc moiety could not be included in the 19F-T2 experiments, 
the normal GalNAc monosaccharide was used to perform STD experiments 
with DC-SIGN. Also, Gal was included in the study with the purpose of 
gathering data for proposing a feasible binding pose, as done for the Fuc-
based recognition models. As the Gal-mediated interaction presumably takes 
place at a low percentage, this information cannot be directly extracted from 
an STD spectrum with the B antigen, in which the STD effects are essentially 
contributed by the major binding structure.  
Following the same experimental methodology, STD spectra were performed 
with a fixed total ligand concentration of 4.2 mM (in D2O) and a protein/ligand 
ratio of 1:70 (60 μM of CRD). The saturation was applied for 2 seconds at the 
aliphatic region (0.76 ppm for Gal and GalNAc; 0.60 ppm for Fuc). In this case, 
according to the structure of the blood groups, only the methyl α-glycosides 
were selected and employed (α-OMe-Gal, α-OMe-GalNAc, α-OMe-Fuc) in 
order to simplify the analyses and minimize signal overlapping issues. 
Unfortunately, both anomeric H1 from α-OMe-Gal and α-OMe-GalNAc 
resonated too close to the signal water, and a consensus temperature could 
not be determined to observe them. Thus, the spectra were recorded at 288 
K, which was the only temperature that allowed measuring at least the H1 
from α-OMe-Fuc. Although the affinities of these ligands were in the same 
range or lower than those of the tetrasaccharides, the exchange regimes were 
expectedly faster, as already proved for Fuc by 15N-HSQC-based titrations. 
Then, the higher inefficiency of the saturation transference resulted in a 
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notorious reduction of the experiment sensitivity, that could be partially 
compensated by two ways: applying a spin-lock filter to suppress the water 
signal (without deeply affecting H1 Fuc) and recording an additional STD of the 
free protein (receptor blank), that was subtracted from the final STDs to 
efficiently remove the protein background. These final spectra are commonly 
named STDD (Saturation Transfer Difference Difference) (Figure 4.56). 
 
 
Figure 4.56. A) Identification of the visible STDs reported for each individual 
monosaccharide. B) Global analysis of the relative STD intensities obtained for the 
three ligands, taking the Fuc H2 proton as the overall reference nucleus, with a relative 
intensity of 100%.  
A) 
B) 




The STDD of the α-OMe-Fuc essentially yielded the same relative STD effects 
as those observed for the blood groups (Figure 4.56). The H2 proton clearly 
displayed the strongest STD (STDrel = 100%), followed by H1. In addition, 
weaker STDs could be also noticed for H3 and H4, ranging around 40-50% in 
relative terms, whereas the contribution of the remaining protons was fairly 
lower (below 15%). For α-OMe-Gal, the strongest STD showed a relative 
intensity of ca. 14% as compared with H2 Fuc, evidencing the lower affinity of 
this monosaccharide. To note, that effect was determined as the sum of 
protons H2 and H3. The other nuclei only provided very weak or residual STDs 
that were still measurable though, except for H5. Besides H2 and H3, 
saturation was also noticeable for H4. This proton showed the second 
strongest relative STD, near to 50% if compared to H2/H3 Gal, while only 7% if 
compared to H2 Fuc. 
Finally, the STDD of the α-OMe-GalNAc provided no STD peaks at all. Even 
subtracting the receptor blank spectrum, only residual STD effects could be 
measured for the N-acetyl and the O-methyl groups (lower than 5%). 
Nevertheless, these ones were better interpreted as artifacts derived from the 
specific pulse sequence applied, as they did not have any sense regarding the 
monosaccharide structure and the possible ligand arrangements.  
In summary, these results further assessed that both blood groups A and B 
target the canonical calcium site of DC-SIGN primarily through the hydroxyl 
groups OH3 and OH4 of their respective Fuc residues and explain why they are 
differentiated in terms of affinities and dynamic behavior. Accordingly, a 
minor binding mode takes place only for the B antigen, which is established 
through the non-reducing α-Gal residue and entails an additional stabilization 
of the complex formed by this antigen.  
To further demonstrate whether this alternative Gal-driven binding mode was 
still feasible when considering a larger oligosaccharide, additional NMR 
experiments were carried out for the lectin in the presence of a related 
antigen: the Galili type VI trisaccharide. In structural terms, this antigen is 
equivalent to the blood group B tetrasaccharide type VI, but it lacks the 
terminal α1-2 Fuc and the only non-reducing sugar is therefore the α1-3-
linked Gal. Following the reasoning proposed above, the binding of this 
antigen to DC-SIGN should be exclusively possible through the terminal α-Gal. 
The specificity of this interaction was simultaneously proved by 15N-HSQC-
based titrations and STD experiments. Of course, for the latter ones, the 
proton chemical shifts of the ligand had to be assigned. However, this task 
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resulted fairly trivial and fast given that in the 13C-HSQC spectrum most of the 
resonances were relatively located at the same positions than those observed 
for the analogous sugars in the blood groups. Thus, the identification of each 
proton via 2D-TOCSY spectra was quickly accomplished (Figure 4.57).  
 The perturbations on the DC-SIGN CRD amide crosspeaks were evaluated by 
15N-HSQC, using a 100 μM 15N-labeled CRD sample. To note, due to the 
markedly poor interaction, the saturation plateau could not be reached and 
the affinity was not calculated either. In spite of the weak binding, the 
resulting spectra at 50-70 eq of ligand already showed noticeable shifts on 
several amino acids. A thorough analysis of the corresponding peaks revealed 
that about 11-13 residues were moderately shifted in the presence of the 
trisaccharide, and specifically four of them were remarkably perturbed (Figure 
4.58 and 4.59A). These four residues were located very close to the calcium 
ion, both at the long loop (N349, V351) and at the opposite β4 strand (D366, 
K368). From an overall perspective, the CSP distribution pattern for Galili was 
fairly similar to these previously evidenced for the Fuc-containing and Man-
containing oligosaccharides. Indeed, a graphic analysis using the CRD structure 
quickly evidenced that the most relevant perturbations were all distributed 
along the protein region surrounding the calcium site 2 (Figure 4.59B). Hence, 
the interaction was likewise deduced to take place in a specific fashion, as 
reported for the blood groups, while the affinity was expectedly reduced, as 
inferred from the large amounts of ligands that were needed to achieve 
observable CSPs. 
Interestingly, the Val351 amide group was actually rather affected in 
comparison with the blood groups, even more that the neighboring N350. The 
same difference was also noticed for K368, which was previously observed to 
undergo large peak displacements exclusively in the presence of the Man 
epitope, but not with Fuc. Moreover, the only clear long-range perturbations 
were reported for S310 and T314, whereas the nearby F313 residue remained 
unperturbed. From a dynamic point of view, and similar to the titration with 
Fuc, the changes in the peak positions were herein accompanied with minor 
broadening effects, which were indicative that the binding process was 
predominantly occurring within a fast exchange regime. In this line, and 
supposing a kon value of the same order for all these ligands (Galili and blood 
groups), the lower affinity would be essentially imposed by a larger koff rate. 
Obviously, the approximate values could not be estimated since the empirical 
equation used for the blood groups was only valid for cases of intermediate 
exchange. 






Figure 4.57. A) 2D-TOCSY correlations established for each independent sugar in the 
Galili antigen. The individual spin systems are detailed in different colors. B) 13C-HSQC 
full assignment of the studied trisaccharide. Color code: Blue: β-Glc; light blue: α-Glc; 
orange: β-Gal; light orange: α-Gal. 
A) 
B) 




Figura 4.58. Average CSPs measured for the Galili epitope (60 eq, right, in orange), 
compared with those reported for a blood group antigen (140 eq, middle) and the Fuc 
monosaccharide (140 eq, left). All data were collected at 310 K.  





Figure 4.59. A) Two sections of the 15N-HSQC spectra of DC-SIGN recorded in the 
presence of the Galili epitope. Some residues significantly perturbed are labeled. Color 
code: black: free CRD; red: 36 eq of Galili; pink: 72 eq of Galili. B) The DC-SIGN CRD 
showing those amino acids that experienced CSPs above the cutoff value. Cutoff CSP = 
µ + σ = 0.0131 ppm.  
The 15N-HSQC titrations unequivocally proved the existence of a specific 
interaction between the Galili trisaccharide and the DC-SIGN CRD, thereby 
demonstrating that the recognition of this scaffold is weak but still possible in 
B) 
A) 
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the absence of Fuc. Subsequently, these studies were complemented with STD 
measurements, applying the same experimental conditions described above (T 
= 288K, 1:70 protein/ligand, aliphatic saturation (2 sec.)). After subtracting the 
protein blank, the resulting STDD allowed to distinguishing a clear set of weak 
STDs arising from the studied trisaccharide (Figure 4.60). Those measurable 
NMR signals ranged between 0,5% and 1% of absolute STD intensity and 
essentially came from the two Gal moieties. The non-reducing α-Gal yielded 
the predominant STDs at H1, H2 and H3, with intensities within the 0,8-0,9% 
range. In relative terms, these intensities were about 25% if compared with H2 
of the α-OMe-Fuc monosaccharide, and therefore slightly higher than those 
measured for α-OMe-Gal (Figure 4.61). For the central β-Gal, some saturated 
protons could be identified as well, namely H3, H4, H5 and H6. Their 
respective contributions were substantially lower than those of the terminal 
α-Gal. Regarding the remaining reducing Glc, their signals were barely 
detectable and so attenuated that it was unworkable to accurately measure 
any STD intensity (<<0.5%).  
 
Figure 4.60. STDD profile obtained for the Galili trisaccharide at 288 K in the presence 
of 60 µM of CRD (70 times lower). The saturation pulse was applied at 0.76 ppm 
(aliphatic region) for 2 seconds. The STDs provided by the non-reducing α-Gal are 
indicated in red.  
Unfortunately, the acquisition of a Tr-NOESY in the case of the Galili epitope 
was not possible given the low affinity of the ligand. Then, the STD and the 19F-
T2 data constituted the unique piece of information from the ligand 
perspective to unveil the binding mode. In this scenario, a manual docking 
protocol was attempted to explain the STD observations and to deduce the 
structure of the lectin-sugar complex by Molecular Dynamics. 





Figure 4.61. Relative STDs calculated for the three residues of the Galili epitope, taking 
the H2 proton from the α-OMe-Fuc monosaccharide as reference (right, separated in 
the red box). 
 
Figure 4.62. Proposed binding model for the interaction between the DC-SIGN CRD and 
the Galili antigen type VI. All the non-polar protons are represented as colored 
spheres. The color depends on the percentage of relative STD, being H2 α-Gal the 
reference nucleus (100%, blue). Several notorious STDs are directly indicated. The 
Val351 sidechain is also depicted as blue tight sticks. 
From the relaxation studies, the binding mediated by the Gal pyranose is 
meant to occur through hydroxyl groups at positions 3 and 4. At this point, a 
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further complication appeared related to the sugar arrangement: since no 
interaction complexes between DC-SIGN and Gal have been described from a 
molecular perspective so far, the binding pose of the Gal ring had to be 
adapted starting from another ligand. Then, the PDB 1SL5 was used again for 
this task. After modeling the trisaccharide structure with the GLYCAM online 
server, O3 Gal and O4 Gal were suitably placed to provide the coordination 
bonds with the metal ion, using the Fuc ring from LNFP III as template. In this 
arrangement, the most hydrophobic face of the pyranose ring is pointing 
towards the Val351 sidechain, in agreement with the observed STD (Figure 
4.62). Noteworthy, as the sugar symmetry is different for Gal (D-sugar), its 
orientation in this model was just the opposite to that of the L-Fuc ring 
(rotated 180º). In the inverted pose, α-Gal H1 and H2 (which provided the 
highest STD) would be placed far away from Val351, whereas α-Gal H5 (whose 
STD was negligible) would be the closest proton to the Val sidechain. 
Therefore, that binding configuration was discarded according to the available 
experimental evidences. 
 
Figure 4.63. Front and back views of the primary binding site displaying the 
intermolecular interactions established between the non-reducing Gal moiety of Galili 
and the surrounding polar amino acids (highlighted as tighter lines). Although not 
shown in this particular pose, the contact between OH4 and N365 is possible in other 
frames of the MD trajectory. The coordination bonds are not represented. 
The stability of the proposed model was eventually assessed by 200 ns of MD 
simulation. Noteworthy, the trisaccharide remained attached to the binding 
site along the entire simulation, with the non-reducing Gal establishing stable 
and fixed hydrogen bonds with several surrounding amino acids that 
coordinated the metal ion as well. A more detailed inspection revealed that 
these residues were the same as those involved in Fuc binding: E347, N349, 
E354, N365 and D367 (Figure 4.63). Besides the participation of hydroxyls OH3 




and OH4, position 6 of the terminal Gal also seemed to be fairly important for 
the hydrogen bond network, instead of OH2 as reported in Fuc. In fact, the 
presence of the OH6 group was mandatory along the simulation to target the 
polar sidechain of D367, which lay too far from OH3 and OH4. Similarly, N365 
simultaneously participated in the interaction with OH4 and, in a lesser extent, 
with OH6 as well.  
  
Figure 4.64. Ligand trajectories registered for the Galili antigen (left) and the blood 
group B (right) along 200 ns of MD simulation, represented as bundles containing 20 
representative frames. In both cases, the oligosaccharides are attached to the 
recognition site through the Gal residue (orange). Color code: blue: β-Glc; purple: β-
Gal; red: α-Fuc; orange: α-Gal. The white spheres represent the calcium ions. The 
residue Val351 is detailed in black.  
Also noting, the flexibility of the trisaccharide was considerably higher than 
that of the blood groups, especially concerning the Galα(1-3)Gal linkage. 
Consequently, the non-reducing Gal was the unique sugar residue placed at a 
relative fixed position, imposed by the two coordination bonds (Figure 4.64). 
On the contrary, the other two residues were along a wide space region, 
always away from the protein surface. Specifically, the average values for the 
φ torsions agreed again with the presence of exo-syn conformations (Figure 
4.65), although the standard deviations were above 15º, meaning that the 
most preferred φ values were distributed within a broad range of 30 degrees 
or higher. Interestingly, two populations were detected for ψ in the Galα(1-
3)Gal bond, centered around ψ = -40º (the major) and ψ = +35º (the minor). 
From the point of view of the ligand recognition, the existence of these two 
populations did not affect the binding, since no relevant vdW contacts with 
the lectin surface were provided by the central Gal moiety in any case.  




Figure 4.65. Distribution of the torsional angles φ (top graphs) and ψ (bottom graphs) 
observed for each glycosidic linkage (orange/blue, indicated on the top), extracted 
from 100000 points of the MD run. The vertical axis indicates the frequency (number of 
frames) of every angle value. 
Finally, as a complementary test, one additional MD simulation was 
performed by placing the blood group B antigen at the binding site, but in this 
case anchoring it through the non-reducing Gal pyranose.  Nicely, the 
tetrassacharide stayed at the binding site over the 200 ns of the MD run, 
thereby assessing the stability of this alternative binding mode. Certainly, the 
mobility of the ligand was reduced in comparison with the Galili epitope, as 
expected given the lower structural flexibility exhibited by the 
tetrasaccharides (Figure 4.64). However, the overall mobility was still high if 
compared to that noticed during the Fuc-mediated binding. In principle, the 
two coordination bonds with the calcium ion substantially fixed the 
orientation of the interacting Gal moiety, although the exact sugar position 
was noticed to remain rather malleable. Obviously, the presence of additional 
structural elements contacting the receptor surface, like bulky substituents 
(other sugars), is expected to limit the ligand positioning when coordinating 
the metal center. Thus, a reasonable explanation for the case of study could 
arise from the recognition roles played by the neighboring sugars: the major 
binding pose is partially defined by the arrangement of the non-reducing 
Gal/GalNAc residue, which provides stable contacts with the protein, while in 
the Gal-driven interaction model the recognition exclusively involves the sugar 
that establishes the coordination bonds. Indeed, the Fuc residue did not 




provide any relevant intermolecular interactions with the nearby protein 
sidechains.  
 In summary, the recognition of the blood groups by the DC-SIGN CRD has 
been demonstrated to chiefly take place through the α(1-2)-linked Fuc 
residue. The direct coordination at the calcium site 2 is driven by the oxygen 
atoms situated in the adjacent positions 3 and 4 of the pyranose ring.  
Additionally, the other non-reducing end (Gal/GalNAc) is also involved in van 
der Waals contacts with neighboring protein amino acids, thus conferring 
these ligands slightly improved affinities. From a dynamic point of view, the 
lectin targeting occurs in an intermediate exchange regime in the chemical 
shift time scale, differing from the corresponding monosaccharides (Fuc, Man) 
that exhibit faster koff rates. Importantly, the A antigen displays a unique 
binding mode, which is also major for the B antigen. Moreover, in the latter 
case a secondary binding mode also takes place, as evidenced by NMR. To 
highlight, the major geometry deduced herein (Figure 4.66) is consistent with 
the crucial role that Val351 plays in molecular recognition processes involving 
fucosylated structures [38,59,80]. In this particular case, both non-reducing 
sugars (Fuc and Gal) simultaneously account for the positive hydrophobic 
stabilization. 
 
Figure 4.66. Final binding model proposed for the histo blood group antigen B, 
detailing the protons that directly make contacts with the sidechain of Val351 at the 
long loop.  
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Schistosomes are parasitic helminths well known for their ability to 
manipulate the host’s immune system and establish chronic infections, and 
are responsible for 280,000 deaths annually and over 250 million infected 
people worldwide [1-2]. As many other pathogens, schistosome parasites 
present a wide plethora of complex N-glycans and O-glycans coating their cell 
surfaces, most of them fucosylated as those from mammals [3]. From a 
biological perspective, DC-SIGN has been already identified as a relevant 
receptor targeted by S. mansoni glycans during schistosomiasis [4]. However, 
the glycan profile displayed by these organisms is remarkably extensive and 
has been shown to significantly vary among male and female individuals and 
also along the different stages of the parasite development [5]. Moreover, the 
immune-modulatory properties of the soluble egg antigen (SEA) of S. mansoni 
have been mainly examined by using glycoprotein mixtures and as a result, 
the potential effects of individual glycans in immunity shaping have been 
difficult to study [6].  
 
Besides LacNAc (LN) and LeX, the SEA of S. mansoni contains a series of sugar 
antigens that are less common or inexistent in mammals, and by contrast, 
they completely lack sialic acid as terminal modification. All these distinct 
antigens share the common disaccharide scaffold LacDiNAc (LDN), which is 
barely present in vertebrates [7]. This simple motif can be then likewise 
modified by fucosyltransferases, giving rise to several mono-Fuc- and di-Fuc-
containing structures, including LDN-F, F-LDN, LDN-DF, F-LDN-F and DF-LDN 
(Figure 5.1A) [3,8]. LDNF and LeX are actually two representative epitopes well 
documented on glycoproteins and glycolipids from the three major 
schistosome species [9]. However, while the latter is easily found in both 
mammals and parasites, the presence of the former in mammal cells is very 
restricted (only found in two glycoproteins till now) [10].  Regarding the 
polyfucosylated structures, they have never been described in any other 
parasitic or mammalian host species, but are known to trigger potent antibody 
responses in humans and primates [11].  
 
Interestingly, two of the aforementioned glycans, LDNF and LDN-DF, have 
been already investigated as potential ligands of DC-SIGN. Early results 
evidenced that LDNF is as good DC-SIGN binder as LeX, whereas LDN-DF is 
strikingly poorly recognized [12]. Taking into account that the structures of 




LDNF and LeX are almost equivalent, it could be hypothesized that the 
recognition takes place in a similar way and that the presence of a N-acetyl 
group in LDNF would not affect the recognition event. However, it remains 
surprising that a di-fucosylated antigen such as LDN-DF can escape from 
detection by DC-SIGN. No structural studies had explained these observations 
yet.  
 
In this scenario, the present chapter has been focused on shedding light into 
this particular question. Thus, the molecular recognition processes of DC-SIGN 
towards these two glycan motifs has been individually analyzed by NMR, using 
the same approach followed in the previous chapter (Figure 5.1B). The results 
should be useful to establish the molecular basis on how S. mansoni parasites 





Figure 5.1. A) Common glycan structures found in Schistosoma mansoni egg proteins. 
B) Structures of the two antigens employed for molecular recognition studies. 
 
5.1. HSQC-based titrations 
The recognition of the two ligands was firstly evaluated from the receptor´s 
point of view, through the 15N-HSQC spectra. The titrations were performed 
with the TROSY pulse sequence and adding relatively high amounts of ligand, 
A) 
B) 




ranging from tens to above one hundred equivalents, thereby maximizing the 
resolution and enabling the detection of noticeable perturbations to build the 
corresponding binding isotherms (310 K).  
In particular, seven titration points were recorded for each ligand, and two 
completely different scenarios were found in each case. For the LDNF 
trisaccharide, protein saturation was almost reached around 70-80 eq of 
ligand, hence optimal CSPs could be perfectly calculated at 100 eq (Figure 5.2). 
On the contrary, the LDN-DF tetrasaccharide yielded very weak perturbations 
at the same relative concentration. Given this particular scenario, more 
titrations points were acquired for the LDN-DF by increasing its relative 
amount up to ca. 300 eq. However, even at this concentration a fully 
saturated binding curve could not be reached (Figure 5.5). These observations 
fittingly assessed the reported extremely low affinity of DC-SIGN for this 
antigen [12].  
In both cases, the set of CSPs above the standard threshold (mean + stdev.) 
were all located around the calcium site 2 (Figure 5.3), thus demonstrating the 
specificity of such interactions. Moreover, both profiles, especially that of the 
LDNF, were significantly similar to those of the blood groups (Figure 5.2), with 
minor differences. For the LDNF antigen, most of its CSPs actually resembled 
those from the B antigen, except for some interesting discrepancies. As 
highlights, perturbations measured for D367 and K368 resulted fairly larger 
than those for both blood groups. In fact, they resembled those measured for 
the Fuc monosaccharide. In addition, the pattern of long-range CSPs slightly 
changed as well: intriguingly, T314 was barely affected upon ligand binding, 
whereas it has been reported so far to be a common shifted residue by both 
Fuc- and Man-containing ligands. The same fact has been observed for G361, 
at the border of the binding site. Alternatively, the R309 residue, which is 
located at the top of the α2-helix (Figure 5.3), was definitely affected by the 
ligand in spite of being placed far away from the binding site. In contrast, for 
LDN-DF, no realistic observations could be derived from the CSP analysis in the 
same conditions (100 eq), since many residues uniformly distributed 
throughout the entire protein construct suffered from notable perturbations 
above or close to the theoretical threshold, due to the low data dispersion. 
Fortunately, some few residues eventually stood out upon adding ca. 200 eq 
more, thereby proving some specificity of the interaction, as mentioned 
above. In particular, only eight residues could be considered as affected by 
specific binding (Figure 5.3).   





Figure 5.2. Average chemical shift perturbations calculated through Eq. 8 using α = 
0.14 (See Methods). For LDNF and LDN-DF, CSPs are estimated in the presence of 100 
eq of ligand. For BgB, values are derived at 140 eq.  In all cases, the working 
temperature was 310 K. 












Blood Group B (140eq) 21.7 35.4 57.2 16 
LDNF (100eq) 20.1 27.2 47.4 15 
LDN-DF (100eq) 7.0 7.6 14.6 8* 
*Checked at 295 eq. 
Figure 5.3. A) CRD structure showing those amino acids which yielded the strongest 
CSPs (Left: LDNF. Right: LDN-DF). Red labels indicate those perturbed amino acids 
located at relatively remote positions from the binding site. Calcium ions are 
represented as white spheres. B) Statistical analysis of the collected CSPs for the two 
fucosylated ligands studied herein as compared with those previously shown for the 
blood group B (values displayed as ppm*1000). 
Regarding the binding kinetics, the crosspeak evolution observed for both 
antigens strongly suggested the existence of an intermediate exchange regime 
on the chemical shift scale. Thus, in both cases, some of the most perturbed 
peaks were observed to deeply broaden at the intermediate points of the 
titration. Then, at a certain point, these peaks were progressively becoming 
sharper again and the signal intensity was partially recovered (Figure 5.4). 
Interestingly, as observed for the A antigen, D366 was highly affected by these 
broadening phenomena and quickly disappeared in the presence of few 
equivalents of ligand. Its evolution was likewise harder to track since it only re-
appeared as a much weakened peak when protein saturation had been almost 
reached. Moreover, for LDNF, a similar effect was also noticed for F313. 
Overall, the intermediate exchange could be readily observed for the LDNF 
antigen, as coalescence effects were more acute, giving rise to the complete 








Instead, the LDN-DF displayed smoother peak broadening effects, although 
still detectable. Obviously, peak recovery could not be observed in all cases, as 
complete saturation had not been achieved yet (for instance, F313 & N349, 
Figure 5.4). 
 
Figure 5.4. Perturbations monitored for six representative amino acids. The four 
titration points represented in black, red, pink and blue correspond, respectively, to 0, 
20, 60 and 100 eq of LDNF and to 0, 50, 100 and 295 eq of LDN-DF.  





Figure 5.5. Binding isotherms built for several residues notably shifted (310 K). The 
green lines correspond to the LDNF antigen and the red lines to the LDN-DF ligand. 
Binding affinities were estimated through the equation y = A(B+x-[(B+x)2-4x]0.5), with A 
= Δδmax/2[P0] and B = [P0] + Kd. 
 
In any case, the peak trajectories were all linear and therefore, indicative of a 
simple binding event (stoichiometry 1:1) at the primary binding site. 
Analogously, the binding isotherms obtained for the LDNF trisaccharide 
showed a normal growing profile, without intermediate steps. As illustrated in 
the previous chapter, this behavior discards the existence of multiple binding 
events either at the same binding site or at different protein sites [13-14]. 
However, it is worth mentioning a particular difference between the build-up 
curves derived for LDNF and for the blood group antigens. In the latter case, 
although the intermediate exchange could be verified by the estimated off 
rate kinetic constants and the coalescence phenomena, the profiles described 
a typical exponential growing, which actually better fits with a fast exchange 
behavior. As reported [15], when the binding kinetics of a ligand becomes 
slower, its corresponding binding isotherms progressively tend to adopt a 
sigmoidal profile. Indeed, this was the case for LDNF (Figure 5.5): the most 
perturbed residues clearly displayed sigmoidal profiles at low protein-ligand 




ratios. With the global CSP data, the curve fitting was carried out by using Eq. 
10 described in Methods and the dissociation constant was estimated as an 
average of the individual values from each case. To highlight, the intense peak 
broadening precluded the use of many of the most affected amino acids which 
still yielded measurable but very irregular peaks at the intermediate titration 
points, whereby the peak centers could not be accurately determined. 
Eventually, four amino acids were suitably employed to give a feasible 
estimation of the dissociation constant, with a value around 1.0 ± 0.5 mM. 
This value is in the same range that the affinities found for the blood groups 
(Chapter 4) and for the Lewis X antigen [16]. Moreover, as can be visually 
checked in Figure 5.2, the absolute values of the CSPs measured for the LDNF 
at 100 eq were of the same order that the same values obtained for the B 
antigen at 140 eq. Therefore, a slightly higher affinity of the former (1.0 mM) 
in comparison with the latter (2.3 mM) was reasonably expected. 
 
Regarding the LDN-DF tetrasaccharide, since the absolute CSP values 
measured for this antigen were extremely low, the binding isotherms 
presented an irregular profile due to the measurement inaccuracies, even 
using the most perturbed residues for the calculations (E347 and G352, Figure 
5.5). In either case, as the CRD could not be properly saturated, the 
corresponding dissociation constant was not estimated. As a rough prediction, 
the curve fitting to the available data afforded a Kd value about 10 mM. 
Hence, the real affinity is expected to be above this value.  
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Figure 5.6. Estimation of the binding kinetics for LDNF as compared with the data 
previously estimated for the blood groups. N350 could not be used in this particular 
case, and G352 was alternatively used. The given values correspond to the same 
measuring temperature, 310 K. 
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Kd ≈ 7.1 mM 
88 2.3·104 1.7·102 94 2.5·104 1.8·102 
10eq BgB 
Kd ≈ 2.3 mM 
107 6.8·104 1.6·102 94 6.0·104 1.4·102 
20eq LDNF 
Kd ≈ 1.0 mM 
200 10.0·104 1.0·102 257 12.8·104 1.3·102 




Finally, the binding kinetics was investigated for LDNF by means of Eq. 7 
(Methods), as shown in Figure 5.6. Using the calculated dissociation constant, 
the resulting kon and koff values suggested that the slightly better affinity of this 
ligand if compared with the blood groups is essentially contributed by a larger 
on-rate. In principle, these results would attribute the LDNF trisaccharide a 
better ability to enter the binding site. Of course, the off-rate had a value in 
accordance with that expected from a system within an intermediate 
exchange regime [17]. To clarify, the coalescence point in this case took place 
around 1 mM (slightly lower than for the blood group antigens), 
corresponding to 20 eq of ligand instead of 10 eq (Figure 5.6) due to a lower 
amount of CRD used during NMR acquisition (50 μM). 
 
5.2. STD and tr-NOESY   
To explore the binding pose of the ligands, more information was gathered 
from the ligand´s point of view. In essence, this information was derived from 
STD NMR and tr-NOESY experiments. Alike to the blood groups (See Section 
4.3), the HSQC-based titrations have pointed out that the interaction of both 
ligands is basically contributed by the Fuc residue, given the strong similarities 
between the CSP patterns from the Fuc monosaccharide and its related 
oligosaccharides, including both the two blood group antigens and the two 
LDN-based antigens. However, as remainder, these observations do not 
necessarily imply that there will not be any secondary contacts established by 
the surrounding sugars. Certainly, despite the importance of such contacts, 
they are roughly or not detectable by 15N-HSQC experiments, especially 
considering the weak nature of the interactions studied herein. Indeed, the 
slight differences found between fucosylated ligands could arise from these 
secondary non-covalent bonds, but in no case precise information can be 
directly inferred on the spatial arrangement of the oligosaccharide. Instead, 
these data could be jointly deduced from STD NMR and tr-NOESY results. 
Firstly, the NMR spectra of both oligosaccharides were fully assigned through 
the same methodology employed for the blood group antigens. To note, for 
both structures the β-anomer of the reducing sugar (core GlcNAc) was fixed by 
a synthetic aglycone (n-aminopentyl chain), thus easing the identification of 
the anomeric protons (two β and one α). From this point, the spin system of 
each sugar residue was individually identified and assigned by means of their 
TOCSY patterns (Figure 5.7). The Fuc ring could be straightforwardly assigned 
due to both the characteristic chemical shift from the methyl group at C6 and 
the only α-proton located at the anomeric region. The other two patterns 




were rather similar, as both displayed their characteristic H2 protons at higher 
field in the 13C dimension, as a result of the N-acetylation. Luckily, the broad 
singlet shape commonly displayed by H4 in Gal pyranoses allowed to 
undoubtedly identifying the GalNAc moiety. In parallel, H3 from the central 
GlcNAc ring could be directly correlated with H1 Fuc in the 2D-HMBC, thereby 
confirming the proposed assignment. The remaining signals with opposite sign 
(CH2) were assigned to the methylene groups from the aglycone chain. The 
assignment of the LDN-DF tetrasaccharide was fairly trivial, considering that 
only the chemical shifts from the analogous Fuc were affected by the presence 
of the other neighboring Fuc (the terminal one now).  
 
 
     *Note: peak colors are inverted in the bottom window. 
A) 





Figure 5.7. A) 13C-HSQC full assignment of the LDNF trisaccharide. Blue: β-GlcNAc; 
orange: β-GalNAc; red: α-Fuc. As noted, the aliphatic region containing Fuc H6, the N-
acetyl groups and the aglycone methylenes is shown on the bottom. B) 2D-TOCSY 
assignment performed for the same antigen at 298 K. Each independent spin system is 
depicted in a different color and corresponds to a single sugar. 
Worth noting, the Fuc moiety α1-3-linked to the core GlcNAc presented in 
both cases an abnormally high chemical shift for H5 (4.7-4.8 ppm), ranging 
within the same values observed for anomeric protons (Figure 5.7). This is a 
particular feature of the Lewis-type antigens, which are known to adopt highly 
rigid structures in solution [18] with the non-reducing residue (often Gal or 
GalNAc) strongly stacking on top of the nearby Fuc. As a result of such an 
interaction, a “non-conventional” H-bond has been noticed to exist between 
H5 and the ring oxygen of the stacking sugar [19-20], which is responsible for 
the observed deshielding of the corresponding Fuc H5.  
Considering that the N-acetyl group from the core GlcNAc has been reported 
to be key in the recognition of Lewis-type antigens [21], the two N-acetyl 
groups were also independently identified through a 2D-NOESY spectrum in 
H2O, by means of correlating the corresponding H2 proton through the 
intermediate NH group. 
B) 




Then, the STD NMR experiments were carried out. To enable a realistic 
comparison between the data collected for the blood groups and those 
discussed herein, the same experimental setup was put in practice. Namely, 
the spectra were acquired with a consensus saturation pulse length of 2 sec. 
applied within the aliphatic region of the protein (0.76 ppm). As already 
stated, these parameters were optimal to guarantee an efficient transference 
of saturation, specially arising from the close Val351 sidechain, which can 
provide intense enough STDs without severe biasing effects arising from the 
different evolution of the saturation profile that may occur at longer 
saturation times. In addition, the recording was performed with the same 
protein:ligand ratios (1:70), using the CRD. In regard to the working 
temperature, H5 Fuc (4.7-4.8 ppm) was the most problematic nucleus. 
Expectedly, any change in the working temperature did not permit to separate 
this signal from the residual water signal (~10 mM), and eventually, the same 
temperature used for the characterization was maintained (298 K), which 
allowed the clean measuring of at least the three anomeric protons. Also, no 
water suppression was applied, but instead, the corresponding STDD spectra 
were obtained by subtracting a reference STD of the sole protein in the same 
conditions.  
A qualitative analysis of the STD effects was carried out by measuring the 
corresponding peak intensities. For LDNF, a clear set of signals could be 
distinguished, whereas for the LDN-DF only some few saturated nuclei were 
detectable. The overall results are summarized as relative STD values in Figure 
5.8. Noteworthy, the absolute STD intensities were substantially higher for 
LDNF than those described for the blood groups: specifically, the highest STD 
percentages noticed in the former case reached 6-7% of saturation, in 
comparison with the 1-2% of maximum intensity yielded by the blood group 
antigens. Interestingly, these found values were within the same order than 
those previously reported for the close LeX analogue (5-6%) [21]. In principle, a 
higher STD intensity is equivalent to a slower koff, which often correlates with 
a better affinity (lower Kd) [22]. In this regard, these observations supported 
that the difference between the koff values estimated for the blood groups and 
for the LDNF was meaningful (Figure 5.6), and hence, the koff of LDNF is 
actually lower and contributes to its improved affinity.  
Going into detail, some similarities and some discrepancies were noticed for 
the STD profile of the LDNF respect to that of the LeX trisaccharide [21]. In fact, 
the most important difference concerned the STD effects found for the 
interacting Fuc pyranose. Undoubtedly, the most affected protons by the 




transference of saturation were Fuc H1 and Fuc H2, but in this case, Fuc H1 
clearly stood out as the most perturbed nucleus. As already commented 
(Chapter 4), the scenario described for both the blood groups and the LeX 
antigen was just the opposite. Strikingly, Fuc H4 has been even reported [21] 
to yield a higher STD than Fuc H1 in LeX, which result a weird finding taking 
into account the relative arrangement of Fuc respect to Val351 when the Ca2+ 
ion is targeted through hydroxyls OH3 and OH4 (Figure 5.9B). In either case, 
the values reported herein are in accordance with the involvement of both 
protons (H1/H2) in close contacts with the Val351 sidechain.  Apart, the STDs 
from Fuc H3, H4 and the methyl group were significantly lower, as found for 
the blood groups.  
 
Figure 5.8. Comparative analysis of the relative STD intensities obtained for both 
Lewis-type antigens in the presence of the DC-SIGN CRD. For the LDNF, Fuc H1 was 
established as the reference nucleus (100% rel.STD), and for LDN-DF, Fuc H2. 
Regarding the core GlcNAc, a clear consensus between the found STD and that 
reported for LeX pointed out the closeness of the N-acetyl group to the Val351 
residue, being actually the third most saturated position behind Fuc H1 and 




H2. The remaining nuclei also received some saturation, although the relative 
percentages were notably lower as compared with that of the cited N-acetyl 
group. In the same line, a set of weak STD could be extracted from the non-
reducing GalNAc peaks, namely H2, H3, H4, H5 and the N-acetyl group (Figure 
5.9A). Even low, these STDs might be meaningful, as all of them ranged 
around 10-20% of intensity in relative terms, similar to those described for the 
terminal Gal in the blood group antigens. Thus, given that this Gal moiety 
contacted the protein surface in the blood group antigens, as demonstrated 
by tr-NOESY spectra and MD calculations, this possibility could not be 
discarded for LDNF. In fact, none of the three residues were completely 
devoid of significant STDs, suggesting that the full ligand structure was 
arranged such that the three sugars are contacting the protein surface. In 
addition, the resemblance between the STD profiles from LDNF and LeX 
strongly supported the possibility that both trisaccharides share a very close, if 









Figure 5.9. A) Assignment of the most notorious STD effects detected for each antigen 
(Top: LDNF. Bottom: LDN-DF). Blue: β-GlcNAc; black: β-GalNAc; red: α-Fuc. B) Reported 
STD values for the Le
X
 antigen in complex with the DC-SIGN CRD, obtained at four 
different saturation times applied into the aliphatic region of the receptor (0 ppm). 
Taken and adapted from Ref. [21]. 
Moving to LDN-DF, the spectrum interpretation was rather simple, as not 
many STD effects were detected even at longer saturation times (3 sec.). In 
particular, 6 peaks were only measurable (Figure 5.9A): Fucter H2, Fucter H4, 
both Fuc methyl groups and both N-acetyl groups. From the former ones, 
which were also the most perturbed nuclei, it could be reasonably thought 
that the terminal Fuc was targeting the primary binding site, since it was the 
only residue considerably affected by the saturation. In this regard, Fucter H1 
was likely to be saturated as well, but it cannot be checked out due to the 
intense overlap with the water signal. Strikingly, the distribution of the 
remaining STDs resulted particularly strange, as no clear epitopes could be 
inferred from them. At first, and considering the spectral region in which these 
groups were located, the possibility that a poorly selective saturation pulse 
was biasing the experimental observations was taken into account. However, 
a control STD of the free ligand with the same pulses totally discarded that 
option, since such a spectrum was completely empty. Therefore, the origin of 
these effects remained in principle unknown. Overall, the binding epitope of 
the LDNF antigen involves the entire trisaccharide, whereas that of the LDN-
DF tetrasaccharide suggested that only the terminal Fuc establishes direct 
contacts at the protein surface.  
In parallel, the conformation of LDNF was evaluated in the bound state by 
means of tr-NOESY experiments. Expectedly, as the molecular weight of this 
compound was ca. 655 Da, the observation of either clear positive or negative 
NOEs was unpractical at 600 MHz in the free state, as occurred to the blood 
groups. In this particular case, LDNF displayed slightly negative NOEs at 600 
B) 




MHz. The spectrum quality marginally improved by increasing the applied field 
at 800 MHz, but it was not enough for a good characterization. Instead, the 
trisaccharide was directly modeled through the GLYCAM-Web server [23-24] 
and the close interresidual distances found on it were simultaneously 
compared to those noticed in the recorded tr-NOESY and with available data 
for the LeX antigen. To clarify, experimental issues relative to low peak 
intensities hindered the utilization of the 2D-ROESY for the estimation of the 




Ref. [21]  
 Tr-NOESY 
(1:5 CRD/LDNF) 
H1Fuc-H2Glc 3.8 -  2.7-2.8 
H1Fuc-H3Glc 2.6 2.8  2.8-3.0 
H1Fuc-AcGlc 3.0 3.8  3.5-3.7 
H5Fuc-H3Glc 3.3 -  - 
H5Fuc-H4Glc 4.0 -  2.5-2.7 
H5Fuc-H2Gal 2.1 -  2.7-2.8 
H1Gal-H4Glc 2.4 2.3  - 
H1Gal-H6Glc 2.7 -  - 
 
Figure 5.10. Interprotonic distances (Ǻ) directly measured on the GLYCAM-derived 
model (left column), reported in ref. [21] (medium column), and experimentally 
estimated through Eq. 2 (Section 4.4), using a tr-NOESY acquired at 298 K with a tmix = 
200 ms and 0.2 eq of CRD (right column). The intrarresidual NOEs corresponding to Fuc 
H1-H2 and Fuc H5-H3 were employed to set two reference distances. 
 
A global analysis of the collected NOEs (Figure 5.10) led to the preliminary 
conclusion that the free conformation of the LDNF was being slightly modified 
upon lectin recognition. In general terms, the GLYCAM model predicted a very 
packed conformation in solution, with the GalNAc moiety tightly stacked on 
top of the Fuc ring. This model actually adjusted well to the aforementioned 
existence of a “non-conventional” hydrogen bond between GalNAc O5 and 
Fuc H5.  However, this conformation placed the Fuc methyl group close to 
GalNAc H2, and similarly, GalNAc H6 would lie on top of Fuc H4 (Figure 5.11). 
On the recorded spectrum, none of these two close contacts was detected. 
Analogously, the Fuc H5/GalNAc H2 NOE was observable, but the 
interprotonic distance was significantly larger than that in the GLYCAM model. 
These findings firmly pointed out that the GalNAc and Fuc moieties were not 
so “stacked” as suggested, but they were more likely to subtly separate from 
each other during ligand accommodation at the binding site. In either case, it 
is important to highlight again that these Lewis-type ligands are commonly 
fairly rigid, showing a limited conformational space [18]. As proof, the other 8 




theoretical interresidue contacts that the modeled free structure suggested 
were actually found in the bound state (Figure 5.12). Unfortunately, signal 
overlap hampered the estimation of some peak areas, and they are not 
included in Figure 5.10.   
 
 LDNF  
 φ ψ 
β-GalNAc +58.5 +0.0 
 α-Fuc +56.5 +20.1 
 
Figure 5.11. Free conformation of the LDNF antigen, as predicted by GLYCAM06. The 
dashed green lines represent the close contacts which have been experimentally 
confirmed to exist in the bound conformation as well. Conversely, the red lines with 
asterisks denote two interresidual contacts which were not found in the tr-NOESY.  The 
table below includes the corresponding dihedral angles φ and ψ observed for the two 
non-reducing moieties. 
 
In view of these results, the GLYCAM-derived model of the free LDNF was 
straightforwardly used as starting conformation for MD simulations. Both non-
reducing sugars displayed glycosidic linkages with exo-syn conformations 
(Figure 5.11), in accordance with the published data for LeX-containing 
structures either in solution or by X-Ray [18,25]. Noteworthy, the reported 
NOEs H1Fuc-H2Glc and H5Fuc-H4Glc were substantially strong and hence yielded 
internuclear distances remarkably short, as compared with those present in 
the modeled antigen. Nevertheless, these values could not be explained on 
the basis of a torsion on the Fuc-GlcNAc linkage, since the proper geometry of 
the oligosaccharide implied an opposite effect in these distances: a torsion to 




increase one distance inevitably decreased the other one even more. Then, 
these values were better attributed to simple experimental overestimations in 
the peak areas. 
 
Figure 5.12. Tr-NOESY spectrum for the LDNF antigen (1 mM ligand, 0.2 mM DC-SIGN 
CRD, in Tris buffer (D2O), tmix=200 ms), displaying the eight interresidual contacts 
detected and assigned. 
 
Previous to the MD run, the tr-NOESY spectrum was further scrutinized in 
search of direct interresidue contacts with the lectin, specifically with the 
Val351 sidechain, which was readily identifiable as explained in Chapter 4. 
Successfully, the methyl groups of Val351 were noticed by means of their 
direct correlation with Fuc H1 at 0.74 ppm, located in a clean spectral region. 
Fittingly, following such a correlation led to unequivocally find the 
intrarresidue NOE with Hα (3.43 ppm), whereas the NOE with Hβ (ca. 1.60-
1.80 ppm) was rather complicated to detect due to the extreme peak 
overlapping. Additionally, two more NOEs appeared at 0.74 ppm in the tr-
NOESY spectrum, which corresponded to Fuc H2 and the N-acetyl group from 
the core GlcNAc (Figure 5.13). Accordingly, the recognition of the Fuc moiety 
through its OH3 and OH4 groups perfectly fulfilled these observations, and 
explained reasonably well the STD values experimentally found (Figure 5.14) 
In particular, the strong STDs of Fuc H1, Fuc H2 and GlcNAc Ac were supported 
by their direct contacts with the Val351 sidechain. In addition, the weak and 
uniform STD profile found for the non-reducing GalNAc was in accordance 




with its positioning at the secondary site of the CRD defined by strands β3 and 
β4, equivalent to the arrangement seen for the analogous Gal moiety in the 
LeX trisaccharide. Under these assumptions, the free ligand geometry (Figure 
5.14) was used to carry out the corresponding MD simulations, as help to 
further evaluate the binding mode. 
 
 
Figure 5.13. In black, the tr-NOESY of the LDNF-DC-SIGN complex, and in red, the same 
experiment recorded for the free receptor (0.2 mM). As indicated, some aliphatic 
correlations appear only in the tr-NOESY which correspond to direct dipolar couplings 
with the ligand protons.  
 
Regarding LDN-DF, its low affinity unfortunately precluded the acquisition of 
the tr-NOESY spectrum, in which the ligand signals were not altered by the 
presence of DC-SIGN. This is actually indicative, as stated in the Methods 
section, that the koff is rather fast. In this regard, it is worth mentioning that 
signal recovering observed in Section 5.1. was less pronounced in the case of 
the LDN-DF titration and then it could be feasible that the broadening effects 
were arising from other unidentified phenomena, for instance non-specific 
binding, which could occur due to the exaggerate amount of equivalents 
added. Hence, the STD effects constituted the only source of information, and 
following this line, the interaction at the calcium site was in principle 
considered to take place through the external Fuc residue. Also, as already 
demonstrated by 19F-NMR, the preferential hydroxyl pair to establish this 
primary interaction is constituted by OH3 and OH4 positions. 





Figure 5.14. Preliminar binding pose proposed for the LDNF trisaccharide on the basis 
of the collected STD and tr-NOESY data. Val351 is represented in blue. The protons are 
colored according to their respective relative STD percentages, from blue (100%) to red 
(0%). Some important STDs (>20%) are directly labeled. The three transferred NOEs 
between Val351 methyl groups and the ligand are detailed as well (the protons of the 
Val351 residue are not represented to simplify the figure). 
 
5.3. Molecular Dynamics and the 3D structure of the 
complexes  
To eventually achieve a precise description of the recognition events involving 
the studied ligands and the lectin CRD, the proposed binding poses were 
subjected to MD simulations.  For both oligosaccharides, the starting 
geometry was built again by using the PDB 1SL5 [25]. For LDNF, the 
superimposition of its Fuc ring with that of the crystallized ligand led to the 
pose already described in Figure 5.14, which nicely agreed with the 
experimental observations. Conversely, the scarce and diffuse information 
derived from the LDN-DF spectra led to primarily consider more than a unique 
option. Firstly, the tetrasaccharide was modeled by employing the GLYCAM06 
force field as well. In parallel, a test experiment consisting of a 2D-NOESY at 
low temperature (281 K) was recorded to try verifying the hypothetical 




structure of the free ligand in solution. Worth mentioning, the structure of the 
LDNF trisaccharide “contained” into the LDN-DF scaffold displayed an 
equivalent arrangement in the modeled ligand. The additional Fuc pyranose 
attached to the other Fuc seemed to occupy a different region far away from 
the GlcNAc and the GalNAc residues. Fortunately, such a structure could be in 
part assessed by the 2D-NOESY, since the only NOEs found for the outer Fuc 
were those corresponding to intrarresidue contacts (Figure 5.15), being the 
unique exceptions the expected NOEs between the protons around the 
glycosidic linkage (Fucext H1 and Fucint H1, H2). Instead, the inner Fuc basically 
yielded analogous interresidue NOEs as those noticed for the LDNF scaffold. In 
this scenario, the GLYCAM-derived structure of the LDN-DF tetrasaccharide 
was analogously employed to build the starting binding pose. Fortunately, 
neither the superimposition through the inner Fuc nor the docking using the 
OH2-OH3 pair from the outer Fuc allowed to placing the ligand at the binding 
site without generating severe clashes, thereby compiling with the starting 
hypothesis in which the outer Fuc ring was supposed to interact at the binding 
site through positions OH3 and OH4 (as suggested by the relatively strong STD 
of Fucext H2). Hence, the ligand was again superimposed through the outer Fuc 
moiety using the LNFP III substrate as template. In both cases, the MD 
simulations were prolonged for 100 ns and a total of 1000 trajectory points 
were extracted for the subsequent analyses. 
 
Figure 5.15. 2D-NOESY spectrum of the free LDN-DF antigen partially assigned (T = 281 
K, buffer H2O, tmix=200 ms). Violet labels correspond to the inner Fuc, and red labels to 
the outer one. As can be noted, the outer Fuc moiety only provided two interresidual 
NOEs with the neighboring Fuc, in specific with the closest protons to the glycosidic 
linkage (H1 and H2).  




Successfully, the two oligosaccharides remained anchored to the calcium ion 
throughout the whole simulation, thus proving the stability of both 
interactions, regardless the particular affinities. However, the dynamic 
behaviors were expectedly different between them. From a general 
perspective, as observed for the blood groups, the LDNF recognition took 
place through a fairly fixed ligand conformation, which was barely affected or 
modified along the MD trajectory. Indeed, the dispersion of the φ and ψ 
torsion angles of the two glycosidic bonds involving the core GlcNAc 
corroborated the rigidity of these ligands (Figure 5.16, top). Thus, the φ angle 
for the GalNAc moiety was checked to slightly decrease by 10 degrees with 
respect to that described in solution, keeping a very low dispersed value 
around 45-50º. Conversely, the dispersion of φ for the Fuc ring was slightly 
larger (stdev. of ca. 15º), but in any case it ranged around an average value 
very similar to the angle found in the free model (56º). Equivalent 
observations were noticed for the corresponding ψ torsions.  
 
Figure 5.16. Distribution of the φ and ψ torsional angles which define each glycosidic 
bond in the studied antigens. The φ dihedral is defined from the anomeric H1 to the 
opposite carbon (H1-C1-O’-C’) and the ψ dihedral, from the anomeric C1 to the 
opposite proton (C1-O’-C’-H’). 
From a global perspective, these subtle variations gave rise to two important 
observations: firstly, the slight twist of the GalNAc glycosidic angle was 
enough to noticeably separate this residue from the stacking Fuc, provoking 
an increase in the Fuc H5–GalNAc H2 distance of ca. 1 Ǻ in average (2.8-3.0 Ǻ), 
which fitted very well with the larger internuclear distance derived from tr-
NOESY. In addition, this small change allowed the GalNAc ring to perfectly 
accommodate on the extended binding site of the DC-SIGN CRD, where other 




ligands have been already reported to interact [26-27]. Given that the Fuc ring 
was tightly attached to the metal ion through both the coordination bonds 
and the additional non-covalent bonds (H-bonds) with the surrounding 
sidechains (Figure 5.17, left), the mobility of the two glycosidic linkages 
exclusively affected the non-reducing GalNAc, which showed a more diffused 
position during the simulation. Specifically, this pyranose was observed to 
move in parallel respect to the β-strands below, establishing in all cases stable 
non-covalent interactions with three nearby protein residues: E358, S360 and 
D367 (Figure 5.18). These interactions were actually formed in two ways: 
simultaneously targeting both S360 and E358 polar groups through OH6, or 
alternatively providing three different H-bonds which in some cases were 
formed at the same time: OH6-D367 (the major one), OH4-E358, and OH3-
S360. The interplay between these different modes of interaction constantly 
occurred along the MD run, as verified by monitoring the distance from some 
surrounding amino acids to the cited ring (Figure 5.19). As remark, it was clear 
that there were always stable secondary interactions provided by this residue, 
with position 6 being especially crucial. 
 
Figure 5.17. Ligand trajectories observed along the MD simulations (left: LDNF; right: 
LDN-DF). The bundle is constituted by 20 representative frames. Color code: blue: β-
GlcNAc; purple: inner Fuc; red: outer Fuc; orange: β-GalNAc. The white spheres 
represent the calcium ions. Residues Val351 and Phe313 are detailed as black lines. 




Finally, it is also worth mentioning the close interaction with the protein 
provided by the N-acetyl group of the central GlcNAc. In agreement with the 
experimental data from STD and tr-NOESY, this acetyl group stacks on top of 
the Val351 sidechain, directly contacting at least one of the two methyl groups 
of this amino acid (~3 Ǻ, Figure 5.19). This result specially underlined the 
crucial role of such a substituent in the stabilization of the Lewis-type antigens 
when interacting with DC-SIGN, and strongly supports the negligible binding 
observed for other related lectins, as L-SIGN [28]. 
 
Figure 5.18. A) On the top row, detailed analysis of the molecular interactions (H 
bonds, dashed black lines) involving the non-reducing GalNAc moiety of the LDNF 
trisaccharide. On the bottom row, front and back views of the binding site displaying 
the molecular interactions provided by the Fuc residue. The coordination bonds are not 
represented. B) H-bond network established by the non-reducing Fuc in the LDN-DF 
complex. As noted, the residue Val351 lies fairly away from the Fuc ring.  
B) 
A) 




The scenario was totally different for LDN-DF, which certainly agreed with the 
poor ability exhibited by this ligand for DC-SIGN targeting. The glycosidic 
linkages involving the core GlcNAc marginally varied, with even less dispersion 
than those of LDNF. In deep contrast, the Fucα1-2Fuc linkage presented a 
relative higher dispersion of the angle values, especially concerning ψ (Figure 
5.16, bottom). Again, taking into account the network of coordination bonds 
and H-bonds which fixed the relative position of the interacting outer Fuc, the 
high angle variability acutely affected to the entire LDNF trisaccharide placed 
above, which displayed a considerably undefined position along the MD 
trajectory (Figure 5.17, right). In addition, the particular geometry of the 
complex inevitably led the upper trisaccharide scaffold to always stay far away 
from the protein surface. Thus, no stable contacts with the protein arising 
from these residues were noticed at all, and consequently, the interacting 
epitope was exclusively reduced to the single non-reducing Fuc (Figure 5.18). 
In essence, the few experimental data supported these results as well, since 
no other binding poses would explain the STDs from Fucext H2 and Fucext H4. 
Moreover, the affinity contributed by a single Fuc is expectedly low as well as 




Figure 5.19. Monitoring of the intermolecular distances between the proximal sugar 
residues of LDNF and some residues of the protein along the MD simulation. Top and 
middle: distance from H4GalNAc to the terminal oxygen and nitrogen of E358 and K373, 
respectively. As noted, both distances oscillate around two average values. Bottom: 
distance from the AcGlcNAc protons to both methyl groups from the V351 sidechain.  




To eventually assess the veracity of the proposed 3D models, the average 
theoretical STD values were estimated for both ligand trajectories by 
CORCEMA-ST calculations. As the particular conditions applied for the STD 
experiments were essentially equivalent as those used for the blood groups 
(saturation, concentrations of protein and ligands), the same theoretical 
parameters were taken to prepare the CORCEMA setup. As exceptions, the 
particular Kd (1 mM) and kon (10
5 M-1 s-1) constants estimated for the LDNF 
antigen from the HSQC-based titrations were applied for the analysis of this 
trisaccharide. Unfortunately, these two values remained unknown for the 
other antigen. As potential solution, the same kon rate was supposed under 
the assumption that the LDN-DF affinity was about 10 mM, considering the 
results from NMR titrations. These values would mean that the off-rate ranges 
around 103 s-1, which is equivalent to consider a fast-intermediate exchange 
regime for this ligand, partially in accordance with the deductions presented 
so far.  
 
Figure 5.20. CORCEMA-ST-derived STDs (orange) as compared with the experimental 
ones (green). The theoretical values are also expressed in relative scale (Ref. H2 Fuc in 
both cases). CORCEMA setup: Δsat: Ile, Leu, Val, Ala, Thr; tsat = 2 sec.; [P0] = 60 µM; [L0] 
= 4.2 mM; rholeak = 0.1; B0 = 600 MHz; τfree = 0.5 ns; τbound = 8.33 ns; τintra = 0.01 ns. 




The calculations were performed for 100 MD frames randomly selected in 
each case. As already stated, this amount is enough to achieve representative 
results as long as no unrealistic conformations or binding poses are 
considered. Successfully, the CORCEMA profile obtained for LDNF matched 
substantially well with the experimental STD pattern, only displaying minor 
discrepancies (Figure 5.20). Indeed, the only detail that deserves attention is 
the fact that CORCEMA-ST predicted the Fuc H2 nucleus to be the most 
affected rather than Fuc H1, as experimentally found. As already stated, such 
a prediction better fitted with the relative values reported for the blood 
groups in this work and also for the LeX antigen. Moreover, the Fuc ring always 
displays Fuc H2 closer to Val351 in the MD simulations, both for the blood 
group antigens and for the LDNF. At this point, considering this, the exact 
reason why the STD of Fuc H1 was more intense than that of Fuc H2 remained 
a mystery. In either case, the R-NOE factor was likewise good considering that 
no further optimizations were applied either to the CORCEMA parameters or 
to the MD simulations (e.g. restrictions via experimental parameters) [29-30]. 
Therefore, from an overall perspective, the proposed 3D model for the DC-
SIGN-LDNF complex can be considered as robust, since it is well justified by 
the NMR observations and further supported by computational calculations 
(Figure 5.21). 
Regarding the LDN-DF antigen, the CORCEMA profile expectedly yielded a 
poor correlation between the theoretical values and the limited experimental 
data (Figure 5.20). In fact, the latter aspect likewise limited the discussion of 
the results, as no realistic comparisons could be done given the lack of 
information derived from the extremely low ligand affinity. As highlights, the 
CORCEMA-ST interestingly predicted the saturation profile of the recognized 
Fuc to be similar to that observed for the LDNF. Also, simulations suggested a 
certain weak and uniform saturation of the GlcNAc residue, and intriguingly, a 
stronger saturation of the N-acetyl group than that observed in the acquired 
STD. Certainly, the GlcNAc moiety was observed to move around the region 
above Val351, but this movement was rather erratic and distant, and in no 
case generated close and stable contacts with the cited residue. Even 
receiving saturation as a result of this “overflying”, the direct involvement of 
this moiety in the recognition event is fairly unlikely. In conclusion, the 
proposed 3D model for the LDN-DF ligand served to explain its markedly low 
affinity, as checked out by NMR methods. However, although it can be 
considered as valid for now, the scarce information from the ligand 
perspective inevitably left the question about the molecular recognition of this 
antigen partially opened.  





Figure 5.21. Final CRD-antigen complexes proposed for the studied ligands (Left: LDNF; 
right: LDN-DF). Color code: Red: non-reducing α-Fuc. Pink: inner α-Fuc. Blue: β-GlcNAc. 
Yellow: β-GalNAc. The white spheres represent the calcium atoms. The Val351 
sidechain is detailed, as well as the hydrophobic stabilization provided by Fuc H1, Fuc 
H2 and Ac GlcNAc in the LDNF-CRD complex. 
In conclusion, the structural model for LDNF was very similar to that described 
for the LeX trisaccharide, indicating that the presence of a β4-linked GalNAc vs. 
a β4-linked Gal moiety does not substantially alter such binding. 
The terminal α1,2-linked fucoside of the LDN-DF tetrasaccharide can also bind 
into the canonical binding site of DC-SIGN but in this case, the GlcNAc and 
GalNAc residues are placed away from the protein surface preventing 
additional contacts. As a result, the binding affinity is at least an order of 
magnitude lower. Interestingly, structures such as LDN-DF and LDNF are part 
of complex oligosaccharides in which multiple copies of these epitopes can be 
presented.  Potentially, such structures can display multivalent interactions 
leading to high avidity of binding. Further biological studies with these 
antigens using multiple presentations are currently underway in the 
laboratory of Prof. G.-J. Boons at Utrecht. 
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CHAPTER 6: SHORT TERM STAY: DE NOVO 






































The following chapter gathers the results derived from the collaboration 
carried out during the short term stay (4 months) at the University of 
Southampton. With the purpose of evaluating the structural requirements 
that makes the Fuc moiety the strongest DC-SIGN binder, three derivatives 
were chosen (2F-Fuc, 3F-Fuc and 4F-Fuc) for the T2 filtered 
19F NMR 
experiments, considering that the natural interaction sugar/lectin should take 
place through hydroxyls at positions 2, 3 and/or 4. Of these three compounds, 
the 3F-Fuc was the only structure whose synthesis had been never 
accomplished before. Therefore, the goal for the stay was to afford it by 
designing an efficient de novo chemical synthesis. 
6.1. Introduction 
Chemical synthesis of fluorine-containing carbohydrates has been extensively 
reported over the last decades [1]. Nowadays, it is still an active area of 
research, with many groups working on developing new and more efficient 
strategies to overcome the usual difficulties associated with functionalizing 
sugars, mainly those regarding regio- and stereoselectivity [2]. The presence 
of multiple chiral centers and several positions with similar reactivity usually 
implies the incorporation of protective steps and the potential formation of 
many side products [3]. Most of the available published data on sugar 
fluorination covers the functionalization of the common monosaccharides: D-
glucose [4], D-galactose [5], and D-mannose [6], as well as D-pentoses [7]. 
Currently, Fuc is known to be a fundamental brick on the structure of N- and 
O-linked glycans and glycolipids present in mammalian cells [8], where it is 
commonly attached to the terminal positions, taking part of biologically 
relevant antigens such as the histo-blood groups and Lewis-type motifs [9], 
which are ligands for specific protein receptors [10-13]. Hence, the increasing 
interest on this sugar and its potential use in therapeutics has encouraged the 
synthesis of new L-fucose mimetics over the last decades, including 
fluorinated derivatives.  
2-deoxy-2-fluorofucose (2F-Fuc) was actually the first fluorinated analogue of 
this monosaccharide to be prepared, and many optimized synthetic routes 
have been proposed since then [14-18]. In parallel, fluorination at position C6 
was also described by directly reacting a protected L-Gal derivative with DAST 
[19], and later, an improved method to yield the corresponding 
trifluoromethyl derivative starting from D-lyxose was presented [20]. Both 2-
fluoro and 6,6,6-trifluoro Fuc analogues immediately gained much more 
attention for their capability to inhibit the enzymatic fucosylation of 




glycoproteins [21-23]. This particular property, in the case of the 2F-Fuc, has 
been widely investigated for the development of antitumoral therapies [24-
26] and treatments for other diseases, like the sickle cell disease (SCD) [27]. 
2F-Fuc is commercially available and very recently, a manufacturing process 
have been designed to commercialize the 6,6,6-trifluorofucose analogue as 
well [28]. Functionalization at position C4 has been attempted by different 
methods, most of them based on the previous preparation of partially 
protected L-Fuc derivatives, readily affordable given the lower reactivity of the 
axial OH-4 [29]. However, the specific introduction of a fluorine atom by 
nucleophilic substitution was not straightforward due to the poor nucleophilic 
character of the fluoride anion. Very recently, an approach based on the 
previous inversion of the 4-OH configuration of the protected L-Fuc has 
permitted the synthesis of the partially protected L-quinovose (6-deoxy-L-Glc), 
which yielded 4-deoxy-4-fluorofucose (4F-Fuc) upon treatment with DAST 
[30]. Regarding our target, 3-deoxy-3-fluorofucose (3F-Fuc), no reports were 
found. Therefore, a new synthetic route was planned based on analogous 
processes that successfully enabled the attachment of a fluorine atom at C3 in 
similar sugar scaffolds. 
6.2. Preliminary tests employing classical synthetic 
approaches 
 
Figure 6.1. Basic retrosynthetic scheme including the two synthetic strategies designed 
to get 1, starting from a cyclic scaffold with the suitable stereochemistry. 
From a general perspective, the preparation of pyranose analogues 
unprotected at O3 remains challenging. The nucleophilic aperture of epoxides 
and aziridines at positions C2 and C3 is often limited by regioselectivity 
problems, leading to mixtures of products with low overall yields [31-32]. 
Similarly, the direct SN2 substitution of leaving groups is hampered by the 
weak nucleophilicity of fluoride. This is also translated into low yields and 
complex mixtures resulting from side elimination reactions [33] and 
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substitutions driven by the proper solvent species or other neighboring 
nucleophilic groups in the scaffold [34]. Despite these drawbacks, there are 
successful examples on selective fluorination at position 3 of sugars, although 
all of them highlight the importance of thoroughly evaluating the 
stereochemistry of the specific substrate, the presence of additional reactive 
groups and the reactants and reaction conditions [35-38]. In this scenario, the 
de novo synthesis of 3-deoxy-3-fluoro-L-Fuc was planned by considering the 
simplest options mentioned above: the aperture of an epoxide moiety and the 
nucleophilic substitution of a leaving group (Figure 6.1).  
6.2.1. Substitution of a leaving group  
The direct SN2 substitution is not straightforward and entails serious 
complications to functionalize the 3F-Fuc ring at position 3, as has been 
recently exemplified by Shimabukuro et al [46] (Figure 6.2A). Although the 
introduction of a leaving group at C3 is readily affordable, the stereochemistry 
at C4 enables the existence of -trans-axial effects [47], arising from electron 
withdrawing groups placed at that position (Figure 6.2B). Even so, 
functionalization at C3 with a triflate group has been successfully carried out, 
although with many protection and deprotection steps, as shown in Figure 
6.2A. Thus, the SN2 alternative was first discarded and other less time-
consuming routes were sought. 
 
 
Figure 6.2. A) The two synthetic routes employed to afford 3-seleno-fucose derivatives 
[46]. On the top, the failed route using acetate as protecting group at position 4. On 









methoxymethyl ether group (MOM) placed at position 4. B) Schematic representation 
of the β-trans-axial effect existing in the Fuc ring as a result of the nucleophilic attack 
at position 3 (SN2 transition state). In both cases, the neighboring electron 
withdrawing group gives rise to a repulsive alignment between the fixed dipole at C4 
and the new dipole that is being formed at the adjacent carbon. The permanent dipole 
created by the presence of the acetyl group is stronger than that of the MOM, acutely 
hindering the nucleophilic displacement.    
6.2.2. Epoxide opening 
A nucleophilic attack on an epoxide always takes place in a stereospecific 
fashion, such that the final product necessarily displays the neighboring 
oxygen in an anti-type configuration. Then, for our particular case, the 
stereochemistry of the final product demands the formation of the epoxide 
exclusively at positions 2 and 3, with the oxygen atom facing to the top part of 
the ring. However, according to the already described epoxide opening for α–
methyl-L-fucopyranosides [39], the expected regioselectivity would be 
opposed to the desired one [40] (Figure 6.3).   
 
Figure 6.3. Representation of the C2-C3 epoxide stereochemistry when undergoing the 
two possible fluoride-mediated opening processes. The case depicted below, which 
leads to the final compound, shows the unfavorable transition conformation adopted, 
just before reaching the more stable 1C4 chair.   
A potential solution to overcome this drawback could be achieved using the 
same strategy in furanoses rather than in pyranoses. In fact, the regioselective 
opening of 2,3-epoxy-furanoses at C3 has been already reported starting from 
protected D-xylose [41-42] and D-arabinose [43-44] analogues to form the 
correct epoxide in few steps (Figure 6.4A). In these cases, the KHF2/NaF 
mixture was always used as nucleophilic species. Intriguingly, there is one 
reported case of an epoxide opening in a β-methyl-L-fucofuranoside scaffold 
that exclusively lead to the C2-functionalized product [45] (Figure 6.4B). As the 
nucleophile was completely different in the latter case (hydride), there were 
no evidences to ensure a priori whether the reaction would work with 
Desired product 
less favored 




fluoride. Moreover, the access to the 2,3-epoxy-L-fucofuranoside substrate 





Figure 6.4. Comparison of the described synthetic methodologies to regioselectively 
functionalize 2,3-epoxyfuranoses. A) Fluorination at position 3 achieved in two 
different pentoses [41,43]. B) Different routes to transform the D-glucofuranose into L-
furanoses functionalized at either C2 or C3 [45].  
The 3-mesylate derivative is easier to afford (route 1 in red), but the yields 
would be notably lower due to the equatorial arrangement unfavorable for 
the SN2 attack. Moreover, the final product would not display the L-Fuc 
stereochemistry and further transformations would be required. Fortunately, 
a shortcut for that problem could be envisaged, based on a stannylene-
mediated benzylation procedure recently published [48], which would permit 
to selectively prepare the protected β-L-fucofuranoside directly from 
commercial L-Fuc. The corresponding 2,3-epoxy-L-fucofuranoside could be 


































arabinose, as shown in Figure 6.5. Counting on the subsequent fluorination 
and deprotection steps, the global synthesis could be presumably addressed 
in 4-5 steps. 
 
Figure 6.5. Proposed plan to synthesize the 3-fluorofucose from commercial L-fucose in 
three main steps (formation of the protected furanose, formation of the epoxide and 
regioselective epoxide opening), combining the methodologies described in Refs. 
[42,43,48]. 
6.2.3. Results 
For the first step, the commercial mixture of α/β-Fuc was reacted with an 
excess of benzyl bromide in the presence of sub-stoichiometric amounts (0.1 
eq) of dibutyltin oxide, following the specific conditions described in Ref. [48] 
(Figure 6.6). The major product of the reaction was the monobenzylated 
sugar, as checked out by HRMS. In addition, the chemical shift of H1 (5.1 ppm) 
and its coupling with H2 (4.4 Hz) assessed that the resulting structure is the 
desired α-furanose, instead of a pyranose. Two other molecules were 
detected by NMR (ca. 15% each) that corresponded to the starting Fuc and to 
a dibenzylated molecule (at O1 and O5).    
 
Figure 6.6. Synthesis of intermediate 3. 
Unfortunately, only one peak was detected in the TLC using a variety of 
conditions, and hence the molecules could not be correctly separated. 
Moderate variations on the experimental conditions (temp., concentrations of 




BnBr and DIPEA) did not trigger significant changes in the yield of 3, and 
always similar residual amounts of both impurities were found. Alternatively, 
the classic methodology described by Gardiner and Percival [49-50] was then 
used.  This strategy relies on the isolation of the different pyranose and 
furanose anomers of a given sugar by forming their corresponding methyl 
glycosides in HCl/MeOH.  
 
Figure 6.7. Alternative synthesis of intermediate 3 as methoxide (7a) instead of benzyl 
glycoside. 
At least three products could be distinguished when accomplishing this 
reaction *50+. Only the most polar product detected by TLC was a pyranose (α 
anomer), while the other ones were fittingly the two furanoside anomers. 
However, the isolation of the desired methyl α-fucofuranoside entailed 
complications due to the very similar polarity of the three obtained 
compounds. The described conditions for the chromatography (EtOAc/MeOH 
95:5) exclusively allowed the isolation of the first eluted compound, the β-
fucofuranoside, whereas the remaining α-fucofuranoside and the pyranoside 
were always accompanied with notable amounts of the previous product. No 
other solvents or EtOAc/MeOH ratios permitted to improve this without 
significantly reducing the starting amount of reactant.  Eventually, as the 
required product eluted at an intermediate Rf between the other two, the 
mixture of fucofuranoses was isolated (α/β 20:80) and used for the 
subsequent reactions, only discarding the six-membered product (Figure 6.7). 
In principle, both furanose anomers were valid for the required 
transformations [43]. 
The second step involved the direct formation of the epoxide at positions 2 
and 3 of the fucofuranose scaffold, by using a Mitsunobu-type reaction (Figure 
6.8A). Nevertheless, new complications precluded the generation of the 
desired epoxide either starting from 3 or 7a. In the first case, the application 
of the specified conditions led to the generation of complex mixtures of 
products, whose separation was unworkable at all. Four to five fucose-related 
species were at least present in the major spot isolated from TLC, as assessed 




by NMR (Figure 6.8B). In the second case, the starting mixture of 
methoxyfuranoses better conducted to only two major products, which 
presumably corresponded to compounds derived from the β-furanoside given 
the extremely short coupling constants displayed by both anomeric protons. 
The desired α-2,3-epoxifuranoside 5b was also detected and identified by 
using H-1 as label ( 4.98 ppm) [45], although it appeared as a minor 
byproduct (ca. 10% yield). To note, the HRMS analysis showed that the 
expected loss of an oxygen atom as a result of the epoxide formation never 
took place in high yield. The chemical nature of the starting substrate could be 




Figure 6.8. A) Experimental procedures accomplished to try affording the intermediate 
2,3-epoxifucofuranose. B) 1H-1D spectrum recorded for the main component of the 
Mitsunobou reaction isolated along the flash chromatography. As noted, it consists of 









indicate some identified doublets (3J = 5-8 Hz) corresponding to independent methyl 
groups (H6) from different reaction products. 
The low yields, especially regarding the second step, and the presence of 
other undesired byproducts in large amounts led to definitely abandon this 
synthetic plan and seek for a more efficient one.  
 
6.3. The alternative route from L-galactopyranose 
In view of the unsuccessful results obtained from the classic methodologies, a 
completely new strategy was then outlined: synthesizing the 3-deoxy-3-fluoro-
L-fucose through the structural modification of a different previously 
fluorinated sugar, more accessible in terms of time and consumables. 
In particular, a detailed inspection of the stereochemistry of 3F-L-Fuc in its 
linear form allowed to designing a novel retrosynthetic route starting from 4F-
D-Gal (Figure 6.9). Certainly, the conversion of the 4F-D-Gal template into the 
3F-L-Fuc scaffold a priori involves only two modifications: the complete 
reduction of the anomeric carbon to yield the C6-methyl group and the 
oxidation of the OH6 of 4F-D-Gal, which would turn into the new anomeric 
center C1. The remaining question concerns the production of 4F-D-Gal, 
whose synthesis is actually rather simple starting from the relatively cheap 
methyl α-D-glucoside and using DAST as fluorinating agent [51]. As reviewed 
by P. J. Card [52], this synthesis only requires the previous 6-O-trityl protection 
[53]. The 4-deoxy-4-fluoro-D-Gal is then transformed into the corresponding 
cyclic thioacetal [54-55], and immediately reduced by Raney Nickel [56-58] to 
yield the linear 3F-fucitol. The last stage involves the oxidation of C6 of the D-
Gal scaffold (now C1) to generate the carbonyl group. From a general 
perspective, the final oxidation would be actually the most challenging step 
and the major source of potential complications: the multiple hydroxyl groups 
are presumably susceptible of undertaking oxidation processes (selectivity) 
and undesired epimerization events at C2 in the linear form arising from the 
basic/acidic conditions employed.  
Theoretically, the over-oxidation and epimerization problems could be 
reasonably overcome by working under mild and neutral oxidizing conditions 
(e.g. TEMPO or Dess-Martin). Even so, chemo-selectivity had to be carefully 
evaluated, since the controlled oxidation at the primary position in the 
presence of the many other hydroxyl groups strongly depends on the nature 




of the substrate and the experimental conditions [59-61]. Overall, the 
synthetic plan involves few transformations (Figure 6.10). 
 
Figure 6.9. Retrosynthetic analysis for the synthesis of 3-fluorofucose through the 




Figure 6.10. Preliminary synthetic plan to afford the desired sugar, based on the 
retrosynthesis shown above. The possible protecting steps after the formation of the 
cyclic thioacetal are not included here. 
 
6.3.1. Results 
The initial protection of the primary 6-OH group was straightforward, giving 
good yields (80-95%) of 6-OTr-α-OMe-D-glucopyranose (9) and no side 
byproducts. Worth noting, the standard conditions required to carry out this 
protection step (Figure 6.10) have been reported to be considerably inefficient 
for this particular substrate, specifically regarding the employed base, NEt3. 
Hence [53], DABCO was chosen as non-nucleophilic base, and the equivalents 




of the reacting trityl chloride (TrCl) and the cited base were suitably adjusted 
to achieve optimal yields in reasonable times (<3.5 h) (Figure 6.11).  
 
Figure 6.11. Synthesis of intermediate 9. 
The presence of the trityl group was confirmed by HRMS and the proton 
chemical shifts already described for 9 [53] allowed verifying the nature of the 
obtained product. For the fluorination step, the regioselectivity was 
thoroughly controlled by reproducing the experimental conditions previously 
described [51-52]. In this regard, it is important to highlight how the 
regioselectivity radically changes depending on multiple factors, namely the 
existing protecting groups, the type of sugar, the specific anomer, and the 
amount of fluorinating agent. Thus, the choice of the starting substrate was 
not trivial: the generation of a D-Gal scaffold fluorinated at C4 firstly 
demanded the utilization of D-Glc as starting compound, since the reaction 
entails an inversion of configuration at the affected C4 carbon. Additionally, 
the selective entrance of a fluorine atom at C4 required the previous blockage 
of the primary OH at C6, and very importantly, the exclusive utilization of the 
α-anomer (Table on Figure 6.12). As depicted below, the major drawback of 
this process was obviously its low yield, whereby higher amounts of the 
starting material would be needed to scale up the global synthesis. 
Interestingly, when the same reaction was performed in neat DAST (not 
described), it successfully conducted to the same product and the yields 
slightly improved up to 30-40%.     
The major product was checked to be monofluorinated by 19F-NMR, and the 
19F chemical shift fitted with the reported value [52]. Analogously, the 1H-NMR 
spectrum showed slight changes on the chemical shifts of the sugar protons, 
except for H4, which displayed a remarkable displacement towards lower 
fields, as well as a large geminal coupling with the adjacent fluorine (2J = 50 
Hz), thereby confirming the identity of the desired product.  
 











R = H 
Neat DAST α 60% 4 & 6 
DAST in DCM α 88% 6 
DAST in DCM β 51% 6 
R = OTr 
DAST in DCM α 23% 4 
DAST in DCM β 50% 3 
R = OPiv 
DAST in DCM α - - 
DAST in DCM β 35% 3 
 
Figure 6.12. On the top, the synthesis of methyl 4-deoxy-4-fluoro-6-O-trityl-α-D-
galactopyranoside performed in neat DAST. On the bottom, the different DAST-driven 
fluorinations that have been described [52] using methyl D-glucopyranoside as starting 
scaffold. The only conditions to selectively introduce the fluorine atom at C4 is 
highlighted in light blue.  
 
At this point, the subsequent steps involved the two transformations to obtain 
the L-Fuc scaffold, already fluorinated. The initial step consists of reacting the 
sugar in its linear form with 1,3-propanedithiol (PDT) to afford the 
corresponding cyclic dithiane at C1, which can be readily hydrogenated with 
Raney nickel. In this regard, it was assumed that the anomeric carbon should 
be free (1-OH) to enable the transient formation of the carbonyl group, which 
would eventually form the cyclic dithiane. For this purpose, the protected 4F-
Gal was peracetylated under strong acidic conditions (including C6) and then, 
the acetyl moiety at C1 was selectively removed in methanolic ammonia, 
providing the corresponding 1-OH free peracetylated fluorosugar in moderate 
yields (Figure 6.13A). However, the further reaction in the presence of PDT 
was unsuccessful.  
 
In parallel, when the same reaction was directly attempted on the starting 
methyl galactoside, the linear structure with the anomeric carbon completely 
blocked as a dithiane was actually obtained. According to previous reports, 
the conditions employed in this reaction have been demonstrated to work for 
methyl D-altropyranosides and for the corresponding free sugars [62]. It has 




been herein proven that they actually work for other methyl glycosides, 
leading to the linear substrate in a unique step. Furthermore, the acidic media 
in which the reaction takes place expectedly triggered the loss of the trityl 
group at C6, which massively precipitated as trityl alcohol (TrOH). Hence, after 
several slight corrections in the experimental protocol (removal of TrOH), 
compound 11 could be readily obtained in one-pot process (protection of C1 + 





Figure 6.13. A) Failed route to afford the required thioacetal through the free sugar. B) 
Successful synthetic route to obtain intermediate 11.   
Once completed this step, the reduction process was directly carried out on 
intermediate 11. Intriguingly, the substrate did not efficiently evolve under 
the imposed conditions even after very long times, as revealed by TLC. Also, 
the reaction was neither well promoted in the simultaneous presence of gas 
hydrogen and Raney Nickel [56], and no products different from the initial 
compound were detected either by TLC or by NMR. Intriguingly, the 1H-1D 
NMR spectrum displayed a striking intense and uniform band which spread 
over more than 1 ppm (3.2-4.6 ppm) at the region of the sugar protons (Figure 
6.14). This band suggested the existence of polymeric species that could arise 
from the nickel-catalyzed coupling of the substrate molecules. On this basis, 
the starting compound was thought to be self-reacting instead of being 
reduced, a process that could be fostered by the presence of the many free 
hydroxyl groups acting as Lewis bases. To avoid these cross-reactivity 
problems, an intermediate protection step was included, in which the linear 
scaffold was transformed into the corresponding diacetonide (Figure 6.15), 









65]. Thus, the subsequent reduction was perfectly accomplished in the sole 
presence of Raney nickel, providing a unique and fairly clean product [66]. By 
NMR, the resulting product was checked to remain protected (Ac groups 
resonating at 1.3-1.5 ppm). As mentioned, the purity was notably high since 
no other fluorinated byproducts could be detected by 19F-NMR. The identity of 
the product could be assessed both by the disappearance of the NMR peaks 
from the six-member thioacetal ring and the drastic change in the chemical 




Figure 6.14. On the top, the reduction process performed on the unprotected polyol. 
On the bottom, the 1H-1D NMR of the reaction crude isolated after the reaction. As 
observed, there is an extremely broad band at the central area, between 3 and 4 ppm. 
 
Figure 6.15. Two-step reduction of C1 from thioacetal to methyl group.  
Before the final oxidation of the opposite carbon (C6), the intermediate 11b 
was easily hydrolyzed into the pure 3-deoxy-3-fluoro-L-fucitol 12 [67-68] 




(Figure 6.16). Different options were considered to selectively oxidate the 
primary position of the unprotected substrate under mild conditions [69-70], 
including not only TEMPO-mediated processes [71-73], but also other 
alternatives as the Dess-Martin periodinane (DMP) [74]. Unfortunately, none 
of these options gave positive results. The oxidation mediated by 
TEMPO/NaOCl [72] led in most of cases to the recovery of the starting fucitol 
and to a mixture of unidentified compounds. Analogously, although the 
reaction progressed in the presence of either TEMPO/TCCA [71] or DMP [74] 
and the final sugar (1) could be actually detected, it only appeared as a minor 
compound in a complex mixture (Figure 6.17).    
 
Figure 6.16. Full deprotection of diacetonide 11b. 
 
 
Figure 6.17. Major products isolated from the treatment of compound 12 with DMP (in 
pyridine and DCM, 0ºC, 3-4 hours). The 19F-{1H}-NMR showed a major peak at -208.6 




H}-NMR and the 2D-COSY suggested the loss of a 
carbon atom, later confirmed by HRMS. The resulting product was probably the 
carboxylic acid (peak at 171 ppm from a carbonyl group) obtained by oxidative 
cleavage of the C1-C2 bond, as supported by the lack of correlations from the 
fluorinated carbon. 




As a potential solution to reduce the possible over-oxidation problems, partial 
deprotection of diacetonide 11b was attempted [75]. However, the classic 
acidic hydrolysis using AcOH did not result effective [76-77], since it led to the 
complete deprotection of the diacetonide intermediate, providing compound 
12 as well. Other alternatives based on catalysis with a Lewis acid (CuCl2) [78] 
utterly failed and yielded the starting substrate.  
At this point, it was decided to investigate an enzymatic oxidation protocol 
instead of carrying on the quest for a different protecting group strategy. In 
this regard, the Galactose Oxidase (GOase) enzyme was evaluated as a 
feasible alternative. While GOase itself is strictly limited to oxidizing the C6 
hydroxyl of non-reducing galactosides and a small number of aromatic 
primary alcohols, previous engineering efforts have greatly expanded its 
substrate scope to a large number of primary and secondary alcohols [79-80]. 
To note, this enzymatic alcohol oxidation protocol generates H2O2, whereby 
the activity of several GOase variants could be tested by monitoring the H2O2 
production through a colorimetric assay using Horse Radish Peroxidase (HRP) 
[81]. This same enzyme was also needed for GOase activation. After several 
tests, the F2 variant [82] was noticed to show a high activity (100 fold higher 
than other tested variants), successfully driving the conversion of 3-deoxy-3-
fluoro-L-fucitol into 3F-Fuc (1) in good yield on mmol scale (Figure 6.18), in the 
presence of HRP and catalase. In view of these results, the process can be 
further scaled up.  
 
Figure 6.18. Enzymatic synthesis of 3F-Fuc directly from 3F-L-fucitol 12. 
Compound 1 was found to exist as a 1:2 mixture of anomers by 19F-NMR in 
favor of the -anomer (in D2O), which is essentially the same ratio observed 
for non-fluorinated Fuc [83]. A basic analysis of the coupling constants (Figure 
6.19) indicated that both anomers exist in the expected 1C4 conformation: the 
3JH1-H2 value was large for the -anomer and small for the -anomer, and both 
showed a large 3JH2-H3 (axial H2 and H3). The equatorial position of the fluorine 
was confirmed by the relatively small 3JF-H4 value. 
 








H-NMR analysis of the final 3F-Fuc in D2O. Full assignment in Figure 6.20.  
In summary, the first synthesis of 3-deoxy-3-fluoro-L-fucose has been 
achieved by using a D- to L-sugar conversion strategy, in 7 steps starting from 
a cheap D-glucose starting material. This strategy allowed dispensing with the 
common fluorination scheme based in an alcohol inversion step prior to the 














6.4. Experimental part  
 
 Synthesis of compound 9: 
 
The starting methyl D-glucopyranoside (20 g, 103 mmol) was firstly mixed with 
DABCO (2 eq) in 400 mL of DCM, and stirred for 20-30 min under inert 
atmosphere at 30 ºC until it became a homogeneous suspension containing 
both solid components. Then, the TrCl (2 eq) was added and the reaction was 
allowed to progress overnight (~12-16 hours). The final product was isolated 
as a pure white solid by flash chromatography using Acetone/Pet. Ether 6:4 as 
eluent (Rf = 0.32). 
1H NMR (500 MHz, CDCl3): δ = 7.47-7.45 (m, 5H, Ar), 7.32-7.24 (m, 10H, Ar), 
4.77 (d, J = 3.8 Hz, 1 H, H1), 3.70-3.64 (m, 2H, H3 and H5), 3.55-3.50 (m, 2H, H2 
and H4), 3.43 (s, 3H, OCH3), 3.41 (dd, J = 10.1, 4.3 Hz, 1H, H6a), 3.37 (dd, J = 
10.1, 5.0 Hz, 1H, H6b), 2.56 (d, J = 2.6 Hz, 1H, OH) ppm. 
13C NMR (125 MHz, CDCl3): δ = 143.7, 128.6, 128.0, 127.9, 127.9, 127.2 (Ph), 
99.1 (C1), 87.1 [C(Ph)3], 74.8 (C3), 72.3 (C2), 71.9 (C4), 69.8 (C5), 64.0 (C6), 
55.3 (OCH3) ppm. 











 Synthesis of compound 10: 
 
Compound 9 (25 g, 57.3 mmol) was slowly added to a flask containing 69 mL 
of DAST (9 eq) while cooling down the system below 0 ºC. The reaction flask 
was sealed and the reaction was allowed to progress under argon atmosphere 
for at least 48 hours (until no further significant changes were noticed by TLC). 
Once finished, the reaction crude was quenched by firstly diluting the 
remaining DAST with DCM (140 mL), and subsequently neutralizing it with 
MeOH (60-70 mL). Then, water was also added and the crude was firstly 
extracted with sat. NaHCO3, neutralized with HCl and washed. The resulting 
syrup was eventually purified by flash chromatography (DCM/Acetone 85:15), 
which yielded a white solid as the final product (Rf = 0.40) 
1H NMR (500 MHz, CDCl3): δ = 7.45-7.43 (m, 5H, Ar), 7.32-7.22 (m, 10H, Ar), 
4.92 (dd, J = 50.4, 2.3 Hz, 1H, H4), 4.80 (d, J = 3.2 Hz, 1H, H1), 3.81-3.74 (m, 2H, 
H3 and H2), 3.75 (dt, J = 30.2, 6.6 Hz, 1H, H5), 3.41 (s, 3H, OCH3), 3.39 (ddd, J = 
9.5, 6.2, 0.9 Hz, 1H, H6a), 3.36 (dd, J = 9.4, 7.0 Hz, 1H, H6b), 2.28 (dd, J = 6.0, 1.0 
Hz, 1H, OH), 2.02 (d, J = 9.0 Hz, 1H, OH) ppm. 
13C NMR (125 MHz, CDCl3): δ = 143.8, 128.7, 128.0, 127.3 (Ph), 99.3 (C1), 90.1, 
88.6 (J = 181.3 Hz, C2), 87.2 [C(Ph)3], 70.5, 70.3 (J = 17.5 Hz, C3), 70.1, 70.0 (J = 
2.2 Hz, C2), 68.8, 68.6 (J = 18.6 Hz, C5), 61.7 (C6), 55.7 (OCH3) ppm. 
19F NMR (472 MHz, CDCl3): δ = -221.1 (F4) ppm. 









 Synthesis of compound 11: 
 
Compound 10 (6.31 g, 14.4 mmol) was dissolved in 20 mL of CH3Cl and 20 mL 
of conc. HCl. Under vigorous stirring, 2.5 mL of PDT (1.5 eq) were dropwise 
added and the reaction was allowed to progress at room temperature for 20 
hours. Afterwards, the crude was neutralized by adding saturated NaHCO3 and 
cooled down to promote the precipitation of the generated TrOH. The cited 
byproduct was filtered off and the crude was dried out and re-suspended in 
DCM before the flash column. The desired thioacetal was isolated as yellowish 
oil by using DCM/MeOH 95:5 as eluent (Rf = 0.28).    
1H NMR (500 MHz, MeOD): δ = 4.62 (ddd, J = 46.1, 9.5, 1.2 Hz, 1H, H4), 4.40 
(ddd, J = 9.5, 3.7, 0.9 Hz, 1H, H3), 4.15 (d, J = 9.8 Hz, 1H, H1), 3.99-3.90 (m, 2H, 
H2 and H5), 3.66 (d, J = 6.8 Hz, 2H, H6), 2.97-2.87 (m, 2H, CH2-S), 2.78-2.72 (m, 
2H, CH2-S), 2.09-2.02 (m, 1H, CH2-C), 1.96-1.88 (m, 1H, CH2-C) ppm. 
13C NMR (125 MHz, MeOD): δ = 92.1, 90.7 (J = 176.3 Hz, C4), 70.8, 70.7 (J = 
18.2 Hz, C5), 70.7, 70.7 (J = 2.7 Hz, C2), 67.8, 67.6 (J = 26.3 Hz, C3), 63.6, 63.5 (J 
= 5.7 Hz, C6), 49.0 (C1), 28.8 (CH2-S), 28.5 (CH2-S), 27.0 (CH2-C) ppm. 
19F NMR (472 MHz, MeOD): δ = -213.3 (F4) ppm. 












 Synthesis of compound 11a: 
 
The starting molecule 11 (2.36 g, 8.67 mmol), Na2SO4 (cat.) and p-TsOH (cat.) 
were directly dissolved in 35 mL of acetone, and finally 2 mL of 2-
methoxypropene (2 eq) were added before sealing the flask. The working 
mixture was then stirred overnight (16-20 hours) at room temperature under 
argon atmosphere, until the reaction was completed. The resulting crude was 
firstly quenched with solid K2CO3, filtered and resuspended in Pet. 
Ether/EtOAc 9:1. Using the same system as eluent, the final diacetonide was 
isolated by flash chromatography as yellow oil (Rf = 0.24).  
1H NMR (500 MHz, CDCl3): δ = 4.46 (dd, J = 6.1, 3.7 Hz, 1H, H2), 4.44-4.32 (m, 
1H, H4*), 4.36-4.31 (m, 1H, H3), 4.31 (dtd, J = 24.2, 6.8, 3.8 Hz, 1H, H5), 4.15 (d, 
J = 3.6 Hz, 1H, H1), 4.10 (td, J = 8.5, 6.8 Hz, 1H, H6a), 3.96 (dd, J = 8.5, 6.8 Hz, 
1H, H6b), 3.05-2.99 (m, 2H, CH2-S), 2.83-2.73 (m, 2H, CH2-S), 2.12-2.05 (m, 1H, 
CH2-C), 2.03-1.95 (m, 1H, CH2-C), 1.49 (d, J = 0.6 Hz, 3H, MeA), 1.43 (s, 3H, 
MeB), 1.39 (d, J = 0.6 Hz, 3H, MeA), 1.39 (d, J = 0.6 Hz, 3H, MeB) ppm. 
13C NMR (125 MHz, CDCl3): δ = 111.4 (CA), 110.1 (CB), 93.3, 91.8 (J = 181.6 Hz, 
C4), 83.1 (C2), 76.6, 76.4 (J = 27.8 Hz, C3), 75.2, 75.1 (J = 16.9 Hz, C5), 65.2, 
65.1 (J = 7.0 Hz, C6), 47.7 (C1), 29.6 (CH2-S), 29.1 (CH2-S), 27.4 (MeA), 27.4 
(MeA), 26.2 (MeB), 25.9 (CH2-C), 25.8 (MeB) ppm.  
19F NMR (472 MHz, CDCl3): δ = -204.5 (F4) ppm. 
*The 2JH4-F4 could be determined in the 
13C-HSQC: 48.3 Hz. 
HRMS (ESI+) (m/z): [M+H+] calcd. for C15H25FO4S2, 353.1279; found 353.3824. 
 
 




 Synthesis of compound 11b: 
 
Compound 11a (5.40 g, 15.34 mmol) was firstly dissolved in a suspension of 
Raney Ni in EtOH (135 mL). The starting mixture was diluted with additional 
210 mL of EtOH and heated at reflux (80 ºC) under continuous stirring. The 
reaction was checked to be moderately completed after 2-3 hours, whereby 
the reaction times were further raised to 16-24 hours to maximize the yields. 
The obtained crude was then filtered through 2-3 cm of celite to retain the 
Raney Ni, and washed in the same filter with DCM, EtOH (three times) and 
finally DCM/MeOH (1:1). The reduced compound 11b could be 
straightforwardly purified by flash chromatography, using DCM/MeOH 95:5 as 
eluent (Rf = 0.32). The product was a colorless liquid with high purity. 
1H NMR (500 MHz, CDCl3): δ = 4.36-4.24 (m, 2H, H4* and H5*), 4.17 (qd, J = 
6.0, 0.8 Hz, 1H, H2), 4.09 (ddd, J = 8.5, 6.7, 1.3 Hz, 1H, H6a), 3.94 (dd, J = 8.5, 6.7 
Hz, 1H, H6b), 3.73 (td, J = 7.6, 5.6 Hz, 1H, H3), 1.43 (s, 3H, MeB), 1.42 (d, J = 0.5 
Hz, 3H, MeA), 1.39 (d, J = 0.5 Hz, 3H, MeB), 1.38 (dd, J = 6.1, 0.9 Hz, 3H, H1), 
1.36 (d, J = 0.5 Hz, 3H, MeA) ppm. 
13C NMR (125 MHz, CDCl3): δ = 109.9 (CB), 109.3 (CA), 93.6, 92.1 (J = 181.5 Hz, 
C4), 79.4, 79.2 (J = 31.3 Hz, C3), 76.2 (C2), 75.3, 75.2 (J = 17.8 Hz, C5), 65.1, 
65.0 (J = 6.6 Hz, C6), 27.4 (MeA), 26.7 (MeA), 26.1 (MeB), 25.6 (MeB), 18.8, 18.8 
(J = 2.2 Hz, C1) ppm. 
19F NMR (472 MHz, CDCl3): δ = -205.4 (F4) ppm. 
* 2JH4-F4 = 46.1 Hz; 
2JH5-F4 = 24.7 Hz. Determined in the 
13C-HSQC. 








 Synthesis of compound 12: 
 
The diacetonide 11b (0.51 g, 2.06 mmol) was dissolved in 12.2 mL of a 
THF/H2O 1:1 solution. Under gentle stirring, 12.1 mL of glacial AcOH (> 50 eq) 
were added and the resulting mixture was then heated overnight at reflux (80 
ºC). The final crude could be readily concentrated and columned on silica. 
DCM/MeOH 9:1 was used to elute compound 12 (Rf = 0.26) with high purity as 
a white solid. 
1H NMR (500 MHz, MeOD): δ = 4.54 (ddd, J = 46.1, 9.1, 1.1 Hz, 1H, H4), 4.00-
3.89 (m, 2H, H2 and H5), 3.67 (dd, J = 4.5, 1.9 Hz, 1H, H3), 3.65 (d, J = 6.8 Hz, 2H, 
H6), 1.25 (d, J = 6.7 Hz, 3H, H1) ppm. 
13C NMR (125 MHz, MeOD): δ = 92.4, 91.0 (J = 175.7 Hz, C4), 72.5, 72.3 (J = 
25.7 Hz, C3), 71.3, 71.2 (J = 18.1 Hz, C5), 67.0, 67.0 (J = 2.6 Hz, C2), 63.7, 63.6 (J 
= 5.7 Hz, C6), 20.0 (C1) ppm. 
19F NMR (472 MHz, MeOD): δ = -212.7 (F4) ppm. 














 Characterization of compound 1: 
1H NMR (600 MHz, D2O): δ = 5.17 (t, J = 4.6 Hz, 1H, H1α), 4.69 (ddd, J = 49.2, 
10.5, 3.1 Hz, 1H, H3α), 4.51 (d, J = 8.1 Hz, 1H, H1β), 4.49 (ddd, J = 48.3, 9.7, 3.6 
Hz, 1H, H3β), 4.15 (q, J = 6.7 H , 1H, H5α), 4.01 (dd, J = 7.3, 3.5 H , 1H, H4α), 
3.95 (ddd, J = 14.4, 10.3, 4.1 Hz, 1H, H2α), 3.94 (dd, J = 6.3, 3.5 H , 1H, H4β), 
3.73 (t, J = 6.5 Hz, 1H, H5β), 3.64 (ddd, J = 8.1 H , 1H, H2β), 1.19 (d, J = 6.5 H , 
3H, H6β), 1.15 (d, J = 6.7 H , 3H, H6α) ppm. 
19F NMR (498 MHz, D2O): δ = -198.5 (F3β), -202.3 (F3α) ppm. 
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The following conclusions can be drawn from the work presented in this 
Thesis: 
 The interaction between DC-SIGN and the blood groups A and B is 
essentially driven by the Fuc moiety. By HSQC-titrations, this 
recognition event has been demonstrated to take place in a specific 
fashion at the primary binding site (Calcium site 2). 
 Both oligosaccharides preserve their respective conformations in the 
free state upon lectin binding, as assessed by tr-NOESY experiments. 
These observations agree with the known rigidity already reported for 
this type of structures. Only minor variations in the glycosidic torsion 
angles could be detected by MD for the terminal Gal/GalNAc, 
although they are simply derived from a suitable ring accommodation 
to the protein surroundings.  
 The stability of the CRD is modified as a result of calcium targeting by 
an entering ligand. Specifically, the long loop region that takes part in 
the structural integrity of the binding site gains stability, as proven by 
HSQC and, indirectly, by DOSY experiments. In addition, the detected 
conformational changes at the protein backbone are exclusively 
triggered by the primary sugar interaction. In fact, the set of affected 
amino acids is similar for every specific ligand, but the magnitude of 
the chemical shift perturbations varies only depending on whether the 
primary sugar is Man or Fuc. 
 The non-reducing end (Gal/GalNAc) establishes close contacts with 
the protein during the interaction, as evidenced by STD NMR 
experiments. These contacts favorably contribute to the affinity. 
According to the performed MD simulations, they basically consist of 
hydrogen bonds involving several hydroxyl groups (OH3, OH4 and 
OH6) and more importantly, the hydrophobic shield jointly formed by 
both non-reducing moieties (Fuc and Gal/GalNAc) around the aliphatic 
residue Val351. These findings are in accordance with the crucial role 
that Val351 plays in the recognition of Fuc-containing glycans and 
could be confirmed by the intermolecular contacts detected in the tr-
NOESY. 
 Although the binding epitope is the same for both blood antigens, 
they clearly differ in their dynamic behavior. In particular, the blood 





existence of an additional binding mode, as evidenced by HSQC-
based titrations. 
 Gal is also a specific substrate for DC-SIGN, although its affinity is 
rather low. By using 19F-NMR, Gal has been shown to exclusively 
interact at the primary binding site through hydroxyl groups OH3 and 
OH4. Surprisingly, the same conclusion has been reached for Fuc, 
which cannot be recognized through the OH2-OH3 pair, as reported 
for langerin or MBL. In this scenario, the secondary binding mode of 
the B antigen that better fulfills the aforementioned observations is 
that in which the saccharide is alternatively anchored to the calcium 
site through OH3 and OH4 of the terminal Gal. Studies carried out in 
parallel with the Galili antigen and MD simulations corroborate these 
findings. 
 Regarding the Lewis-type antigens also studied herein, the LDNF 
trisaccharide is placed at the binding site in the same way as already 
described for the LeX antigen. In fact, the same secondary contacts 
with the protein surface are also found for our antigen, namely the 
accommodation of the GalNAc moiety at the adjacent shallow site and 
the aliphatic contact between the Fuc moiety and Val351, which in 
this case is also assisted by the N-acetyl group of the core GlcNAc, as 
evidenced by STD-NMR and tr-NOESY. The MD simulations actually 
highlight the importance of such a hydrophobic stabilization mediated 
by the central residue. 
 In contrast, the LDN-DF displays a negligible binding, rather difficult to 
detect either by HSQC-based titrations and STD-NMR. Consequently, 
the binding mode has not been entirely delineated, although the MD 
simulations strongly suggest that the recognition is exclusively driven 
by the external Fuc, while the surrounding sugars (the LDNF portion) 
is placed away from the protein surface. This is supported by the 
observed low affinities, above 10 mM.   
 The first synthesis of 3-deoxy-3-fluoro-L-Fuc has been achieved by 
using a D- to L-sugar conversion strategy, in 7 steps starting from a 
cheap commercial D-Glc material. Thestrategy was based in an alcohol 
inversion step prior to the deoxyfluorination operation, in contrast to 
the classical methodology that uses straight SN2 fluorination in a 
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